syndrome	score	normalized_score
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	2.010735944	100.0
CRANIO-CERVICAL DYSTONIA WITH LARYNGEAL AND UPPER-LIMB INVOLVEMENT	1.1455937999999999	56.973855936600295
SPINOCEREBELLAR ATAXIA TYPE 20	1.1227388999999999	55.837212407239875
NETHERTON SYNDROME; NETH	1.0719741539999998	53.3125275448898
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	1.0714286	53.28539548900609
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0232558	50.889615966401614
HYPERLIPOPROTEINEMIA, TYPE I	1.0232558	50.889615966401614
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	1.0172660199999999	50.59172603123267
TRICARBOXYLIC ACID CYCLE, DEFECT OF	1.0172414	50.59050160392419
HEPARIN-INDUCED THROMBOCYTOPENIA	1.0136986	50.414307409426804
SENGERS SYNDROME	1.00684932	50.073671931136474
INFANTILE DYSTONIA-PARKINSONISM	1.002714754	49.86804741776677
OCULOSKELETODENTAL SYNDROME; OCSKD	1.000545554	49.76016651940848
EHLERS-DANLOS SYNDROME, TYPE I	1.0	49.73303446352477
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.0	49.73303446352477
MULTIPLE MYELOMA	1.0	49.73303446352477
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.933333	46.41748225494496
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.667212554	33.182504942578376
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.5954755	29.614803563684646
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.5954755	29.614803563684646
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.594593804	29.57095414613029
BIOTINIDASE DEFICIENCY	0.583878554	29.038052248595008
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.5555556	27.629465801204184
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.554992024	27.601437456573365
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.546756484	27.191859061927627
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.5448995000000001	27.09950561265742
TREMOR, HEREDITARY ESSENTIAL, 5; ETM5	0.5324612000000001	26.480911210089758
SPINOCEREBELLAR ATAXIA TYPE 42	0.5184698999999999	25.785081405000238
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.516413354	25.682803131906418
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.516030184	25.663746925091026
PITT-HOPKINS-LIKE SYNDROME	0.51109745	25.418427095069624
XYLT1-CDG	0.50075643	24.904136791021628
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.50075643	24.904136791021628
%109160 AZOTEMIA, FAMILIAL	0.5	24.866517231762383
BARTH SYNDROME; BTHS	0.5	24.866517231762383
GLYCINE ENCEPHALOPATHY	0.5	24.866517231762383
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.5	24.866517231762383
CHYLOMICRON RETENTION DISEASE	0.5	24.866517231762383
SECONDARY SHORT BOWEL SYNDROME	0.5	24.866517231762383
RENAL TUBULAR ACIDOSIS III	0.5	24.866517231762383
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.5	24.866517231762383
BRANCHIOOTORENAL SYNDROME 1	0.5	24.866517231762383
CALCIPHYLAXIS	0.5	24.866517231762383
POEMS SYNDROME	0.5	24.866517231762383
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.4787875	23.81155523820486
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.461841344	22.968771477832597
CHRONIC ACTINIC DERMATITIS	0.4047616	20.130022602311428
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.384083824	19.10165405587438
GLUTATHIONE SYNTHETASE DEFICIENCY	0.37914580000000003	18.85607113810067
PLACENTAL INSUFFICIENCY	0.3768113	18.73996936914557
SPINOCEREBELLAR ATAXIA TYPE 12	0.36579419999999996	18.19205555515747
POSTENCEPHALITIC PARKINSONISM	0.3619044	17.998603997701252
ACUTE ADRENAL INSUFFICIENCY	0.35369827	17.590488251599087
INSULINOMA	0.35264303	17.5380079643118
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.348584754	17.336177584141303
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.3480389	17.309030608347246
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.345506454	17.183084384152238
GLUTATHIONE SYNTHETASE DEFICIENCY	0.3449609	17.155952328268523
ADDISON DISEASE	0.33999967	16.90921530569705
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.338422864	16.830795958556756
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.337927134	16.80614180138215
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.33791923	16.805748711477754
ACITRETIN/ETRETINATE EMBRYOPATHY	0.33777946999999997	16.79879802258113
EPIDERMAL NEVUS SYNDROME	0.337568594	16.7883105192056
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.33680418399999995	16.750294090331337
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.3355022	16.685542475188377
DISTAL MONOSOMY 12Q	0.33463498399999997	16.642413191973056
DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS	0.333333	16.5776615768301
CANAVAN DISEASE	0.333333	16.5776615768301
NEUROMYELITIS OPTICA	0.333333	16.5776615768301
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.333333	16.5776615768301
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE III; CDG3	0.333333	16.5776615768301
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.333333	16.5776615768301
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.333333	16.5776615768301
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.333333	16.5776615768301
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.333333	16.5776615768301
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	16.5776615768301
CYSTINOSIS, NEPHROPATHIC; CTNS	0.333333	16.5776615768301
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.333333	16.5776615768301
PSEUDOHYPOALDOSTERONISM, TYPE II	0.333333	16.5776615768301
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.32152769999999997	15.990548185077852
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.319381454	15.88380885879265
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.31691903400000004	15.76134524006898
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.3055556	15.196207185322988
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.30000000000000004	14.919910339057433
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.2954755	14.694893224627211
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.29239448000000007	14.541664750784406
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.28678662	14.26276885613778
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.285028354	14.175324952563736
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.2822581	14.037551814909023
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.27815542000000004	13.833513089076208
INSULIN AUTOIMMUNE SYNDROME	0.27777799999999997	13.81474284720898
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.275315754	13.692287882033307
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.273801354	13.616972174641745
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.26716978399999997	13.287164075284466
CITRULLINEMIA TYPE II	0.264082984	13.13364814450246
HSD10 DISEASE	0.25473841399999997	12.668914322645639
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.25347118399999996	12.605891129382426
AL KAISSI SYNDROME; ALKAS	0.251301984	12.498010231024148
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.25114939999999997	12.490421765693565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.250545554	12.460390671764905
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.250545554	12.460390671764905
HEMOPHILIA B	0.25	12.433258615881192
SEVERE HEMOPHILIA A	0.25	12.433258615881192
HYPERPARATHYROIDISM 2	0.25	12.433258615881192
CONGENITAL FACTOR II DEFICIENCY	0.25	12.433258615881192
LACTIC ACIDOSIS, CHRONIC ADULT FORM	0.25	12.433258615881192
DYSTONIA 6, TORSION	0.25	12.433258615881192
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	12.433258615881192
SPINOCEREBELLAR ATAXIA TYPE 18	0.24545450000000002	12.207197107727241
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.24545450000000002	12.207197107727241
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.22859747	11.368845853784569
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.2285714	11.367549313576106
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.22272730000000002	11.076904486867821
TRICHOTHIODYSTROPHY	0.222363844	11.058828717093846
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.22222199999999998	11.051774384553399
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.22010343000000002	10.946411469730013
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.216667	10.77550737810852
ANGELMAN SYNDROME	0.21664233400000002	10.774280663080445
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.21586780000000003	10.735760736965274
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.21526794999999999	10.705928376242326
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.214172374	10.651442057276915
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.212929884	10.58964925928633
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.20740741000000001	10.314999869520411
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.207394874	10.314376416200377
SPINOCEREBELLAR ATAXIA TYPE 13	0.20423559400000002	10.157255835080454
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.20419286	10.155130543585688
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.20347118400000003	10.11923940620619
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.20054555400000001	9.973738948588668
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.20054555400000001	9.973738948588668
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.20054555400000001	9.973738948588668
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	9.946606892704954
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	9.946606892704954
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.2	9.946606892704954
SHOX-RELATED SHORT STATURE	0.2	9.946606892704954
BETA-THALASSEMIA	0.2	9.946606892704954
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.2	9.946606892704954
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	9.946606892704954
JUVENILE HYALINE FIBROMATOSIS	0.2	9.946606892704954
6P22 MICRODELETION SYNDROME	0.2	9.946606892704954
BENIGN SCHWANNOMA	0.2	9.946606892704954
MALARIA	0.2	9.946606892704954
MEDULLARY SPONGE KIDNEY	0.2	9.946606892704954
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.2	9.946606892704954
ALPHA-METHYLACETOACETIC ACIDURIA	0.2	9.946606892704954
ROMANO-WARD SYNDROME	0.2	9.946606892704954
INFANTILE MYOFIBROMATOSIS	0.2	9.946606892704954
POLYARTERITIS NODOSA	0.2	9.946606892704954
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.18398889	9.150325807275667
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.18329603	9.11586777701727
HEREDITARY FRUCTOSE INTOLERANCE	0.1770837	8.806909755028482
MUCOLIPIDOSIS TYPE II	0.17407441	8.657248631747741
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.171000434	8.504370477399693
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.16783220000000001	8.346804586689183
PGM3-CDG	0.16678534	8.294741062230695
DERMATOLEUKODYSTROPHY	0.166667	8.288855654932282
PROPROTEIN CONVERTASE 1/3 DEFICIENCY	0.166667	8.288855654932282
CEREBROOCULONASAL SYNDROME	0.166667	8.288855654932282
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	8.288855654932282
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.16583513	8.24748423555311
SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.16233770000000003	8.073546428829346
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.161651754	8.039432252771228
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.15796865400000001	7.856260513538619
DE BARSY SYNDROME	0.157101154	7.813117106141511
WRINKLY SKIN SYNDROME	0.157101154	7.813117106141511
SPINOCEREBELLAR ATAXIA TYPE 28	0.1565655	7.786477407298986
SPINOCEREBELLAR ATAXIA TYPE 15/16	0.1565655	7.786477407298986
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.15591140000000003	7.753947029456397
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.1487204	7.396316778629189
EHLERS-DANLOS SYNDROME, TYPE VI	0.14664487999999998	7.293094870939452
GITELMAN SYNDROME	0.14545450000000001	7.233893661374764
CONGENITAL FACTOR XIII DEFICIENCY	0.14285699999999998	7.104712104355756
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.14285699999999998	7.104712104355756
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.14285699999999998	7.104712104355756
HEREDITARY THROMBOPHILIA DUE TO CONGENITAL ANTITHROMBIN DEFICIENCY	0.14285699999999998	7.104712104355756
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.14285699999999998	7.104712104355756
RESTRICTIVE DERMOPATHY, LETHAL	0.14285699999999998	7.104712104355756
AUTOIMMUNE HYPOPARATHYROIDISM	0.14285699999999998	7.104712104355756
FAMILIAL ISOLATED HYPERPARATHYROIDISM	0.14285699999999998	7.104712104355756
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.14285699999999998	7.104712104355756
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.14285699999999998	7.104712104355756
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.14285699999999998	7.104712104355756
13Q12.3 MICRODELETION SYNDROME	0.1409091	7.007837126524258
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.1409091	7.007837126524258
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.14052279999999998	6.988625255310997
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.13970846999999997	6.948126153356314
DERMATITIS, ATOPIC	0.13465044	6.696574973048774
SPINOCEREBELLAR ATAXIA TYPE 2	0.1319443	6.56199041916565
DYSTONIA 16; DYT16	0.1319443	6.56199041916565
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.129627494	6.446768626522351
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.1279861	6.365137122152127
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.1266234	6.2973659160886815
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.1266234	6.2973659160886815
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.1266234	6.2973659160886815
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.1266234	6.2973659160886815
PULMONARY ARTERIOVENOUS MALFORMATION	0.1266234	6.2973659160886815
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.12454210000000002	6.193856551459748
PACHYDERMOPERIOSTOSIS	0.12454210000000002	6.193856551459748
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.12313256	6.1237558500620315
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.12152769999999999	6.043941292372898
GALACTOSEMIA	0.12152769999999999	6.043941292372898
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.12152769999999999	6.043941292372898
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.12144403999999999	6.03978062670968
EOSINOPHILIC GASTROENTERITIS	0.12142860000000001	6.039012748657564
PYRUVATE CARBOXYLASE DEFICIENCY	0.12110379400000001	6.022859160665604
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.119262304	5.931276275031368
IMMUNODEFICIENCY 58; IMD58	0.1190476	5.920598393599912
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.11850587399999998	5.8936567157721225
ADNP SYNDROME	0.11657144	5.79745144298271
METHYLMALONIC ACIDURIA, CBLA TYPE	0.11648646400000001	5.7932253286461375
BECKWITH-WIEDEMANN SYNDROME	0.11545448000000001	5.741901632808331
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.11511287	5.724912330905246
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.11420897999999999	5.67995913838401
METHYLMALONIC ACIDURIA, CBLB TYPE	0.11305003400000001	5.6223212370246465
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.112893094	5.614516134595942
FAMILIAL HYPOALDOSTERONISM	0.1125859	5.599238444806954
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.11245416999999999	5.592687112177073
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.112412984	5.5906388074196585
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.112412984	5.5906388074196585
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.112412984	5.5906388074196585
SAY SYNDROME	0.11186753	5.563511724839391
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.11165655399999999	5.553019248160414
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.11165655399999999	5.553019248160414
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.11165655399999999	5.553019248160414
TREMOR, NYSTAGMUS, AND DUODENAL ULCER	0.11111099999999999	5.5258871922766994
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.11111099999999999	5.5258871922766994
PRIMARY DYSTONIA, DYT27 TYPE	0.11111099999999999	5.5258871922766994
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.11111099999999999	5.5258871922766994
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.11111099999999999	5.5258871922766994
NEPHROPATHIC INFANTILE CYSTINOSIS	0.11111099999999999	5.5258871922766994
PRIMARY DYSTONIA, DYT4 TYPE	0.11111099999999999	5.5258871922766994
COMPLEX REGIONAL PAIN SYNDROME	0.11111099999999999	5.5258871922766994
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.11111099999999999	5.5258871922766994
BRUNNER SYNDROME; BRNRS	0.11111099999999999	5.5258871922766994
RENAL AGENESIS, BILATERAL	0.11111099999999999	5.5258871922766994
ENTERIC ANENDOCRINOSIS	0.11111099999999999	5.5258871922766994
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.11096225400000001	5.51848960233239
OCULOCEREBRORENAL SYNDROME OF LOWE	0.11089790000000001	5.515289082632523
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.1104167	5.4913575464486755
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.11034432000000001	5.487757869414206
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.10960418	5.450948461286371
SILVER-RUSSELL SYNDROME	0.1083733	5.3897330638259096
HENNEKAM-BEEMER SYNDROME	0.10816384000000001	5.379315982427179
SPINOCEREBELLAR ATAXIA 12	0.10795450000000001	5.368904868992585
ESOPHAGEAL ATRESIA	0.10773862000000001	5.358168501512599
DILATED CARDIOMYOPATHY WITH ATAXIA	0.10752216000000002	5.347403288872625
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.10721222400000001	5.331989231103138
HYPOALPHALIPOPROTEINEMIA	0.10714290000000001	5.328541538221988
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.1064425	5.293708520883735
TRICHOHEPATOENTERIC SYNDROME 1	0.10633490000000001	5.28835724637546
MELAS	0.10546631000000002	5.245159629970788
BETA-KETOTHIOLASE DEFICIENCY	0.10530529	5.23715161676147
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.10500619400000002	5.222276665085569
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.10467990000000002	5.206049074338328
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.103082554	5.126608210670153
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.102537	5.099476154786439
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.10253699400000002	5.099475856388233
WERNER SYNDROME	0.1023018	5.0877789450806175
RABSON-MENDENHALL SYNDROME	0.10054555400000001	5.000435502236191
ACRAL PEELING SKIN SYNDROME	0.10034306000000001	4.990364861155534
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.1	4.973303446352477
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.1	4.973303446352477
X-LINKED ACROGIGANTISM	0.1	4.973303446352477
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.1	4.973303446352477
DRACUNCULIASIS	0.1	4.973303446352477
ACQUIRED ICHTHYOSIS	0.1	4.973303446352477
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.1	4.973303446352477
INSULIN-RESISTANCE SYNDROME TYPE B	0.1	4.973303446352477
LOWE OCULOCEREBRORENAL SYNDROME	0.1	4.973303446352477
BEHÃ‡ET DISEASE	0.1	4.973303446352477
INTESTINAL LYMPHANGIECTASIA	0.1	4.973303446352477
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.1	4.973303446352477
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.1	4.973303446352477
CONGENITAL ANALBUMINEMIA	0.0989922	4.9231824942201365
GLYCEROL KINASE DEFICIENCY; GKD	0.098086664	4.878147441124174
HISTIOCYTOID CARDIOMYOPATHY	0.09704222000000001	4.826204071676953
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.096624054	4.805407407587478
PELIZAEUS-MERZBACHER DISEASE	0.09564751400000002	4.756841110112468
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.09562707399999999	4.755824566888032
CHRISTIANSON SYNDROME	0.09554572000000001	4.751778585602288
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.0954755	4.74828633192226
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.0954755	4.74828633192226
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.09496968400000001	4.723130567362057
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.09425110000000002	4.68739320452512
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0937982	4.6648691132165885
PONTINE TEGMENTAL CAP DYSPLASIA	0.093623854	4.656198357590012
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.0930783	4.629066301706297
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.09280117	4.6152837858654205
CONGENITAL ENTEROVIRUS INFECTION	0.091629	4.556988214858311
SPINOCEREBELLAR ATAXIA TYPE 36	0.0915652	4.5538152472595375
BARDET-BIEDL SYNDROME 1; BBS1	0.09145465400000001	4.5483174592317335
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.09145465400000001	4.5483174592317335
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.09145465400000001	4.5483174592317335
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.09145465400000001	4.5483174592317335
ACROKERATODERMA, HEREDITARY PAPULOTRANSLUCENT	0.0909091	4.52118540334802
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.0909091	4.52118540334802
ARTERIAL TORTUOSITY SYNDROME	0.0909091	4.52118540334802
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.0909091	4.52118540334802
MALIGNANT ATROPHIC PAPULOSIS	0.0909091	4.52118540334802
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.0909091	4.52118540334802
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.0909091	4.52118540334802
VERNAL KERATOCONJUNCTIVITIS	0.0909091	4.52118540334802
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.09074071000000002	4.512810857674707
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.09037555000000001	4.494650342810006
CONGENITAL ISOLATED ACTH DEFICIENCY	0.0900384	4.477882850240628
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.08941614999999999	4.446936469545699
WILLIAMS SYNDROME	0.08932006	4.4421576222641
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.08902640000000002	4.427553019363542
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.08868386400000002	4.410517664670544
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.08842121	4.397455084236561
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.08792743400000001	4.3728981054113
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.08791923	4.372490095596561
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.08752616000000002	4.352941531739984
RFT1-CDG	0.08680448400000002	4.317050394360486
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.08676973000000002	4.3153219724807395
INHERITED CREUTZFELDT-JAKOB DISEASE	0.08676973000000002	4.3153219724807395
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.08635706000000001	4.2947986411486765
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.08604805400000001	4.279430835101241
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.08593534000000001	4.2738252258547185
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.085784784	4.266337619118028
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.085784784	4.266337619118028
LYSOSOMAL ACID LIPASE DEFICIENCY	0.085337854	4.244110434025245
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.085028354	4.228718059858784
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.084995784	4.227098254926307
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.08470384	4.212578993912888
ERMINE PHENOTYPE	0.08408973000000002	4.182037440118493
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.08408973000000002	4.182037440118493
ETHYLMALONIC ENCEPHALOPATHY	0.08396535000000001	4.17585164529192
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.08387885400000002	4.171549936742963
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.08340378400000001	4.147923264060376
ALKAPTONURIA	0.08333330000000001	4.144417880859249
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.08333330000000001	4.144417880859249
POSTORGASMIC ILLNESS SYNDROME	0.08333330000000001	4.144417880859249
PERIPARTUM CARDIOMYOPATHY	0.08333330000000001	4.144417880859249
OROMANDIBULAR DYSTONIA	0.08333330000000001	4.144417880859249
DPM3-CDG	0.08333330000000001	4.144417880859249
MUCKLE-WELLS SYNDROME	0.08333330000000001	4.144417880859249
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.08333330000000001	4.144417880859249
STORMORKEN SYNDROME; STRMK	0.08333330000000001	4.144417880859249
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.08333330000000001	4.144417880859249
SCLEROSTEOSIS	0.08333330000000001	4.144417880859249
DIPROSOPUS	0.08333330000000001	4.144417880859249
IMMUNODEFICIENCY 23; IMD23	0.08140811400000002	4.048672539172554
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.08140811400000002	4.048672539172554
IGE RESPONSIVENESS, ATOPIC	0.08086256000000001	4.02154048328884
DDOST-CDG	0.08035953000000001	3.996523274962653
PRIMARY CILIARY DYSKINESIA	0.0791926	3.9384883050561315
FAMILIAL THROMBOCYTOSIS	0.0791926	3.9384883050561315
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.07809527000000001	3.883914754348272
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.07798412	3.8783869275676515
AMISH INFANTILE EPILEPSY SYNDROME	0.07780285000000002	3.869371820410449
TRISOMY 8P	0.07767953000000001	3.8632387426004065
XP21 MICRODELETION SYNDROME	0.077313254	3.845022725669244
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.07692310000000001	3.825619183341163
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.07692310000000001	3.825619183341163
PAGET DISEASE, EXTRAMAMMARY	0.07692310000000001	3.825619183341163
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE II; CDG2	0.07692310000000001	3.825619183341163
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.07692310000000001	3.825619183341163
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.07692310000000001	3.825619183341163
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	3.825619183341163
ICHTHYOSIS VULGARIS	0.07692310000000001	3.825619183341163
TUBEROUS SCLEROSIS COMPLEX	0.07692310000000001	3.825619183341163
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	3.825619183341163
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE I; CDG1	0.07692310000000001	3.825619183341163
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-NEGATIVE	0.07692310000000001	3.825619183341163
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.0761495	3.7871457078801787
TEMPLE SYNDROME	0.07547718	3.7537091941496623
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.07509375400000001	3.7346402556774514
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.07490474	3.725240015901362
17Q23.1Q23.2 MICRODELETION SYNDROME	0.07468122999999999	3.7141241853684193
WOLCOTT-RALLISON SYNDROME	0.0740898	3.684710576795657
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.0740259	3.6815326358934386
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.07277741000000001	3.619441439696073
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.07273058400000001	3.6171126406242835
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.07269885000000001	3.6155344125086177
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.072293704	3.5953852725278583
GRISCELLI SYNDROME	0.07197415400000001	3.5794930813650394
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.07197415400000001	3.5794930813650394
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.07197415400000001	3.5794930813650394
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.07197415400000001	3.5794930813650394
IMMUNODEFICIENCY 49; IMD49	0.07197415400000001	3.5794930813650394
IDIOPATHIC LOCALIZED LIPODYSTROPHY	0.07142860000000001	3.552361025481326
CENTRIFUGAL LIPODYSTROPHY	0.07142860000000001	3.552361025481326
PRIMARY BILIARY CHOLANGITIS	0.07142860000000001	3.552361025481326
KENNEDY DISEASE	0.07142860000000001	3.552361025481326
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.07142860000000001	3.552361025481326
PRESSURE-INDUCED LOCALIZED LIPOATROPHY	0.07142860000000001	3.552361025481326
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.07142860000000001	3.552361025481326
KERATOSIS PILARIS ATROPHICANS	0.07142860000000001	3.552361025481326
MELKERSSON-ROSENTHAL SYNDROME	0.07142860000000001	3.552361025481326
ADULT-ONSET STILL DISEASE	0.07142860000000001	3.552361025481326
ULERYTHEMA OPHRYOGENESIS	0.07142860000000001	3.552361025481326
MAJEED SYNDROME	0.07142860000000001	3.552361025481326
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.07142860000000001	3.552361025481326
VERRUCOUS HEMANGIOMA	0.07142860000000001	3.552361025481326
%609197 GLUCOCORTICOID DEFICIENCY 3; GCCD3;;FAMILIAL GLUCOCORTICOID DEFICIENCY 3; FGD3;;GLUCOCORTICOID DEFICIENCY 2, FORMERLY; GCCD2, FORMERLY	0.07142860000000001	3.552361025481326
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.07142860000000001	3.552361025481326
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.07142860000000001	3.552361025481326
JUVENILE TEMPORAL ARTERITIS	0.07142860000000001	3.552361025481326
EOSINOPHILOPENIA	0.07142860000000001	3.552361025481326
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.07142860000000001	3.552361025481326
INTERSTITIAL GRANULOMATOUS DERMATITIS WITH ARTHRITIS	0.07142860000000001	3.552361025481326
STIFF SKIN SYNDROME	0.07142860000000001	3.552361025481326
PANNICULITIS-INDUCED LOCALIZED LIPODYSTROPHY	0.07142860000000001	3.552361025481326
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.07065130400000001	3.513703736724966
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.07019710000000001	3.491114793539495
SCHINZEL-GIEDION SYNDROME	0.07019710000000001	3.491114793539495
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.07019710000000001	3.491114793539495
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.069511154	3.4570006174813774
YOU-HOOVER-FONG SYNDROME; YHFS	0.06927438400000001	3.445225326911449
ALAGILLE SYNDROME 1; ALGS1	0.0692541	3.4442165420403903
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.06918021	3.440541768123881
ATYPICAL WERNER SYNDROME	0.0689245	3.427824533881213
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.06854771	3.4090856238257015
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.06805546400000001	3.3846047365431695
9P13 MICRODELETION SYNDROME	0.06674089999999999	3.31922747982666
DIABETES MELLITUS, KETOSIS-PRONE; KPD	0.0666667	3.3155372886694665
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.0666667	3.3155372886694665
LETTERER-SIWE DISEASE	0.0664869	3.306595289072925
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0664869	3.306595289072925
SPINOCEREBELLAR ATAXIA 27; SCA27	0.06628780000000001	3.2966934419112373
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.06628780000000001	3.2966934419112373
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.066007884	3.282772369836345
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.0647059	3.218020754693387
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.06385627	3.1757660766221427
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.06325643	3.145934213229542
X-LINKED DYSTONIA-PARKINSONISM	0.0630542	3.135876701669984
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.06282199	3.124328193737208
DRAVET SYNDROME	0.0625	3.108314653970298
HUNTINGTON DISEASE-LIKE 2	0.0625	3.108314653970298
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0625	3.108314653970298
CARIBBEAN PARKINSONISM	0.0625	3.108314653970298
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.0625	3.108314653970298
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.0625	3.108314653970298
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.0625	3.108314653970298
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.0625	3.108314653970298
UROCANIC ACIDURIA	0.0625	3.108314653970298
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.0625	3.108314653970298
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.062060824	3.0864730988267453
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.061938810000000004	3.0804049723597124
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.06103259999999999	3.0353363991985214
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0607197	3.019774932714885
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.060705954	3.019091302423149
VICI SYNDROME; VICIS	0.060125484	2.990222767908107
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.059938910000000005	2.9809438767361094
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.05957993	2.9630907120243934
BAZEX SYNDROME; BZX	0.05943396	2.9558311809837523
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.059369054	2.952603208648863
WHITE-SUTTON SYNDROME; WHSUS	0.059026784	2.9355810829430324
FABRY DISEASE	0.058970100000000004	2.932762015617502
CEREBRAL ARTERIOVENOUS MALFORMATION	0.0588235	2.925471152765149
LYMPHEDEMA-CEREBRAL ARTERIOVENOUS ANOMALY SYNDROME	0.0588235	2.925471152765149
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4	0.0588235	2.925471152765149
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.0588235	2.925471152765149
VON HIPPEL-LINDAU DISEASE	0.0588235	2.925471152765149
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.0588235	2.925471152765149
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	0.0588235	2.925471152765149
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.0588235	2.925471152765149
GAPO SYNDROME	0.0588235	2.925471152765149
PSEUDOXANTHOMA ELASTICUM	0.0588235	2.925471152765149
3M SYNDROME	0.0588235	2.925471152765149
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN S DEFICIENCY	0.0588235	2.925471152765149
MOYAMOYA DISEASE	0.0588235	2.925471152765149
VEIN OF GALEN ANEURYSMAL MALFORMATION	0.0588235	2.925471152765149
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.0588235	2.925471152765149
ACQUIRED METHEMOGLOBINEMIA	0.0588235	2.925471152765149
TIGLIC ACIDEMIA	0.0588235	2.925471152765149
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.0588235	2.925471152765149
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN C DEFICIENCY	0.0588235	2.925471152765149
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.0577386	2.871515783675671
MEIER-GORLIN SYNDROME 1; MGORS1	0.05743661	2.856496904598031
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.057407410000000006	2.8550446999916965
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.057173184	2.8433959302614427
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.057173184	2.8433959302614427
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.05712903	2.8412000178577403
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.057082400000000005	2.8388809664607066
HYDROXYKYNURENINURIA	0.056416754	2.805776371002199
EMANUEL SYNDROME	0.056102784	2.7901616901716864
GRISCELLI SYNDROME TYPE 1	0.056059453999999995	2.788006757788381
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.7629485694417966
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.7629485694417966
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.7629485694417966
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.7629485694417966
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.7629485694417966
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.7629485694417966
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.7629485694417966
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.05536529999999999	2.7534843729833876
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.0553161	2.751037507687782
TREMOR, HEREDITARY ESSENTIAL, 1	0.0553161	2.751037507687782
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0548008	2.7254100750287282
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.054483964	2.7096528593214426
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.054446470000000004	2.7077881689272676
CHROMOSOME 18Q DELETION SYNDROME	0.05419286	2.695175374056973
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.054048580000000006	2.6879998918445756
AICARDI SYNDROME	0.05387912	2.679572131824387
AICARDI-GOUTIERES SYNDROME 7	0.053471184000000005	2.6592842366774745
MECKEL SYNDROME, TYPE 1; MKS1	0.05338803	2.655148735929694
KEARNS-SAYRE SYNDROME; KSS	0.053253180000000004	2.648442236232288
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.053077054	2.639682955804365
22Q11.2 DELETION SYNDROME	0.052969564000000004	2.634337151929881
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.05291226	2.631487250122983
PROPIONIC ACIDEMIA	0.052859614	2.6288690047906162
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.052849374	2.6283597385177098
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.052714753999999996	2.62166467741823
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.0526316	2.61752917667045
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0526316	2.61752917667045
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.0526316	2.61752917667045
SEVERE CONGENITAL NEMALINE MYOPATHY	0.0526316	2.61752917667045
LETHAL KNIEST-LIKE DYSPLASIA	0.0526316	2.61752917667045
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.0526316	2.61752917667045
KNIEST-LIKE DYSPLASIA, LETHAL	0.0526316	2.61752917667045
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0526316	2.61752917667045
15Q OVERGROWTH SYNDROME	0.0526316	2.61752917667045
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.052564599999999996	2.614197063361394
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.0525315	2.6125508999206515
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.052356634000000006	2.603854283116153
AMYLOIDOSIS	0.052139099999999994	2.593035657197164
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.05212117	2.5921439438892335
XQ12-Q13.3 DUPLICATION SYNDROME	0.051857089999999995	2.579010444148105
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.0515821	2.565334357000981
CORNELIA DE LANGE SYNDROME 3	0.051125134	2.542608051174322
EVEN-PLUS SYNDROME	0.050545554	2.5137837790599518
PROPIONIC ACIDEMIA	0.050489523999999994	2.5109972371389606
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.05032155399999999	2.5026435793401225
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.05019229399999999	2.496215087305367
VICI SYNDROME	0.050048634	2.4890704395743377
HYPER-IGE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.05	2.4866517231762386
COMBINED IMMUNODEFICIENCY DUE TO DOCK8 DEFICIENCY	0.05	2.4866517231762386
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.05	2.4866517231762386
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.05	2.4866517231762386
IMMUNODEFICIENCY WITH DEFECTIVE LEUKOCYTE AND LYMPHOCYTE FUNCTION AND WITH RESPONSE TO HISTAMINE-1 ANTAGONIST	0.05	2.4866517231762386
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.05	2.4866517231762386
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.05	2.4866517231762386
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.05	2.4866517231762386
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.04983053999999999	2.478223963156049
COG1-CDG	0.049646739999999995	2.469083031421653
MULTIPLE SYSTEM ATROPHY	0.049404699999999996	2.457045647760102
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.049404699999999996	2.457045647760102
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.049404699999999996	2.457045647760102
PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	0.049404699999999996	2.457045647760102
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.049404699999999996	2.457045647760102
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.049245753999999996	2.4491407808642625
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.049196840000000006	2.4467081392165144
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.04907410999999999	2.440604403896805
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.049064484000000005	2.44012567370706
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.04889093	2.431494306643777
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.048739529999999996	2.423964725225999
MONOSOMY 22	0.048375430000000004	2.40585692737783
TRANSKETOLASE DEFICIENCY	0.048164554	2.3953694240022996
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.048164554	2.3953694240022996
DIGEORGE SYNDROME; DGS	0.048164554	2.3953694240022996
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.04774945	2.3747250424643527
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.047619	2.368237368118586
EPIDERMODYSPLASIA VERRUCIFORMIS	0.047619	2.368237368118586
ERYTHRODERMA DESQUAMATIVUM	0.047619	2.368237368118586
CANDIDIASIS, FAMILIAL, 8; CANDF8	0.047619	2.368237368118586
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0475513	2.364870441685405
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.04738142	2.3564217937907417
LISSENCEPHALY, X-LINKED, 2	0.047170290000000004	2.3459216582244578
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.047076554	2.3412598825059847
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.04698282399999999	2.3365984051857183
RHEUMATOID ARTHRITIS	0.0466532	2.3202052034337135
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.046193054000000004	2.2973207465574608
HYPOTONIA-CYSTINURIA SYNDROME	0.046119184	2.29364696730164
XP22.13P22.2 DUPLICATION SYNDROME	0.046113169999999995	2.2933478728323764
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.046047340000000006	2.2900739471736427
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.04593879	2.284675426282627
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.0458153	2.2785338938567263
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.04571528	2.2735595957496844
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.0454545	2.2605902150222867
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.0454545	2.2605902150222867
RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	0.0454545	2.2605902150222867
OSTEOPETROSIS AND RELATED DISORDERS	0.0454545	2.2605902150222867
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.0454545	2.2605902150222867
DYSTONIA 23; DYT23	0.0454545	2.2605902150222867
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.0454545	2.2605902150222867
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.0454545	2.2605902150222867
X-LINKED CENTRONUCLEAR MYOPATHY	0.0454545	2.2605902150222867
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.0454545	2.2605902150222867
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.0454545	2.2605902150222867
ALAGILLE SYNDROME 2	0.0454545	2.2605902150222867
PIERPONT SYNDROME	0.045361394	2.2559597711155255
49,XXXYY SYNDROME	0.04535673999999999	2.255728313573132
GABRIELE-DE VRIES SYNDROME	0.04532664	2.25423134923578
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.04514826	2.2453599705481766
ECTODERMAL DYSPLASIA SYNDROME	0.04514826	2.2453599705481766
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.045129353999999997	2.244419717798609
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.04459233	2.2177118846988693
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.04459233	2.2177118846988693
NON-DISTAL MONOSOMY 20Q	0.04447052	2.2116539037708676
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.04420735399999999	2.198565860023239
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.044023854	2.1894398481991826
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04387814000000001	2.1821930488153654
NAVAJO NEUROHEPATOPATHY	0.043666274	2.1716563097357153
HYDATIDIFORM MOLE	0.043478300000000004	2.1623077923154694
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.043478300000000004	2.1623077923154694
GESTATIONAL TROPHOBLASTIC NEOPLASM	0.043478300000000004	2.1623077923154694
HAND-FOOT-GENITAL SYNDROME	0.043478300000000004	2.1623077923154694
FAMILIAL AFIBRINOGENEMIA	0.043478300000000004	2.1623077923154694
GESTATIONAL CHORIOCARCINOMA	0.043478300000000004	2.1623077923154694
ASHERMAN SYNDROME	0.043478300000000004	2.1623077923154694
VIRAL HEMORRHAGIC FEVER	0.043478300000000004	2.1623077923154694
YELLOW FEVER	0.043478300000000004	2.1623077923154694
PLACENTAL SITE TROPHOBLASTIC TUMOR	0.043478300000000004	2.1623077923154694
KEUTEL SYNDROME; KTLS	0.043478300000000004	2.1623077923154694
LASSA FEVER	0.043478300000000004	2.1623077923154694
PRIMARY HYPEROXALURIA TYPE 1	0.0429832	2.1376849669525777
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.04259114	2.118186633460808
DISTAL 17P13.1 MICRODELETION SYNDROME	0.042423129999999996	2.109830986340591
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.042423129999999996	2.109830986340591
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.042380970000000004	2.1077342416076092
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.04227	2.102215366773192
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.04222542399999999	2.099998467028945
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.04189021	2.0833272576142896
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.041695024000000004	2.0736200655494925
HISTIDINEMIA	0.041666699999999994	2.0722114270813474
HAMAMY SYNDROME; HMMS	0.041666699999999994	2.0722114270813474
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.041666699999999994	2.0722114270813474
49,XYYYY SYNDROME	0.041666699999999994	2.0722114270813474
GLYCOGEN STORAGE DISEASE 0, LIVER	0.04133212	2.055571748410541
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.04133212	2.055571748410541
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.04100072	2.0390902207893293
COFS SYNDROME	0.04078382	2.028303125614191
SHORT SYNDROME	0.0405229	2.015326782261968
ZELLWEGER SYNDROME	0.04051931000000001	2.0151482406682444
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.040342039999999996	2.0063320656488948
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.0401993	1.999233172309571
SMITH-MAGENIS SYNDROME; SMS	0.040058354	1.9922235000340751
GLYCOGEN STORAGE DISEASE VI	0.04002347	1.9904886128598496
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.039968699999999996	1.987764734562282
SOTOS SYNDROME	0.039832204	1.9809763742901492
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.0397706	1.9779126204350583
CEREBROFACIOARTICULAR SYNDROME	0.039474824	1.9632027824335745
OROFACIODIGITAL SYNDROME TYPE 14	0.039474824	1.9632027824335745
JUVENILE POLYPOSIS SYNDROME	0.03940434	1.9596973992324476
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.03940434	1.9596973992324476
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.03918548400000001	1.9488130262418986
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.039185484	1.9488130262418981
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.03910742	1.9449306666395376
OCULODENTODIGITAL DYSPLASIA	0.03892477	1.9358469278947747
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.038735323999999995	1.9264252034477978
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.038718393999999996	1.9255832231743302
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.03863859	1.9216143280920035
RAMOS-ARROYO SYNDROME	0.038531380000000004	1.916282449467169
HURLER SYNDROME	0.038429054	1.9111934669826542
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.03817284	1.8984511672906168
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.03817284	1.8984511672906168
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.03817284	1.8984511672906168
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.0378835	1.8840614110989404
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.037878800000000004	1.883827665836962
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.037063109999999996	1.8432609269554094
GLYCOGEN STORAGE DISEASE IB	0.03696472	1.8383676936945432
GLYCOGEN STORAGE DISEASE IA	0.03696472	1.8383676936945432
PYRIDOXINE-DEPENDENT EPILEPSY	0.036591533999999995	1.8198080214952381
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.03647073000000001	1.8138000719999068
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.03647073000000001	1.8138000719999068
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.03647073000000001	1.8138000719999068
MICROHYDRANENCEPHALY; MHAC	0.03647073000000001	1.8138000719999068
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.03647073000000001	1.8138000719999068
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.03630668	1.8056413676961653
VASCULAR EHLERS-DANLOS SYNDROME	0.036259854	1.8033125686243763
OCULOECTODERMAL SYNDROME; OES	0.036259854	1.8033125686243763
THUMBS, CONGENITAL CLASPED	0.0361093	1.7958250613537545
NEURONAL CEROID LIPOFUSCINOSIS	0.03604598	1.7926759656115243
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.03604598	1.7926759656115243
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.035784784	1.7796858959417898
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.035784784	1.7796858959417898
CONGENITAL DISORDER OF GLYCOSYLATION	0.035783624	1.779628205621812
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.035714300000000004	1.776180512740663
CILIARY DYSKINESIA, PRIMARY, 38; CILD38	0.035714300000000004	1.776180512740663
FAMILIAL CERVICAL ARTERY DISSECTION	0.035714300000000004	1.776180512740663
SLC39A8-CDG	0.035714300000000004	1.776180512740663
CILIARY DYSKINESIA, PRIMARY, 24; CILD24	0.035714300000000004	1.776180512740663
CILIARY DYSKINESIA, PRIMARY, 28; CILD28	0.035714300000000004	1.776180512740663
CILIARY DYSKINESIA, PRIMARY, 26; CILD26	0.035714300000000004	1.776180512740663
MICROSPORIDIOSIS	0.035714300000000004	1.776180512740663
PARTIAL ATRIOVENTRICULAR CANAL	0.035714300000000004	1.776180512740663
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.035714300000000004	1.776180512740663
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.035714300000000004	1.776180512740663
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.035714300000000004	1.776180512740663
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.035714300000000004	1.776180512740663
SCHEIE SYNDROME	0.035714300000000004	1.776180512740663
CILIARY DYSKINESIA, PRIMARY, 27; CILD27	0.035714300000000004	1.776180512740663
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.035714300000000004	1.776180512740663
PAROXYSMAL HEMICRANIA	0.035714300000000004	1.776180512740663
CILIARY DYSKINESIA, PRIMARY, 23; CILD23	0.035714300000000004	1.776180512740663
FELTY SYNDROME	0.035714300000000004	1.776180512740663
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.035714300000000004	1.776180512740663
HURLER-SCHEIE SYNDROME	0.035714300000000004	1.776180512740663
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.035714300000000004	1.776180512740663
CILIARY DYSKINESIA, PRIMARY, 22; CILD22	0.035714300000000004	1.776180512740663
LEISHMANIASIS	0.035714300000000004	1.776180512740663
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.035714300000000004	1.776180512740663
CILIARY DYSKINESIA, PRIMARY, 40; CILD40	0.035714300000000004	1.776180512740663
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.035714300000000004	1.776180512740663
ESSENTIAL THROMBOCYTHEMIA	0.035714300000000004	1.776180512740663
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.035714300000000004	1.776180512740663
CILIARY DYSKINESIA, PRIMARY, 19; CILD19	0.035714300000000004	1.776180512740663
YELLOW NAIL SYNDROME	0.035714300000000004	1.776180512740663
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.035714300000000004	1.776180512740663
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.035694529999999995	1.7751972906493183
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.035569074	1.768957983077663
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.03542072	1.761579888482861
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.03542072	1.761579888482861
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.035321194	1.7566301584948443
COG5-CDG	0.03523923	1.752553840058076
ISOTRETINOIN-LIKE SYNDROME	0.035183729999999996	1.74979365664535
MEIER-GORLIN SYNDROME 5; MGORS5	0.035183729999999996	1.74979365664535
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.035028354	1.7420663366825455
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.035028354	1.7420663366825455
HYDRANENCEPHALY	0.035028354	1.7420663366825455
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.035028354	1.7420663366825455
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.035028354	1.7420663366825455
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.035028354	1.7420663366825455
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.035028354	1.7420663366825455
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.035028354	1.7420663366825455
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.035028354	1.7420663366825455
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.035028354	1.7420663366825455
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.035028354	1.7420663366825455
YUNIS-VARON SYNDROME	0.035028354	1.7420663366825455
JAWAD SYNDROME	0.035028354	1.7420663366825455
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.034802394	1.7308286602151675
SPINAL MUSCULAR ATROPHY, TYPE IV	0.0344828	1.714934280798832
SPINAL MUSCULAR ATROPHY, TYPE III; SMA3	0.0344828	1.714934280798832
PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK	0.0344828	1.714934280798832
SPINAL MUSCULAR ATROPHY, TYPE II	0.0344828	1.714934280798832
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.0344828	1.714934280798832
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.0344828	1.714934280798832
NORMAL PRESSURE HYDROCEPHALUS	0.0344828	1.714934280798832
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.0344828	1.714934280798832
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.0344828	1.714934280798832
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.0344828	1.714934280798832
DYSTONIA 7, TORSION	0.0344828	1.714934280798832
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.0344828	1.714934280798832
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.0344828	1.714934280798832
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.0344828	1.714934280798832
BECKWITH-WIEDEMANN SYNDROME	0.0344828	1.714934280798832
MODY	0.0344828	1.714934280798832
SPINOCEREBELLAR ATAXIA TYPE 27	0.0344828	1.714934280798832
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.0344828	1.714934280798832
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.0344828	1.714934280798832
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0344828	1.714934280798832
SLC35A2-CDG	0.034403824	1.7110065646690402
COWDEN SYNDROME 5; CWS5	0.0343552	1.7085883456012863
COWDEN SYNDROME 6; CWS6	0.0343552	1.7085883456012863
CHARGE SYNDROME	0.033921964000000006	1.6870422046824467
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0338384	1.6828863133905363
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.033689694	1.6754907127676035
WOLF-HIRSCHHORN SYNDROME	0.033560084	1.669044814170786
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.033560084	1.669044814170786
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.03346038	1.6640862317026348
HYPOADRENOCORTICISM, FAMILIAL	0.03344255	1.6631994916981503
SCHWARTZ-JAMPEL SYNDROME	0.03337641	1.6599101487987329
MYELOPEROXIDASE DEFICIENCY	0.033199679999999995	1.6511208296179938
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.033199679999999995	1.6511208296179938
BLOOD GROUP, DUFFY SYSTEM; FY	0.033199679999999995	1.6511208296179938
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.033091253999999994	1.6457284756232513
SECKEL SYNDROME 2; SCKL2	0.03301453	1.6419127582870723
ISOLATED CEREBELLAR AGENESIS	0.03301453	1.6419127582870723
SECKEL SYNDROME	0.03301453	1.6419127582870723
ATYPICAL RETT SYNDROME	0.03301453	1.6419127582870723
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.03301453	1.6419127582870723
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.033006754	1.641526034211084
MONOMELIC AMYOTROPHY	0.03284823	1.6336421546557882
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.032803653999999995	1.6314252549115418
OXOGLUTARIC ACIDURIA	0.032803653999999995	1.6314252549115418
SARCOSINEMIA	0.032803653999999995	1.6314252549115418
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.032803653999999995	1.6314252549115418
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.032803653999999995	1.6314252549115418
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.03261998	1.6222905895394886
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.032461199999999996	1.61439397832737
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.032371934	1.609954509272949
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.032334824000000005	1.608108916364008
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0322581	1.6042931990278282
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.0322581	1.6042931990278282
LESCH-NYHAN SYNDROME	0.0322581	1.6042931990278282
DENT DISEASE	0.0322581	1.6042931990278282
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.0322581	1.6042931990278282
DIENCEPHALIC SYNDROME	0.0322581	1.6042931990278282
SANDHOFF DISEASE	0.0322581	1.6042931990278282
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	1.6042931990278282
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.0322581	1.6042931990278282
HUNTINGTON DISEASE	0.0322581	1.6042931990278282
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0322581	1.6042931990278282
HSD10 DISEASE, ATYPICAL TYPE	0.0322581	1.6042931990278282
FLYNN-AIRD SYNDROME	0.0322581	1.6042931990278282
LEIGH SYNDROME	0.0322581	1.6042931990278282
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.0322581	1.6042931990278282
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	1.6042931990278282
DYSTONIA, JUVENILE-ONSET	0.0322581	1.6042931990278282
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0322581	1.6042931990278282
MILD CANAVAN DISEASE	0.0322581	1.6042931990278282
DEND SYNDROME	0.0322581	1.6042931990278282
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	1.6042931990278282
ATTENUATED CHÃ‰DIAK-HIGASHI SYNDROME	0.0322581	1.6042931990278282
MERRF	0.0322581	1.6042931990278282
PARKINSON DISEASE, LATE-ONSET; PD	0.03200783	1.591846512492642
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.03184915	1.5839548745839698
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.031581	1.5706189613925756
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.031119253999999996	1.5476549316611807
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.030080234	1.4959813141928895
CIRCUMVALLATE PLACENTA SYNDROME	0.029979	1.4909466401820088
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.029957354	1.4898701189180115
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.02992247	1.488135231743786
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.029899454	1.4869905762225732
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.029873384	1.4856940360141093
GALLOWAY-MOWAT SYNDROME	0.029873384	1.4856940360141093
22Q11.2 MICRODUPLICATION SYNDROME	0.029873384	1.4856940360141093
PENTASOMY X	0.029873384	1.4856940360141093
ALG1-CDG	0.029873384	1.4856940360141093
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.029873384	1.4856940360141093
FETAL ALCOHOL SYNDROME	0.029873384	1.4856940360141093
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.029873384	1.4856940360141093
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.029716734	1.4779033561653983
ECHO VIRUS 11 SENSITIVITY	0.0294118	1.4627380630342977
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0294118	1.4627380630342977
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0294118	1.4627380630342977
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0294118	1.4627380630342977
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0294118	1.4627380630342977
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0294118	1.4627380630342977
RAGWEED SENSITIVITY	0.0294118	1.4627380630342977
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0294118	1.4627380630342977
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0294118	1.4627380630342977
MYASTHENIA GRAVIS; MG	0.0294118	1.4627380630342977
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0294118	1.4627380630342977
IMMUNE SUPPRESSION	0.0294118	1.4627380630342977
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0294118	1.4627380630342977
NORRIE DISEASE	0.02932783	1.4585619801303955
C SYNDROME	0.02932783	1.4585619801303955
DISTAL MONOSOMY 7Q36	0.02932783	1.4585619801303955
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.02932783	1.4585619801303955
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.029143024	1.4493710169633294
WAISMAN SYNDROME; WSMN	0.029116954	1.4480744767548654
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.029116954	1.4480744767548654
TETRASOMY X	0.029116954	1.4480744767548654
MAN1B1-CDG	0.029116954	1.4480744767548654
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.029079784	1.4462258998638562
15Q13.3 MICRODELETION SYNDROME	0.029079784	1.4462258998638562
CITRULLINEMIA, CLASSIC	0.028950053999999996	1.439774033302903
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.028889570000000003	1.4367659804464112
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.028654524	1.4250764296278977
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0285714	1.4209424208711514
ATYPICAL JUVENILE PARKINSONISM	0.0285714	1.4209424208711514
ALG12-CDG	0.0285714	1.4209424208711514
ALPHA-THALASSEMIA	0.0285714	1.4209424208711514
CHEILITIS GLANDULARIS	0.0285714	1.4209424208711514
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.0285714	1.4209424208711514
ACRODYSOSTOSIS	0.0285714	1.4209424208711514
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.0285714	1.4209424208711514
CONGENITAL LOBAR EMPHYSEMA	0.0285714	1.4209424208711514
FAMILIAL DYSKINESIA AND FACIAL MYOKYMIA	0.0285714	1.4209424208711514
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.0285714	1.4209424208711514
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.0285714	1.4209424208711514
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.0285714	1.4209424208711514
PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8	0.0285714	1.4209424208711514
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0285714	1.4209424208711514
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.0285714	1.4209424208711514
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0285714	1.4209424208711514
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.0285714	1.4209424208711514
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.0285714	1.4209424208711514
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.0285714	1.4209424208711514
RAPID-ONSET DYSTONIA-PARKINSONISM	0.0285714	1.4209424208711514
PARKINSONISM WITH SPASTICITY, X-LINKED	0.0285714	1.4209424208711514
DOWN SYNDROME	0.0285714	1.4209424208711514
COG7-CDG	0.0285714	1.4209424208711514
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.0285714	1.4209424208711514
PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	0.0285714	1.4209424208711514
15Q24 RECURRENT MICRODELETION SYNDROME	0.02853423	1.4190938439801424
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.02853423	1.4190938439801424
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.02853423	1.4190938439801424
MENKES DISEASE	0.02853423	1.4190938439801424
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.028471874	1.4159926908831348
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.028352500000000003	1.4100558596270862
POTOCKI-LUPSKI SYNDROME	0.028077863999999998	1.3963973779741612
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	1.3814742847208983
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.3814742847208983
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	1.3814742847208983
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.3814742847208983
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	1.3814742847208983
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.3814742847208983
DWARFISM, LEVI TYPE	0.027777800000000002	1.3814742847208983
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	1.3814742847208983
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	1.3814742847208983
CLEFT CHIN	0.027777800000000002	1.3814742847208983
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	1.3814742847208983
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.3814742847208983
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.3814742847208983
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	1.3814742847208983
DIMPLES, FACIAL	0.027777800000000002	1.3814742847208983
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.3814742847208983
NASAL BONES, ABSENCE OF	0.027777800000000002	1.3814742847208983
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.3814742847208983
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.3814742847208983
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	1.3814742847208983
OROFACIAL CLEFT 3	0.027777800000000002	1.3814742847208983
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.3814742847208983
COG8-CDG	0.027772679999999998	1.3812196515844448
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.027596804	1.372472804415138
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.027407519999999998	1.3630591367197442
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.027403873999999998	1.3628778100760903
LYSINURIC PROTEIN INTOLERANCE	0.0269761	1.3416033109914904
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.026700494	1.3278965882951363
NEPHROSIALIDOSIS	0.02634582	1.31025757402982
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.026292354	1.3075985476091934
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.025970554	1.2915944571188311
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.02593977	1.290063475385906
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.025911019999999996	1.2886336506450793
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.025825323999999997	1.284371728523693
UNILATERAL POLYMICROGYRIA	0.025552479999999995	1.270802368468527
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0253265	1.2595636973404598
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0248965	1.2381784925211443
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.024671174	1.2269723467976164
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.024671174	1.2269723467976164
19P13.12 MICRODELETION SYNDROME	0.024557784	1.221333118019797
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.024540224	1.2204598059346177
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.024443654000000002	1.215657086796475
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.02430827	1.2089240296586652
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.024029283999999998	1.1950492093058243
FETAL HYDANTOIN SYNDROME	0.024029283999999998	1.1950492093058243
MICROTRIPLICATION 11Q24.1	0.02401223	1.1942010621360832
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.02393269	1.1902452965748545
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.023275209999999998	1.1575468210757762
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.023275209999999998	1.1575468210757762
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.023272993999999998	1.157436612671405
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.023272993999999998	1.157436612671405
KAGAMI-OGATA SYNDROME	0.023272854	1.1574296500465802
SILVER-RUSSELL SYNDROME; SRS	0.023272854	1.1574296500465802
CHOLESTEROL-ESTER TRANSFER PROTEIN DEFICIENCY	0.0232558	1.1565815028768391
GRISCELLI SYNDROME TYPE 2	0.0232558	1.1565815028768391
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.0232558	1.1565815028768391
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.0232558	1.1565815028768391
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.0232558	1.1565815028768391
WOODHOUSE-SAKATI SYNDROME	0.0232558	1.1565815028768391
MOSAIC MONOSOMY X	0.0232558	1.1565815028768391
ACUTE INTERMITTENT PORPHYRIA	0.0232558	1.1565815028768391
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.0232558	1.1565815028768391
TURNER SYNDROME	0.0232558	1.1565815028768391
COMBINED DEFICIENCY OF FACTOR V AND FACTOR VIII	0.0232558	1.1565815028768391
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.0232558	1.1565815028768391
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.0232558	1.1565815028768391
WOODHOUSE-SAKATI SYNDROME	0.0232558	1.1565815028768391
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.0232558	1.1565815028768391
MONOSOMY X	0.0232558	1.1565815028768391
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.0232558	1.1565815028768391
HYPERLIPIDEMIA, FAMILIAL COMBINED, 3; FCHL3	0.0232558	1.1565815028768391
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.0232558	1.1565815028768391
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	0.0232558	1.1565815028768391
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19	0.0232558	1.1565815028768391
PRIMARY LIPODYSTROPHY	0.0232558	1.1565815028768391
FAMILIAL MULTIPLE LIPOMATOSIS	0.0232558	1.1565815028768391
AROMATASE DEFICIENCY	0.0232558	1.1565815028768391
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.0230025	1.1439841252472283
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.022892040000000002	1.1384906142603877
SPINOCEREBELLAR ATAXIA 34; SCA34	0.022739000000000002	1.1308794706660898
RHOMBENCEPHALOSYNAPSIS	0.0227273	1.1302975941628663
ARTERIES, ANOMALIES OF	0.0227273	1.1302975941628663
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0227273	1.1302975941628663
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	1.1302975941628663
BETHLEM MYOPATHY 1	0.0227273	1.1302975941628663
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	1.1302975941628663
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	1.1302975941628663
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	1.1302975941628663
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	1.1302975941628663
THUMB DEFORMITY	0.0227273	1.1302975941628663
PREPAPILLARY VASCULAR LOOPS	0.0227273	1.1302975941628663
ACRORENAL-MANDIBULAR SYNDROME	0.0227273	1.1302975941628663
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.0227273	1.1302975941628663
SIRENOMELIA	0.0227273	1.1302975941628663
ATROPHODERMA VERMICULATA; AVA	0.0227273	1.1302975941628663
MILLER-DIEKER SYNDROME	0.0227273	1.1302975941628663
MUSCULAR HYPERTONIA, LETHAL	0.0227273	1.1302975941628663
CONGENITAL ATRANSFERRINEMIA	0.0227273	1.1302975941628663
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	1.1302975941628663
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	1.1302975941628663
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0227273	1.1302975941628663
WATSON SYNDROME	0.0227273	1.1302975941628663
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	1.1302975941628663
COCAINE EMBRYOFETOPATHY	0.0227273	1.1302975941628663
FATCO SYNDROME	0.0227273	1.1302975941628663
LARSEN SYNDROME	0.0227273	1.1302975941628663
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.02265578	1.1267406875380352
SPINAL ARACHNOIDITIS	0.02265578	1.1267406875380352
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.02265578	1.1267406875380352
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.02265578	1.1267406875380352
MEGAEPIPHYSEAL DWARFISM	0.02255794	1.1218748074461238
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.02233395	1.1107351050566392
GLUTAMINE DEFICIENCY, CONGENITAL	0.022113309999999997	1.0997620083326067
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.021922134	1.090254245736008
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.02163019	1.0757349847225888
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.021612274	1.0748439676771404
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.021612274	1.0748439676771404
LYSINURIC PROTEIN INTOLERANCE; LPI	0.02155522	1.0720064991288585
ORNITHINE TRANSCARBAMYLASE DEFICIENCY	0.02137257	1.0629227603840956
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.02137257	1.0629227603840956
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.02137257	1.0629227603840956
INFANTILE LIVER FAILURE SYNDROME 2	0.02137257	1.0629227603840956
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.02137257	1.0629227603840956
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.02128784	1.058708880374001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.021286404	1.0586374637365112
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0212121	1.0549421003437338
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.021106009999999998	1.0496659227174983
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.021106009999999998	1.0496659227174983
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.021106009999999998	1.0496659227174983
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.021093473999999997	1.0490424693974634
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	1.0458499069831122
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	1.0458499069831122
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	1.0458499069831122
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	1.0458499069831122
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	1.0458499069831122
ENDOCARDIAL FIBROELASTOSIS	0.02093144	1.0409840268912007
MANGANESE POISONING	0.0208333	1.0361032268889505
LEBER HEREDITARY OPTIC NEUROPATHY	0.0208333	1.0361032268889505
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 4	0.0208333	1.0361032268889505
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.0208333	1.0361032268889505
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.0208333	1.0361032268889505
SPINOCEREBELLAR ATAXIA 2; SCA2	0.0208333	1.0361032268889505
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.0208333	1.0361032268889505
DYSTONIA, DOPA-RESPONSIVE; DRD	0.0208333	1.0361032268889505
GILLESPIE SYNDROME; GLSP	0.0208333	1.0361032268889505
PRIMARY DYSTONIA, DYT13 TYPE	0.0208333	1.0361032268889505
SPINOCEREBELLAR ATAXIA 15	0.0208333	1.0361032268889505
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 72	0.0208333	1.0361032268889505
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.0208333	1.0361032268889505
DYSTONIA 16	0.0208333	1.0361032268889505
SPINOCEREBELLAR ATAXIA TYPE 1	0.0208333	1.0361032268889505
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.0208333	1.0361032268889505
PRIMARY PROGRESSIVE FREEZING GAIT	0.0208333	1.0361032268889505
DYSTONIA 27; DYT27	0.0208333	1.0361032268889505
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 17	0.0208333	1.0361032268889505
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.0208333	1.0361032268889505
SPINOCEREBELLAR ATAXIA 20	0.0208333	1.0361032268889505
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.0208333	1.0361032268889505
AMISH LETHAL MICROCEPHALY	0.02074974	1.0319475345291782
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.02054506	1.0217681770351843
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.0205177	1.020407481212262
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.02038458	1.0137870196644778
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.020365269999999998	1.012826674768987
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.020169884	1.0031095360972968
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.020103394	0.999802786635817
WEBB-DATTANI SYNDROME; WEDAS	0.020001164000000002	0.994718578522611
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.019779204	0.983679834193087
PROTOPORPHYRIA, ERYTHROPOIETIC	0.01953496	0.9715328389235778
WARBURG MICRO SYNDROME 2; WARBM2	0.01945561	0.9675865226388972
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.01945561	0.9675865226388972
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.01945561	0.9675865226388972
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.01943522	0.9665724660661857
BAND HETEROTOPIA; BH	0.019413454	0.9654899768380527
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.019413454	0.9654899768380527
ARGININOSUCCINIC ACIDURIA	0.019300034	0.9598492560691998
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.019059484	0.9478859746289989
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.019049163999999997	0.9473727297133352
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0188679	0.9383579209543389
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.9383579209543389
VESICOURETERAL REFLUX 1	0.0188679	0.9383579209543389
THROMBOCYTOPENIA 3	0.0188679	0.9383579209543389
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.9383579209543389
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.9383579209543389
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.9383579209543389
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.9383579209543389
TRACHEOBRONCHOMEGALY	0.0188679	0.9383579209543389
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.9383579209543389
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	0.9383579209543389
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.9383579209543389
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.9383579209543389
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.9383579209543389
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.9383579209543389
CARPAL DISPLACEMENT	0.0188679	0.9383579209543389
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.9383579209543389
HHHH SYNDROME	0.0188679	0.9383579209543389
MONOPHALANGY OF GREAT TOE	0.0188679	0.9383579209543389
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.9383579209543389
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.9383579209543389
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.9383579209543389
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.9383579209543389
RAYNAUD DISEASE	0.0188679	0.9383579209543389
VAN DEN BOSCH SYNDROME	0.0188679	0.9383579209543389
TOE, MISSHAPEN	0.0188679	0.9383579209543389
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.9383579209543389
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.9383579209543389
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.9383579209543389
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.9383579209543389
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.9383579209543389
PUBIC BONE DYSPLASIA	0.0188679	0.9383579209543389
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.9383579209543389
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.9383579209543389
KNUCKLE PADS	0.0188679	0.9383579209543389
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.9383579209543389
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.018840124	0.9369765361890801
FUMARASE DEFICIENCY; FMRD	0.018760934	0.9330381771899136
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.018760934	0.9330381771899136
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.01851393	0.9207539187452851
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.018485704	0.9193501541145175
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.018474564	0.9187961281105939
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.018474564	0.9187961281105939
PEHO SYNDROME; PEHO	0.018292733999999998	0.9097531704540912
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.01824357	0.9073080955477266
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.01815532	0.9029191552563204
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.018127164	0.9015188719379655
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.018069654	0.8986587251259682
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.018022450000000002	0.8963111269671521
LIVER FAILURE, INFANTILE, TRANSIENT	0.017940150000000002	0.8922180982308039
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.017934193999999997	0.8919218882775389
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.017934193999999997	0.8919218882775389
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.017934193999999997	0.8919218882775389
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.017934193999999997	0.8919218882775389
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.01792901	0.89166407222688
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.017811574	0.8858236235916217
MAPLE SYRUP URINE DISEASE; MSUD	0.017757500000000002	0.8831343594860411
WILLIAMS-BEUREN SYNDROME; WBS	0.017747179999999998	0.8826211145703774
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.017727914	0.8816629579284032
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.017680584	0.8793090934072446
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.017680584	0.8793090934072446
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.017628924	0.8767398848468589
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.017577924	0.8742035000892191
PEARSON SYNDROME	0.01745895	0.8682865620469558
COLCHICINE POISONING	0.01745895	0.8682865620469558
PRADER-WILLI SYNDROME	0.017388639999999997	0.8647898323938252
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.017362754	0.8635024430637026
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.017362754	0.8635024430637026
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.017328	0.8617740211839571
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.017328	0.8617740211839571
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.01726602	0.8586915677079079
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.01726602	0.8586915677079079
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.01726602	0.8586915677079079
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.857467140399416
269800 SENILE PLAQUE FORMATION	0.0172414	0.857467140399416
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.857467140399416
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.857467140399416
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.857467140399416
PALMOMENTAL REFLEX	0.0172414	0.857467140399416
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.857467140399416
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.857467140399416
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.857467140399416
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.857467140399416
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.857467140399416
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.857467140399416
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.857467140399416
SICKLE CELL ANEMIA	0.0172414	0.857467140399416
ERYTHERMALGIA, PRIMARY	0.0172414	0.857467140399416
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.857467140399416
CARDIAC ARRHYTHMIA	0.0172414	0.857467140399416
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.857467140399416
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.857467140399416
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.857467140399416
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.857467140399416
JUMPING FRENCHMAN OF MAINE	0.0172414	0.857467140399416
DIASTEMATOMYELIA	0.0172414	0.857467140399416
MOTION SICKNESS	0.0172414	0.857467140399416
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.857467140399416
MOSAIC TRISOMY 15	0.0172414	0.857467140399416
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.857467140399416
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.857467140399416
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.857467140399416
CERVICAL RIB	0.0172414	0.857467140399416
MYOPATHY, CONGENITAL	0.0172414	0.857467140399416
ALCOHOL DEPENDENCE	0.0172414	0.857467140399416
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.857467140399416
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.857467140399416
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.857467140399416
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.857467140399416
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.857467140399416
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.857467140399416
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.857467140399416
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.857467140399416
TRANSSEXUALITY	0.0172414	0.857467140399416
ISOLATED COMPLEX I DEFICIENCY	0.017180103999999998	0.8544187043189396
GLYCOGEN STORAGE DISEASE IXC	0.01714325	0.8525858430668208
SNEDDON SYNDROME	0.01713503	0.8521770375235308
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.01708337	0.8496078289631451
RIBOFLAVIN DEFICIENCY	0.01708337	0.8496078289631451
GLUTARIC ACIDEMIA I; GA1	0.01708337	0.8496078289631451
CITRULLINEMIA TYPE I	0.016875099999999997	0.8392499298754267
GLYCOGEN STORAGE DISEASE IXA	0.016767670000000002	0.8339071099830104
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.016767670000000002	0.8339071099830104
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.016642334	0.8276737703754901
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.016642334	0.8276737703754901
BRAIN-LUNG-THYROID SYNDROME	0.016619924	0.8265592530731624
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.016606324	0.8258828838044584
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.016413353999999998	0.816285900144032
PEHO-LIKE SYNDROME; PEHOL	0.016413353999999998	0.816285900144032
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.016413353999999998	0.816285900144032
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.016413353999999998	0.816285900144032
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.016413353999999998	0.816285900144032
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.016222034	0.8067709759904704
VERVERI-BRADY SYNDROME; VERBRAS	0.01607437	0.7994271971894485
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.01606077	0.7987508279207446
HYPERMANGANESEMIA WITH DYSTONIA 2	0.016030184000000003	0.7972296933286435
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.015961334	0.7938055739058296
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.015867799999999998	0.7891538442603182
HOLOPROSENCEPHALY	0.015707274	0.7811703991700265
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.015519384000000002	0.771826059324675
GALACTOSEMIA	0.015453664	0.7685576042997321
SMITH-MAGENIS SYNDROME	0.015451564000000003	0.7684531649273587
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.01541578	0.7666735180221158
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.01541578	0.7666735180221158
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.015251454	0.7585010874008626
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.015251454	0.7585010874008626
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.015251454	0.7585010874008626
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.015251454	0.7585010874008626
ARGININEMIA	0.015251454	0.7585010874008626
LEPRECHAUNISM	0.015161720000000002	0.7540383432863128
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.015159680000000002	0.7539368878960072
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.015099083999999999	0.7509232649396553
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.015099083999999999	0.7509232649396553
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.015010904	0.7465378059606618
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.015000583999999999	0.7460245610449981
CEDNIK SYNDROME	0.015000583999999999	0.7460245610449981
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.015000583999999999	0.7460245610449981
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.014898980000000001	0.7409714858113663
KERATOSIS, FAMILIAL ACTINIC	0.014898980000000001	0.7409714858113663
GLOMUVENOUS MALFORMATIONS	0.014898980000000001	0.7409714858113663
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.014898980000000001	0.7409714858113663
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.014898980000000001	0.7409714858113663
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.014898980000000001	0.7409714858113663
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.01489242	0.7406452371052855
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.01480114	0.7361056057194549
KOOLEN-DE VRIES SYNDROME; KDVS	0.014784524000000002	0.7352792416188091
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.014762954000000002	0.7342065000654309
MENTAL RETARDATION, X-LINKED 98; MRX98	0.014762954000000002	0.7342065000654309
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.014762954000000002	0.7342065000654309
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.014762954000000002	0.7342065000654309
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.014762954000000002	0.7342065000654309
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.014762954000000002	0.7342065000654309
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.014762954000000002	0.7342065000654309
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.0147059	0.7313690315171488
PATENT DUCTUS VENOSUS	0.0147059	0.7313690315171488
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.0147059	0.7313690315171488
SPLENOPORTAL VASCULAR ANOMALIES	0.0147059	0.7313690315171488
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.0147059	0.7313690315171488
ARGININOSUCCINIC ACIDURIA	0.0147059	0.7313690315171488
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.014648	0.7284894888217107
GM1 GANGLIOSIDOSIS	0.01454753	0.7234928108491604
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.014437123999999999	0.7180019854461805
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.014437123999999999	0.7180019854461805
LEIGH SYNDROME; LS	0.014437123999999999	0.7180019854461805
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.014437123999999999	0.7180019854461805
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.014437123999999999	0.7180019854461805
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.014437123999999999	0.7180019854461805
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.014425984000000001	0.7174479594422569
SAY-BARBER-MILLER SYNDROME	0.014425984000000001	0.7174479594422569
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.014425984000000001	0.7174479594422569
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.014336594000000001	0.7130023234915625
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.014256729999999999	0.7090304444271673
2P21 MICRODELETION SYNDROME	0.014254474	0.7089182467014177
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.014254474	0.7089182467014177
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.014244153999999998	0.708405001785754
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.014244153999999998	0.708405001785754
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.014244153999999998	0.708405001785754
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.014244153999999998	0.708405001785754
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.014244153999999998	0.708405001785754
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.014244153999999998	0.708405001785754
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.014244153999999998	0.708405001785754
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.014244153999999998	0.708405001785754
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.014244153999999998	0.708405001785754
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.014244153999999998	0.708405001785754
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.014244153999999998	0.708405001785754
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.014244153999999998	0.708405001785754
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.014244153999999998	0.708405001785754
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.014244153999999998	0.708405001785754
ABETAL34V AMYLOIDOSIS	0.014244153999999998	0.708405001785754
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.014244153999999998	0.708405001785754
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.014244153999999998	0.708405001785754
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.014244153999999998	0.708405001785754
MEIER-GORLIN SYNDROME 7	0.014244153999999998	0.708405001785754
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.014244153999999998	0.708405001785754
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.014244153999999998	0.708405001785754
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.014244153999999998	0.708405001785754
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.014244153999999998	0.708405001785754
DUBOWITZ SYNDROME	0.014238970000000002	0.7081471857350953
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.014217400000000002	0.707074444181717
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.014217400000000002	0.707074444181717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.014217400000000002	0.707074444181717
PALLISTER-KILLIAN SYNDROME	0.014217400000000002	0.707074444181717
CLASSIC PHENYLKETONURIA	0.014172374	0.7048351645719623
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.01407408	0.6999467056824046
JACOBSEN SYNDROME	0.014028094000000001	0.6976596823595651
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.013891569999999999	0.6908699295624667
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.013891569999999999	0.6908699295624667
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.013891569999999999	0.6908699295624667
IMMUNODEFICIENCY 55; IMD55	0.013880430000000001	0.6903159035585431
NEUROLEPTIC MALIGNANT SYNDROME	0.013853130000000002	0.688958191717689
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.013827894	0.6877031288599673
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.0137971	0.6861716497966975
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0137971	0.6861716497966975
CUTIS LAXA	0.013767394	0.6846942802749241
SALT-AND-PEPPER SYNDROME	0.013756933999999998	0.6841740727344355
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.01370892	0.681786190817704
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.013698599999999998	0.6812729459020402
AORTA COARCTATION	0.013698599999999998	0.6812729459020402
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.013698599999999998	0.6812729459020402
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.013698599999999998	0.6812729459020402
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.013698599999999998	0.6812729459020402
SECONDARY POLYCYTHEMIA	0.013698599999999998	0.6812729459020402
ABETA AMYLOIDOSIS, IOWA TYPE	0.013698599999999998	0.6812729459020402
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.013698599999999998	0.6812729459020402
STROKE, ISCHEMIC	0.013698599999999998	0.6812729459020402
ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	0.013698599999999998	0.6812729459020402
DERMOGRAPHISM, FAMILIAL	0.013698599999999998	0.6812729459020402
WALDENSTRÃ–M MACROGLOBULINEMIA	0.013698599999999998	0.6812729459020402
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.013698599999999998	0.6812729459020402
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.013698599999999998	0.6812729459020402
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.013698599999999998	0.6812729459020402
RETT SYNDROME, CONGENITAL VARIANT	0.013698599999999998	0.6812729459020402
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.013698599999999998	0.6812729459020402
ACYS AMYLOIDOSIS	0.013698599999999998	0.6812729459020402
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.013698599999999998	0.6812729459020402
ABETA AMYLOIDOSIS, DUTCH TYPE	0.013698599999999998	0.6812729459020402
CARDIOMYOPATHY, DILATED, 1E	0.013698599999999998	0.6812729459020402
EISENMENGER SYNDROME	0.013698599999999998	0.6812729459020402
POLYCYTHEMIA VERA	0.013698599999999998	0.6812729459020402
WOLFF-PARKINSON-WHITE SYNDROME	0.013698599999999998	0.6812729459020402
MOYAMOYA DISEASE WITH EARLY-ONSET ACHALASIA	0.013698599999999998	0.6812729459020402
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.013698599999999998	0.6812729459020402
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.013698599999999998	0.6812729459020402
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.013698599999999998	0.6812729459020402
ANEURYSM OF SINUS OF VALSALVA	0.013698599999999998	0.6812729459020402
SICKLE CELL ANEMIA	0.013698599999999998	0.6812729459020402
APPARENT MINERALOCORTICOID EXCESS	0.013698599999999998	0.6812729459020402
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.013698599999999998	0.6812729459020402
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.013698599999999998	0.6812729459020402
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.013698599999999998	0.6812729459020402
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.013698599999999998	0.6812729459020402
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.013698599999999998	0.6812729459020402
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.013698599999999998	0.6812729459020402
ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	0.013698599999999998	0.6812729459020402
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.013698599999999998	0.6812729459020402
AMYLOIDOSIS VI	0.013698599999999998	0.6812729459020402
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.013698599999999998	0.6812729459020402
STURGE-WEBER SYNDROME	0.013698599999999998	0.6812729459020402
PSEUDOXANTHOMA ELASTICUM; PXE	0.013698599999999998	0.6812729459020402
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.013698599999999998	0.6812729459020402
FAMILIAL AORTIC DISSECTION	0.013698599999999998	0.6812729459020402
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.013698599999999998	0.6812729459020402
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.01353743	0.6732574727375541
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.01353743	0.6732574727375541
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.013350184000000003	0.6639451609663971
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01326665	0.6597907616655208
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.013124	0.652696344299299
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.012929884	0.6430423665813775
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.012905144	0.6418119713087499
COG2-CDG	0.012593754000000002	0.626325601707153
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.012593754000000002	0.626325601707153
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.012593754000000002	0.626325601707153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012593754000000002	0.626325601707153
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.012593754000000002	0.626325601707153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.012593754000000002	0.626325601707153
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.012593754000000002	0.626325601707153
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.012593754000000002	0.626325601707153
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.012593754000000002	0.626325601707153
RECOMBINANT CHROMOSOME 8 SYNDROME	0.012593754000000002	0.626325601707153
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.012593754000000002	0.626325601707153
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.012593754000000002	0.626325601707153
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.012593754000000002	0.626325601707153
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.012593754000000002	0.626325601707153
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.012593754000000002	0.626325601707153
8Q24.3 MICRODELETION SYNDROME	0.012593754000000002	0.626325601707153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.012593754000000002	0.626325601707153
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.012593754000000002	0.626325601707153
LISSENCEPHALY 1; LIS1	0.012593754000000002	0.626325601707153
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.012413084000000001	0.617340334370628
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.01235959	0.6146799154250361
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.01235959	0.6146799154250361
CLASSIC GALACTOSEMIA	0.0122723	0.610338718846715
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.0122702	0.6102342794743416
TEMPLE SYNDROME	0.0122702	0.6102342794743416
BOWEN-CONRADI SYNDROME	0.012212420000000002	0.6073607047430392
COFFIN-LOWRY SYNDROME	0.01221242	0.6073607047430392
ALLAN-HERNDON-DUDLEY SYNDROME	0.01221242	0.6073607047430392
21Q22.11Q22.12 MICRODELETION SYNDROME	0.01221242	0.6073607047430392
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.01221242	0.6073607047430392
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.012173454	0.6054228073221335
CEREBELLAR ATAXIA, CAYMAN TYPE	0.012173454	0.6054228073221335
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.012173454	0.6054228073221335
MEDULLOBLASTOMA	0.012173454	0.6054228073221335
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.012173454	0.6054228073221335
SPINOCEREBELLAR ATAXIA TYPE 29	0.012173454	0.6054228073221335
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.012173454	0.6054228073221335
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.012173454	0.6054228073221335
PEROXISOME BIOGENESIS DISORDER 6B	0.012173454	0.6054228073221335
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.012173454	0.6054228073221335
SPINOCEREBELLAR ATAXIA 5; SCA5	0.012173454	0.6054228073221335
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.012173454	0.6054228073221335
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.012173454	0.6054228073221335
RETT SYNDROME; RTT	0.012048200000000002	0.5991935458234392
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.012048200000000002	0.5991935458234392
MENTAL RETARDATION, X-LINKED 1	0.012048200000000002	0.5991935458234392
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.012048200000000002	0.5991935458234392
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.012048200000000002	0.5991935458234392
BARAITSER-WINTER SYNDROME 2; BRWS2	0.012048200000000002	0.5991935458234392
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.012048200000000002	0.5991935458234392
WARBURG MICRO SYNDROME 3; WARBM3	0.012048200000000002	0.5991935458234392
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.012048200000000002	0.5991935458234392
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.01195172	0.5943953026583982
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.01195172	0.5943953026583982
CAMOS SYNDROME	0.011867530000000001	0.5902082784869142
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.011867530000000001	0.5902082784869142
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.011867530000000001	0.5902082784869142
AICARDI SYNDROME; AIC	0.011867530000000001	0.5902082784869142
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.011867530000000001	0.5902082784869142
ADENYLOSUCCINATE LYASE DEFICIENCY	0.01185388	0.589529422566487
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.011740844	0.5839077992828681
CURRY-JONES SYNDROME	0.011656654	0.5797207751113839
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.011636384	0.5787126865028082
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.0116279	0.5782907514384196
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.0116279	0.5782907514384196
SPINOCEREBELLAR ATAXIA TYPE 6	0.0116279	0.5782907514384196
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.0116279	0.5782907514384196
MYOCLONUS AND ATAXIA	0.0116279	0.5782907514384196
EPISODIC ATAXIA, TYPE 8	0.0116279	0.5782907514384196
SPINOCEREBELLAR ATAXIA TYPE 10	0.0116279	0.5782907514384196
SPINOCEREBELLAR ATAXIA TYPE 35	0.0116279	0.5782907514384196
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.0116279	0.5782907514384196
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.0116279	0.5782907514384196
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.0116279	0.5782907514384196
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.0116279	0.5782907514384196
DEMENTIA, FAMILIAL DANISH	0.0116279	0.5782907514384196
SPINOCEREBELLAR ATAXIA 40; SCA40	0.0116279	0.5782907514384196
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.0116279	0.5782907514384196
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.0116279	0.5782907514384196
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.0116279	0.5782907514384196
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.0116279	0.5782907514384196
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0116279	0.5782907514384196
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.0116279	0.5782907514384196
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0116279	0.5782907514384196
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.0116279	0.5782907514384196
UNVERRICHT-LUNDBORG DISEASE	0.0116279	0.5782907514384196
SPINOCEREBELLAR ATAXIA TYPE 40	0.0116279	0.5782907514384196
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.0116279	0.5782907514384196
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.0116279	0.5782907514384196
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.0116279	0.5782907514384196
BOUCHER-NEUHAUSER SYNDROME	0.0116279	0.5782907514384196
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.0116279	0.5782907514384196
FRIEDREICH ATAXIA	0.0116279	0.5782907514384196
PARKINSONIAN-PYRAMIDAL SYNDROME	0.0116279	0.5782907514384196
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.01160316	0.577060356165792
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.011587733999999999	0.5762931743761577
MENKES DISEASE	0.011471680000000001	0.5705214567945278
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.01145599	0.5697411454837951
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.01145599	0.5697411454837951
SHASHI-PENA SYNDROME; SHAPNS	0.011260804000000001	0.5600339534189976
NEONATAL ADRENOLEUKODYSTROPHY	0.01119529	0.5567757433991541
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.01111314	0.5526901746179756
GROWTH HORMONE INSENSITIVITY SYNDROME	0.01111314	0.5526901746179756
TRIOPIA	0.0111111	0.55258871922767
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.0111111	0.55258871922767
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0111111	0.55258871922767
COMEDONES, FAMILIAL DYSKERATOTIC	0.0111111	0.55258871922767
PYCNODYSOSTOSIS	0.0111111	0.55258871922767
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.0111111	0.55258871922767
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	0.0111111	0.55258871922767
POLYVALVULAR HEART DISEASE SYNDROME	0.0111111	0.55258871922767
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0111111	0.55258871922767
AMYLOIDOSIS, CUTANEOUS BULLOUS	0.0111111	0.55258871922767
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.0111111	0.55258871922767
CALLOSITIES, HEREDITARY PAINFUL	0.0111111	0.55258871922767
PRENATAL BOWING	0.0111111	0.55258871922767
MARFANOID HYPERMOBILITY SYNDROME	0.0111111	0.55258871922767
CAROTENEMIA, FAMILIAL	0.0111111	0.55258871922767
PAPILLOMATOSIS, FLORID, OF NIPPLE	0.0111111	0.55258871922767
LICHEN PLANUS, FAMILIAL	0.0111111	0.55258871922767
SCALP-EAR-NIPPLE SYNDROME	0.0111111	0.55258871922767
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.0111111	0.55258871922767
SYRINGOMAS, MULTIPLE	0.0111111	0.55258871922767
FUTCHER LINE	0.0111111	0.55258871922767
131600 EPIDERMOID CYSTS	0.0111111	0.55258871922767
INSECT STINGS, HYPERSENSITIVITY TO	0.0111111	0.55258871922767
PSEUDOATROPHODERMA COLLI	0.0111111	0.55258871922767
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.0111111	0.55258871922767
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.0111111	0.55258871922767
PILONIDAL SINUS	0.0111111	0.55258871922767
PIGMENTED PURPURIC ERUPTION	0.0111111	0.55258871922767
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.0111111	0.55258871922767
LATERAL MENINGOCELE SYNDROME	0.0111111	0.55258871922767
PERIODONTITIS, AGGRESSIVE, 1	0.0111111	0.55258871922767
METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	0.0111111	0.55258871922767
EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	0.0111111	0.55258871922767
TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	0.0111111	0.55258871922767
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0111111	0.55258871922767
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.0111111	0.55258871922767
PATELLA APLASIA-HYPOPLASIA	0.0111111	0.55258871922767
FASCIAL DYSTROPHY, CONGENITAL	0.0111111	0.55258871922767
TRICHILEMMAL CYST 1	0.0111111	0.55258871922767
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.0111111	0.55258871922767
NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	0.0111111	0.55258871922767
SIMOSA CRANIOFACIAL SYNDROME	0.0111111	0.55258871922767
SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	0.0111111	0.55258871922767
DERMATOSIS PAPULOSA NIGRA	0.0111111	0.55258871922767
LENTIGINES	0.0111111	0.55258871922767
HYPOPLASMINOGENEMIA	0.0111111	0.55258871922767
PARANA HARD-SKIN SYNDROME	0.0111111	0.55258871922767
KYRLE DISEASE	0.0111111	0.55258871922767
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.0111111	0.55258871922767
ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL	0.0111111	0.55258871922767
DERMAL RIDGES, PATTERNLESS	0.0111111	0.55258871922767
ACROMIAL DIMPLES	0.0111111	0.55258871922767
MUCOPOLYSACCHARIDOSIS TYPE IX	0.0111111	0.55258871922767
TYROSINE TRANSAMINASE DEFICIENCY	0.0111111	0.55258871922767
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0111111	0.55258871922767
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.0111111	0.55258871922767
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.0111111	0.55258871922767
CONO-SPONDYLAR DYSPLASIA	0.01109745	0.551909863307243
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.011024234	0.5482686094559615
MICROVILLUS INCLUSION DISEASE	0.010962254000000001	0.5451861559799123
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.010962254000000001	0.5451861559799123
ISOVALERIC ACIDEMIA	0.010962254000000001	0.5451861559799123
ISOLATED GLYCEROL KINASE DEFICIENCY	0.010962254000000001	0.5451861559799123
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.010962254000000001	0.5451861559799123
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.010962254000000001	0.5451861559799123
HYDROXYKYNURENINURIA	0.010962254000000001	0.5451861559799123
4Q21 MICRODELETION SYNDROME	0.01084384	0.5392970684369485
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.01084384	0.5392970684369485
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.010735944	0.5339310729504719
ROIFMAN SYNDROME; RFMN	0.010735944	0.5339310729504719
2Q37 MICRODELETION SYNDROME	0.010735944	0.5339310729504719
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.010735944	0.5339310729504719
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.01071525	0.5329018975352838
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.010646554	0.5294854369997776
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.010646554	0.5294854369997776
ALSTROM SYNDROME; ALMS	0.010646554	0.5294854369997776
ALSTRÃ–M SYNDROME	0.010646554	0.5294854369997776
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.010646554	0.5294854369997776
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.010646554	0.5294854369997776
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.010513434	0.5228649754519931
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.010416700000000001	0.5180541000961986
MALIGNANT HYPERTHERMIA OF ANESTHESIA	0.010416700000000001	0.5180541000961986
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.010416700000000001	0.5180541000961986
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.010416700000000001	0.5180541000961986
PRIMARY HYPEROXALURIA	0.010416700000000001	0.5180541000961986
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.010416700000000001	0.5180541000961986
LACTASE DEFICIENCY, CONGENITAL	0.010416700000000001	0.5180541000961986
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.010416700000000001	0.5180541000961986
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.010416700000000001	0.5180541000961986
SUDDEN CARDIAC FAILURE, INFANTILE	0.010416700000000001	0.5180541000961986
HAWKINSINURIA	0.010416700000000001	0.5180541000961986
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.010416700000000001	0.5180541000961986
HAWKINSINURIA	0.010416700000000001	0.5180541000961986
LARON SYNDROME	0.01035671	0.5150706153587317
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.01033304	0.51389343443298
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.01033304	0.51389343443298
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.01033304	0.51389343443298
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.010320504	0.5132699811129452
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.010320504	0.5132699811129452
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.01028575	0.5115415592331999
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.01019039	0.5067990170667582
ROIFMAN SYNDROME	0.01019039	0.5067990170667582
DISTAL TRISOMY 5Q	0.01019039	0.5067990170667582
PHENYLKETONURIA	0.01019039	0.5067990170667582
DUBOWITZ SYNDROME	0.01019039	0.5067990170667582
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.010101	0.5023533811160638
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.010101	0.5023533811160638
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.010101	0.5023533811160638
HYPERTRIGLYCERIDEMIA, FAMILIAL	0.010101	0.5023533811160638
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.010101	0.5023533811160638
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.010101	0.5023533811160638
MICROCEPHALIC PRIMORDIAL DWARFISM-INSULIN RESISTANCE SYNDROME	0.010101	0.5023533811160638
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.010101	0.5023533811160638
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.010101	0.5023533811160638
NEUTRAL LIPID STORAGE MYOPATHY	0.010101	0.5023533811160638
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.010101	0.5023533811160638
RECURRENT ACUTE PANCREATITIS	0.010101	0.5023533811160638
TANGIER DISEASE	0.010101	0.5023533811160638
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.010101	0.5023533811160638
HYPERLIPOPROTEINEMIA, TYPE IV	0.010101	0.5023533811160638
NIEMANN-PICK DISEASE, TYPE B	0.010101	0.5023533811160638
CIDEC-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.5023533811160638
HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE; ARH	0.010101	0.5023533811160638
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.010101	0.5023533811160638
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.010101	0.5023533811160638
LIPE-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.5023533811160638
LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	0.010101	0.5023533811160638
HYPERLIPIDEMIA DUE TO HEPATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.010101	0.5023533811160638
LCAT DEFICIENCY	0.010101	0.5023533811160638
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.010101	0.5023533811160638
FISH-EYE DISEASE	0.010101	0.5023533811160638
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.010101	0.5023533811160638
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.010101	0.5023533811160638
NIEMANN-PICK DISEASE TYPE B	0.010101	0.5023533811160638
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.5023533811160638
AKT2-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.5023533811160638
ACQUIRED GENERALIZED LIPODYSTROPHY	0.010101	0.5023533811160638
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.010101	0.5023533811160638
APOLIPOPROTEIN C-II DEFICIENCY	0.010101	0.5023533811160638
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.010101	0.5023533811160638
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.010101	0.5023533811160638
LYSOSOMAL ACID LIPASE DEFICIENCY	0.010101	0.5023533811160638
ATHEROSCLEROSIS SUSCEPTIBILITY	0.010101	0.5023533811160638
DYSBETALIPOPROTEINEMIA	0.010101	0.5023533811160638
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.010101	0.5023533811160638
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.010101	0.5023533811160638
CHOLESTERYL ESTER STORAGE DISEASE	0.010101	0.5023533811160638
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.010101	0.5023533811160638
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.010101	0.5023533811160638
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.010101	0.5023533811160638
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.010101	0.5023533811160638
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.010101	0.5023533811160638
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.010101	0.5023533811160638
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.010101	0.5023533811160638
MANDIBULOACRAL DYSPLASIA	0.010101	0.5023533811160638
PLIN1-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.5023533811160638
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.010101	0.5023533811160638
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.010101	0.5023533811160638
HYPERCHOLESTEROLEMIA DUE TO CHOLESTEROL 7ALPHA-HYDROXYLASE DEFICIENCY	0.010101	0.5023533811160638
H SYNDROME	0.010101	0.5023533811160638
PELGER-HUET ANOMALY; PHA	0.009979514	0.4963115136912279
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.009979514	0.4963115136912279
SULFOCYSTEINURIA	0.009979514	0.4963115136912279
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.009979514	0.4963115136912279
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.009979514	0.4963115136912279
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.009979514	0.4963115136912279
NETHERTON SYNDROME	0.009979514	0.4963115136912279
CHROMOSOME 2Q37 DELETION SYNDROME	0.009979514	0.4963115136912279
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.009979514	0.4963115136912279
SHWACHMAN-DIAMOND SYNDROME	0.009979514	0.4963115136912279
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.009757004	0.48524541619274897
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.009757004	0.48524541619274897
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.009757004	0.48524541619274897
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.009757004	0.48524541619274897
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00957661	0.47627387517373587
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.00957661	0.47627387517373587
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.00957661	0.47627387517373587
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.009564073999999999	0.47565042185370116
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.009564073999999999	0.47565042185370116
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.009564073999999999	0.47565042185370116
WISKOTT-ALDRICH SYNDROME	0.00943396	0.4691794578075141
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00943396	0.4691794578075141
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.00943396	0.4691794578075141
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.00943396	0.4691794578075141
CASPASE 8 DEFICIENCY	0.00943396	0.4691794578075141
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00943396	0.4691794578075141
PORPHYRIA CUTANEA TARDA, TYPE I	0.00943396	0.4691794578075141
CHRONIC GRANULOMATOUS DISEASE	0.00943396	0.4691794578075141
PITYRIASIS RUBRA PILARIS	0.00943396	0.4691794578075141
DERMATITIS HERPETIFORMIS	0.00943396	0.4691794578075141
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00943396	0.4691794578075141
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.00943396	0.4691794578075141
8Q21.11 MICRODELETION SYNDROME	0.00943396	0.4691794578075141
AUTOSOMAL DOMINANT HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00943396	0.4691794578075141
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.00943396	0.4691794578075141
HEREDITARY ACROKERATOTIC POIKILODERMA	0.00943396	0.4691794578075141
NEUTROPHIL CHEMOTACTIC RESPONSE	0.00943396	0.4691794578075141
EPIDERMOLYTIC PALMOPLANTAR KERATODERMA	0.00943396	0.4691794578075141
MYCOSIS FUNGOIDES	0.00943396	0.4691794578075141
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.00943396	0.4691794578075141
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.00943396	0.4691794578075141
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00943396	0.4691794578075141
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00943396	0.4691794578075141
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.00943396	0.4691794578075141
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.00943396	0.4691794578075141
COFFIN-SIRIS SYNDROME 8; CSS8	0.00943396	0.4691794578075141
IMMUNODEFICIENCY 50; IMD50	0.00943396	0.4691794578075141
THROMBOCYTOPENIA 1	0.00943396	0.4691794578075141
CLASSICAL EHLERS-DANLOS SYNDROME	0.00943396	0.4691794578075141
BULLOUS PEMPHIGOID	0.00943396	0.4691794578075141
CLASSIC MYCOSIS FUNGOIDES	0.00943396	0.4691794578075141
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.00943396	0.4691794578075141
BLAU SYNDROME	0.00943396	0.4691794578075141
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.00943396	0.4691794578075141
AUTOSOMAL ERYTHROPOIETIC PROTOPORPHYRIA	0.00943396	0.4691794578075141
ELASTODERMA	0.00943396	0.4691794578075141
CRANIO-OSTEOARTHROPATHY	0.00943396	0.4691794578075141
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.00921145	0.4581133603090352
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.00921145	0.4581133603090352
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.009138444	0.4544825503949912
CHROMOSOME 16P13.3 DELETION SYNDROME	0.009040604	0.4496166703030799
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.009040604	0.4496166703030799
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.009018519999999999	0.4485183659699873
SMITH-KINGSMORE SYNDROME; SKS	0.00883587	0.43943462722522453
PYRUVATE DEHYDROGENASE DEFICIENCY	0.008786994000000001	0.4370038754327854
ADENYLOSUCCINASE DEFICIENCY	0.008709394	0.43314459195841587
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.008709394	0.43314459195841587
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.008709394	0.43314459195841587
JABERI-ELAHI SYNDROME; JABELS	0.008428454	0.41917259325623313
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.008428454	0.41917259325623313
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.008382014	0.41686299113574715
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.008344233999999999	0.4149840770937151
INFANTILE LIVER FAILURE SYNDROME 1	0.008344233999999999	0.4149840770937151
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.008344233999999999	0.4149840770937151
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.008284174	0.4119971110438358
DPM1-CDG	0.00816384	0.406012536074702
YUNIS-VARON SYNDROME	0.00816384	0.406012536074702
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.00816384	0.406012536074702
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00816384	0.406012536074702
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.00816384	0.406012536074702
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.00816384	0.406012536074702
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00816384	0.406012536074702
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.00816384	0.406012536074702
MONOSOMY 5P	0.00816384	0.406012536074702
MEHMO SYNDROME	0.00816384	0.406012536074702
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00816384	0.406012536074702
LOWRY-MACLEAN SYNDROME	0.00816384	0.406012536074702
HEREDITARY METHEMOGLOBINEMIA	0.00816384	0.406012536074702
DISTAL MONOSOMY 10P	0.00816384	0.406012536074702
CROME SYNDROME	0.00816384	0.406012536074702
KEPPEN-LUBINSKY SYNDROME	0.00816384	0.406012536074702
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00816384	0.406012536074702
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00816384	0.406012536074702
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.00816384	0.406012536074702
HALL-RIGGS SYNDROME	0.00816384	0.406012536074702
RING CHROMOSOME 7 SYNDROME	0.00816384	0.406012536074702
TEMPLE-BARAITSER SYNDROME	0.00816384	0.406012536074702
SECKEL SYNDROME 7; SCKL7	0.00816384	0.406012536074702
JOUBERT SYNDROME	0.008030564	0.39938431617354136
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.008030564	0.39938431617354136
OROFACIODIGITAL SYNDROME TYPE 6	0.008030564	0.39938431617354136
48,XXYY SYNDROME	0.008030564	0.39938431617354136
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.007968654	0.3963053440099045
HOLOPROSENCEPHALY 1; HPE1	0.007968654	0.3963053440099045
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.007968654	0.3963053440099045
MEHMO SYNDROME; MEHMO	0.007968654	0.3963053440099045
300270 ADRENOMYODYSTROPHY	0.007952964	0.3955250326991718
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.3955250326991718
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.007952964	0.3955250326991718
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.3955250326991718
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.007952964	0.3955250326991718
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00783646	0.3897309352520333
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.00783646	0.3897309352520333
CONGENITAL ADRENAL HYPERPLASIA	0.00783646	0.3897309352520333
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00783646	0.3897309352520333
%608572 BURN-MCKEOWN SYNDROME	0.00783646	0.3897309352520333
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00779868	0.38785202121000134
3-HYDROXYISOBUTYRIC ACIDURIA	0.00779868	0.38785202121000134
PSEUDO-TORCH SYNDROME 2	0.00779868	0.38785202121000134
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00779868	0.38785202121000134
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00779868	0.38785202121000134
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.00773862	0.38486505516012204
CAMURATI-ENGELMANN DISEASE	0.00773862	0.38486505516012204
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.0076720239999999995	0.3815530339969891
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.00760575	0.37825702687095347
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00760575	0.37825702687095347
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.007587804	0.3773645178344711
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.007587804	0.3773645178344711
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.007587804	0.3773645178344711
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.007587804	0.3773645178344711
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.007587804	0.3773645178344711
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.007587804	0.3773645178344711
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.007587804	0.3773645178344711
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.007587804	0.3773645178344711
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.007587804	0.3773645178344711
GAUCHER DISEASE	0.00748501	0.37225226028982755
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00748501	0.37225226028982755
EPILEPSY-TELANGIECTASIA	0.00747792	0.3718996530754811
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00747792	0.3718996530754811
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.0074231	0.36917328812619066
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00740741	0.36839297681545796
QAZI-MARKOUIZOS SYNDROME	0.00740741	0.36839297681545796
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.36839297681545796
TRISOMY 13	0.00740741	0.36839297681545796
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.00740741	0.36839297681545796
ADRENOMYODYSTROPHY	0.00740741	0.36839297681545796
TRISOMY XQ28	0.00740741	0.36839297681545796
1Q41Q42 MICRODELETION SYNDROME	0.00740741	0.36839297681545796
ALLAN-HERNDON-DUDLEY SYNDROME	0.00740741	0.36839297681545796
8P INVERTED DUPLICATION/DELETION SYNDROME	0.00740741	0.36839297681545796
CRANIOFACIAL DYSSYNOSTOSIS	0.00740741	0.36839297681545796
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.36839297681545796
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00740741	0.36839297681545796
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.00740741	0.36839297681545796
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.36839297681545796
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.00740741	0.36839297681545796
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.00740741	0.36839297681545796
2Q24 MICRODELETION SYNDROME	0.00740741	0.36839297681545796
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.00740741	0.36839297681545796
SMITH-FINEMAN-MYERS SYNDROME	0.00740741	0.36839297681545796
KID SYNDROME	0.00740741	0.36839297681545796
LISSENCEPHALY 5; LIS5	0.00740741	0.36839297681545796
FRYNS SYNDROME	0.00740741	0.36839297681545796
INTELLECTUAL DISABILITY, WOLFF TYPE	0.00740741	0.36839297681545796
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.00740741	0.36839297681545796
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.007394874	0.36776952349542325
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.007394874	0.36776952349542325
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.007394874	0.36776952349542325
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.007394874	0.36776952349542325
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.007394874	0.36776952349542325
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.007394874	0.36776952349542325
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.007394874	0.36776952349542325
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.007394874	0.36776952349542325
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.007394874	0.36776952349542325
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.007394874	0.36776952349542325
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.007394874	0.36776952349542325
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.007394874	0.36776952349542325
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.007394874	0.36776952349542325
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.007394874	0.36776952349542325
EMANUEL SYNDROME	0.007259063999999999	0.3610152800849319
MYOPATHY, SPHEROID BODY	0.007224309999999999	0.3592868582051866
PERRY SYNDROME	0.007224309999999999	0.3592868582051866
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.007224309999999999	0.3592868582051866
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.007224309999999999	0.3592868582051866
GLUTATHIONURIA	0.007224309999999999	0.3592868582051866
TIMOTHY SYNDROME; TS	0.007212224000000001	0.3586857847506605
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.007212224000000001	0.3586857847506605
MIRAGE SYNDROME; MIRAGE	0.007212224000000001	0.3586857847506605
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.007212224000000001	0.3586857847506605
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.007212224000000001	0.3586857847506605
COSTELLO SYNDROME; CSTLO	0.007212224000000001	0.3586857847506605
SIMPSON-GOLABI-BEHMEL SYNDROME	0.007212224000000001	0.3586857847506605
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.007212224000000001	0.3586857847506605
PITUITARY STALK INTERRUPTION SYNDROME	0.007212224000000001	0.3586857847506605
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.007212224000000001	0.3586857847506605
HOLMES-GANG SYNDROME	0.007161224	0.3561493999930207
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.007161224	0.3561493999930207
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.007161224	0.3561493999930207
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.007161224	0.3561493999930207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.007161224	0.3561493999930207
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.007161224	0.3561493999930207
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.007161224	0.3561493999930207
SSR4-CDG	0.007161224	0.3561493999930207
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.007161224	0.3561493999930207
ALG11-CDG	0.007161224	0.3561493999930207
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.007161224	0.3561493999930207
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.007161224	0.3561493999930207
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.007161224	0.3561493999930207
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.007161224	0.3561493999930207
SÃ‰ZARY SYNDROME	0.007126469999999999	0.35442097811327533
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.00704225	0.35023246195075725
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00704225	0.35023246195075725
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.00704225	0.35023246195075725
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00704225	0.35023246195075725
SUCCINIC ACIDEMIA	0.00704225	0.35023246195075725
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 4; CEMCOX4	0.00704225	0.35023246195075725
PHENFORMIN 4-HYDROXYLATION	0.00704225	0.35023246195075725
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00704225	0.35023246195075725
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.00704225	0.35023246195075725
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.00704225	0.35023246195075725
GRACILE SYNDROME	0.00704225	0.35023246195075725
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00704225	0.35023246195075725
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.00704225	0.35023246195075725
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.00704225	0.35023246195075725
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00704225	0.35023246195075725
MYOPATHY, MITOCHONDRIAL, LETHAL INFANTILE	0.00704225	0.35023246195075725
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.006907613999999999	0.34353660512272616
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.006907613999999999	0.34353660512272616
TONNE-KALSCHEUER SYNDROME; TOKAS	0.006907613999999999	0.34353660512272616
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00684932	0.34063746761170943
GLYCOGEN STORAGE DISEASE XI; GSD11	0.00684932	0.34063746761170943
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.00684932	0.34063746761170943
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00684932	0.34063746761170943
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.00684932	0.34063746761170943
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00684932	0.34063746761170943
LEBER OPTIC ATROPHY AND DYSTONIA	0.00684932	0.34063746761170943
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00684932	0.34063746761170943
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00684932	0.34063746761170943
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00684932	0.34063746761170943
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00684932	0.34063746761170943
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00684932	0.34063746761170943
GLYCOGEN STORAGE DISEASE DUE TO LACTATE DEHYDROGENASE DEFICIENCY	0.00684932	0.34063746761170943
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.00684932	0.34063746761170943
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.00684932	0.34063746761170943
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.00684932	0.34063746761170943
PERRAULT SYNDROME 5; PRLTS5	0.00684932	0.34063746761170943
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00684932	0.34063746761170943
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00684932	0.34063746761170943
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.00684932	0.34063746761170943
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00671351	0.33388322420121813
HEMOCHROMATOSIS, NEONATAL	0.00666667	0.3315537288669467
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00666667	0.3315537288669467
PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL	0.00666667	0.3315537288669467
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00666667	0.3315537288669467
ENDOCARDIAL FIBROELASTOSIS	0.00666667	0.3315537288669467
POST-TRAUMATIC PITUITARY DEFICIENCY	0.00666667	0.3315537288669467
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.00666667	0.3315537288669467
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.00666667	0.3315537288669467
CADASIL	0.00666667	0.3315537288669467
SHEEHAN SYNDROME	0.00666667	0.3315537288669467
HEPATOCELLULAR CARCINOMA	0.00666667	0.3315537288669467
PANHYPOPITUITARISM	0.00666667	0.3315537288669467
SHORT STATURE DUE TO PARTIAL GHR DEFICIENCY	0.00666667	0.3315537288669467
MPI-CDG	0.00666667	0.3315537288669467
PITUITARY APOPLEXY	0.00666667	0.3315537288669467
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.00666667	0.3315537288669467
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.00666667	0.3315537288669467
SHORT STATURE DUE TO GHSR DEFICIENCY	0.00666667	0.3315537288669467
VISCERAL STEATOSIS, CONGENITAL	0.00666667	0.3315537288669467
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.00666667	0.3315537288669467
TYROSINEMIA, TYPE I; TYRSN1	0.00666667	0.3315537288669467
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.00666667	0.3315537288669467
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.00666667	0.3315537288669467
TENORIO SYNDROME; TNORS	0.00666667	0.3315537288669467
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00666667	0.3315537288669467
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2	0.00666667	0.3315537288669467
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00666667	0.3315537288669467
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.00666667	0.3315537288669467
CONGENITAL ISOLATED HYPERINSULINISM	0.00666667	0.3315537288669467
ORTHOSTATIC HYPOTENSION 2; ORTHYP2	0.00666667	0.3315537288669467
FRUCTOSE AND GALACTOSE INTOLERANCE	0.00666667	0.3315537288669467
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00666667	0.3315537288669467
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.00666667	0.3315537288669467
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00666667	0.3315537288669467
NEONATAL HEMOCHROMATOSIS	0.00666667	0.3315537288669467
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.00666667	0.3315537288669467
GLYCOGEN STORAGE DISEASE DUE TO LIVER GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00666667	0.3315537288669467
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00666667	0.3315537288669467
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.00661567	0.3290173441093069
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00661567	0.3290173441093069
DUPLICATION/INVERSION 15Q11	0.00661567	0.3290173441093069
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.006404794	0.31852984073377666
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.006404794	0.31852984073377666
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.006404794	0.31852984073377666
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.006404794	0.31852984073377666
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.006404794	0.31852984073377666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.006404794	0.31852984073377666
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.006404794	0.31852984073377666
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.006404794	0.31852984073377666
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.006404793999999999	0.3185298407337766
COCKAYNE SYNDROME	0.006362059999999999	0.31640454923901234
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.006151184	0.3059170458634821
JOUBERT SYNDROME WITH OCULAR DEFECT	0.006151184	0.3059170458634821
JOUBERT SYNDROME WITH RENAL DEFECT	0.006151184	0.3059170458634821
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.006151184	0.3059170458634821
GABRIELE-DE VRIES SYNDROME; GADEVS	0.006151184	0.3059170458634821
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00585924	0.29139778485006285
CRISS-CROSS HEART	0.00585924	0.29139778485006285
PRIMARY DYSTONIA, DYT2 TYPE	0.0056056299999999995	0.2787849899797683
CHOREOACANTHOCYTOSIS	0.0056056299999999995	0.2787849899797683
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.0056056299999999995	0.2787849899797683
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.005350564	0.26609978381129495
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.005350564	0.26609978381129495
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.005350564	0.26609978381129495
XQ28 (MECP2) DUPLICATION	0.005350564	0.26609978381129495
COFFIN-SIRIS SYNDROME 1; CSS1	0.005350564	0.26609978381129495
1P36 DELETION SYNDROME	0.005350564	0.26609978381129495
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.005350564	0.26609978381129495
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.005350564	0.26609978381129495
SMITH-LEMLI-OPITZ SYNDROME	0.005350564	0.26609978381129495
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.005350564	0.26609978381129495
KOOLEN-DE VRIES SYNDROME	0.005350564	0.26609978381129495
COFFIN-SIRIS SYNDROME	0.005350564	0.26609978381129495
PETERS-PLUS SYNDROME; PTRPLS	0.005350564	0.26609978381129495
TURNPENNY-FRY SYNDROME; TPFS	0.005350564	0.26609978381129495
RUBINSTEIN-TAYBI SYNDROME	0.005350564	0.26609978381129495
AICARDI-GOUTIERES SYNDROME 5	0.005350564	0.26609978381129495
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.005350564	0.26609978381129495
WITTEVEEN-KOLK SYNDROME	0.005350564	0.26609978381129495
CHROMOSOME 1P36 DELETION SYNDROME	0.005350564	0.26609978381129495
COHEN SYNDROME	0.005350564	0.26609978381129495
PETERS PLUS SYNDROME	0.005350564	0.26609978381129495
KABUKI SYNDROME 1	0.005350564	0.26609978381129495
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.005350564	0.26609978381129495
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.005089864	0.25313438172665403
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.005089864	0.25313438172665403
CHROMOSOME 10Q26 DELETION SYNDROME	0.0050898639999999995	0.25313438172665403
BARAITSER-WINTER SYNDROME 1; BRWS1	0.0050898639999999995	0.25313438172665403
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.004992024	0.2482685016347428
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.004992024	0.2482685016347428
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.004992024	0.2482685016347428
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.004992024	0.2482685016347428
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.004992024	0.2482685016347428
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.004992024	0.2482685016347428
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.004992024	0.2482685016347428
OROFACIODIGITAL SYNDROME XIV; OFD14	0.004992024	0.2482685016347428
HOLOPROSENCEPHALY 5; HPE5	0.004992024	0.2482685016347428
RING CHROMOSOME 12 SYNDROME	0.004992024	0.2482685016347428
16P13.2 MICRODELETION SYNDROME	0.004992024	0.2482685016347428
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.004992024	0.2482685016347428
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.004992024	0.2482685016347428
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.004992024	0.2482685016347428
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.004992024	0.2482685016347428
MONOSOMY 13Q34	0.004992024	0.2482685016347428
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.004992024	0.2482685016347428
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.004992024	0.2482685016347428
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.004992024	0.2482685016347428
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.004992024	0.2482685016347428
MATERNAL PHENYLKETONURIA	0.004992024	0.2482685016347428
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.004992024	0.2482685016347428
RIDDLE SYNDROME	0.004992024	0.2482685016347428
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.004992024	0.2482685016347428
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.004992024	0.2482685016347428
KLEEFSTRA SYNDROME 2; KLEFS2	0.004992023999999999	0.24826850163474273
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.004992023999999999	0.24826850163474273
MONOSOMY 18Q	0.004992023999999999	0.24826850163474273
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.004992023999999999	0.24826850163474273
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.004992023999999999	0.24826850163474273
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.004992023999999999	0.24826850163474273
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.004992023999999999	0.24826850163474273
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.004992023999999999	0.24826850163474273
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.004992023999999999	0.24826850163474273
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00480501	0.23896772792758114
2P15-16.1 MICRODELETION SYNDROME	0.00480501	0.23896772792758114
RING CHROMOSOME 1 SYNDROME	0.00480501	0.23896772792758114
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00480501	0.23896772792758114
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00480501	0.23896772792758114
CORNELIA DE LANGE SYNDROME	0.00480501	0.23896772792758114
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00480501	0.23896772792758114
COHEN SYNDROME	0.00480501	0.23896772792758114
GMS SYNDROME	0.00480501	0.23896772792758114
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.00480501	0.23896772792758114
MARTSOLF SYNDROME	0.00480501	0.23896772792758114
CRI-DU-CHAT SYNDROME	0.00480501	0.23896772792758114
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00480501	0.23896772792758114
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00480501	0.23896772792758114
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.00480501	0.23896772792758114
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00480501	0.23896772792758114
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.00480501	0.23896772792758114
PEDIATRIC-ONSET GRAVES DISEASE	0.004738414	0.23565570676444825
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.004738414	0.23565570676444825
AICARDI-GOUTIERES SYNDROME 6	0.004738414	0.23565570676444825
AICARDI-GOUTIÃˆRES SYNDROME	0.004738414	0.23565570676444825
12Q14 MICRODELETION SYNDROME	0.004738414	0.23565570676444825
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.004738414	0.23565570676444825
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.004738414	0.23565570676444825
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.004738414	0.23565570676444825
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.004738414	0.23565570676444825
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.004738414	0.23565570676444825
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.004738414	0.23565570676444825
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.004738414	0.23565570676444825
CONGENITAL HYPOTHYROIDISM	0.004594134000000001	0.22848022455205091
WEAVER SYNDROME	0.004594134000000001	0.22848022455205091
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.004594134000000001	0.22848022455205091
NIEMANN-PICK DISEASE, TYPE A	0.004594134000000001	0.22848022455205091
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.004594134000000001	0.22848022455205091
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.004594134000000001	0.22848022455205091
3C SYNDROME	0.004594134000000001	0.22848022455205091
JOUBERT SYNDROME 10	0.004594134000000001	0.22848022455205091
CANAVAN DISEASE	0.004594134000000001	0.22848022455205091
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.004594134000000001	0.22848022455205091
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.004594134000000001	0.22848022455205091
FOLATE MALABSORPTION, HEREDITARY	0.004594134000000001	0.22848022455205091
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.004594134000000001	0.22848022455205091
OCULOFACIOCARDIODENTAL SYNDROME	0.004594134000000001	0.22848022455205091
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.004594134000000001	0.22848022455205091
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.004594134000000001	0.22848022455205091
CARDIOFACIOCUTANEOUS SYNDROME	0.004594134000000001	0.22848022455205091
FLOATING-HARBOR SYNDROME	0.004594134000000001	0.22848022455205091
XYLOSIDASE DEFICIENCY	0.00454431	0.22600232584294022
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00454431	0.22600232584294022
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00454431	0.22600232584294022
ASPARTYLGLUCOSAMINURIA; AGU	0.00454431	0.22600232584294022
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00454431	0.22600232584294022
CARDIAC LIPIDOSIS, FAMILIAL	0.00454431	0.22600232584294022
46,XX GONADAL DYSGENESIS	0.00454431	0.22600232584294022
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00444647	0.22113644575102895
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00444647	0.22113644575102895
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.00444647	0.22113644575102895
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00444647	0.22113644575102895
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00444647	0.22113644575102895
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00444647	0.22113644575102895
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00444647	0.22113644575102895
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00444647	0.22113644575102895
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00444647	0.22113644575102895
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00444647	0.22113644575102895
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00444647	0.22113644575102895
RING CHROMOSOME 13 SYNDROME	0.00444647	0.22113644575102895
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00444647	0.22113644575102895
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00444647	0.22113644575102895
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00444647	0.22113644575102895
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00444647	0.22113644575102895
MENTAL RETARDATION, X-LINKED 102	0.00444647	0.22113644575102895
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00444647	0.22113644575102895
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00444647	0.22113644575102895
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00444647	0.22113644575102895
LARSEN-LIKE SYNDROME	0.004333434	0.21551482246740997
SALLA DISEASE	0.004333434	0.21551482246740997
EPILEPSY, PYRIDOXINE-DEPENDENT	0.004333434	0.21551482246740997
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004333434	0.21551482246740997
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.004333434	0.21551482246740997
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.004333434	0.21551482246740997
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.004333434	0.21551482246740997
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.004333434	0.21551482246740997
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.004333434	0.21551482246740997
REVESZ SYNDROME	0.004333434	0.21551482246740997
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.004235594	0.2106489423754987
MENTAL RETARDATION, X-LINKED 91; MRX91	0.004235594	0.2106489423754987
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.004235594	0.2106489423754987
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.004235594	0.2106489423754987
COFFIN-SIRIS SYNDROME 6; CSS6	0.004235594	0.2106489423754987
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.004235594	0.2106489423754987
7P22.1 MICRODUPLICATION SYNDROME	0.004235594	0.2106489423754987
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.004235594	0.2106489423754987
JOUBERT SYNDROME 35; JBTS35	0.004235594	0.2106489423754987
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.004235594	0.2106489423754987
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.004235594	0.2106489423754987
TRANSALDOLASE DEFICIENCY	0.004235594	0.2106489423754987
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.004235594	0.2106489423754987
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.004235594	0.2106489423754987
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.004235594	0.2106489423754987
6Q TERMINAL DELETION SYNDROME	0.004235594	0.2106489423754987
WILSON-TURNER SYNDROME	0.004235594	0.2106489423754987
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.004235594	0.2106489423754987
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.004235594	0.2106489423754987
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.004235594	0.2106489423754987
11P15.4 MICRODUPLICATION SYNDROME	0.004235594	0.2106489423754987
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.004235594	0.2106489423754987
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.004235594	0.2106489423754987
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.004235594	0.2106489423754987
FREE SIALIC ACID STORAGE DISEASE	0.004235594	0.2106489423754987
NOONAN SYNDROME 5; NS5	0.004235594	0.2106489423754987
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.004235594	0.2106489423754987
SYNDROMIC DIARRHEA	0.004235594	0.2106489423754987
ROIFMAN-CHITAYAT SYNDROME	0.004235594	0.2106489423754987
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.004235594	0.2106489423754987
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.004235594	0.2106489423754987
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.004235594	0.2106489423754987
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.004235594	0.2106489423754987
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.004235594	0.2106489423754987
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.004235594	0.2106489423754987
CHROMOSOME 16P13.2 DELETION SYNDROME	0.004235594	0.2106489423754987
SRD5A3-CDG	0.004235594	0.2106489423754987
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00419286	0.20852365088073443
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00419286	0.20852365088073443
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00419286	0.20852365088073443
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00419286	0.20852365088073443
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00419286	0.20852365088073443
COCKAYNE SYNDROME A; CSA	0.00419286	0.20852365088073443
TYROSINEMIA TYPE 2	0.00419286	0.20852365088073443
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.00419286	0.20852365088073443
DERMATOMYOSITIS	0.00404858	0.20134816866833713
FAMILIAL DYSAUTONOMIA	0.00404858	0.20134816866833713
ISOLATED POLYCYSTIC LIVER DISEASE	0.00404858	0.20134816866833713
AORTIC ARCH DEFECTS	0.00404858	0.20134816866833713
CHERUBISM	0.00404858	0.20134816866833713
ACROCARDIOFACIAL SYNDROME	0.00404858	0.20134816866833713
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.00404858	0.20134816866833713
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.00404858	0.20134816866833713
CAFFEY DISEASE	0.00404858	0.20134816866833713
FREEMAN-SHELDON SYNDROME	0.00404858	0.20134816866833713
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.00404858	0.20134816866833713
POTASSIUM-AGGRAVATED MYOTONIA	0.00404858	0.20134816866833713
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.00404858	0.20134816866833713
SCLERODERMA	0.00404858	0.20134816866833713
MYOTONIC DYSTROPHY 1	0.00404858	0.20134816866833713
HYPOPHOSPHATASIA	0.00404858	0.20134816866833713
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00404858	0.20134816866833713
STICKLER SYNDROME	0.00404858	0.20134816866833713
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.00404858	0.20134816866833713
MALAN OVERGROWTH SYNDROME	0.00404858	0.20134816866833713
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00404858	0.20134816866833713
MOEBIUS SYNDROME; MBS	0.00404858	0.20134816866833713
PIERRE ROBIN SYNDROME	0.00404858	0.20134816866833713
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.00404858	0.20134816866833713
GOLDENHAR SYNDROME	0.00404858	0.20134816866833713
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.00404858	0.20134816866833713
WOLFRAM SYNDROME	0.00404858	0.20134816866833713
NOONAN SYNDROME 7; NS7	0.00404858	0.20134816866833713
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.00404858	0.20134816866833713
JEUNE SYNDROME	0.00404858	0.20134816866833713
HYPOGLOSSIA WITH SITUS INVERSUS	0.00404858	0.20134816866833713
NEMALINE MYOPATHY 4	0.00404858	0.20134816866833713
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.00404858	0.20134816866833713
MOEBIUS SYNDROME	0.00404858	0.20134816866833713
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00404858	0.20134816866833713
INCLUSION BODY MYOSITIS	0.00404858	0.20134816866833713
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.00404858	0.20134816866833713
NOONAN SYNDROME	0.00404858	0.20134816866833713
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00404858	0.20134816866833713
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00404858	0.20134816866833713
HYPERKALEMIC PERIODIC PARALYSIS	0.00404858	0.20134816866833713
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00404858	0.20134816866833713
PEMPHIGUS VULGARIS	0.00404858	0.20134816866833713
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.00404858	0.20134816866833713
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00404858	0.20134816866833713
NEMALINE MYOPATHY 3; NEM3	0.00404858	0.20134816866833713
SYSTEMIC SCLEROSIS	0.00404858	0.20134816866833713
PRADER-WILLI SYNDROME (TYPE 2)	0.00404858	0.20134816866833713
OHDO SYNDROME	0.00404858	0.20134816866833713
2Q33.1 DELETION SYNDROME	0.00404858	0.20134816866833713
APERT SYNDROME	0.00404858	0.20134816866833713
STÃœVE-WIEDEMANN SYNDROME	0.00404858	0.20134816866833713
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00404858	0.20134816866833713
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00404858	0.20134816866833713
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.00404858	0.20134816866833713
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00404858	0.20134816866833713
16P11.2-P12.2 MICRODELETION SYNDROME	0.00404858	0.20134816866833713
PRADER-WILLI SYNDROME (TYPE 1)	0.00404858	0.20134816866833713
ADENOCARCINOMA OF THE ESOPHAGUS	0.00404858	0.20134816866833713
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.003981984	0.19803614750520418
PEROXISOME BIOGENESIS DISORDER 5B	0.003981984	0.19803614750520418
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.003981984	0.19803614750520418
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.003981984	0.19803614750520418
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.003981984	0.19803614750520418
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.003981984	0.19803614750520418
SIALIDOSIS TYPE 2	0.003981984	0.19803614750520418
NIEMANN-PICK DISEASE TYPE C	0.003981984	0.19803614750520418
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.003981984	0.19803614750520418
MENTAL RETARDATION, X-LINKED 104; MRX104	0.003981984	0.19803614750520418
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.003981984	0.19803614750520418
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.003981984	0.19803614750520418
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.003981984	0.19803614750520418
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.003981984	0.19803614750520418
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.003981984	0.19803614750520418
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.003981984	0.19803614750520418
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.003981984	0.19803614750520418
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.003981984	0.19803614750520418
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.003981984	0.19803614750520418
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.003981984	0.19803614750520418
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.003981984	0.19803614750520418
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.003981984	0.19803614750520418
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.003981984	0.19803614750520418
TRISOMY X	0.003981984	0.19803614750520418
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.003981984	0.19803614750520418
ADULT-ONSET DYSTONIA-PARKINSONISM	0.003981984	0.19803614750520418
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.003981984	0.19803614750520418
CHÃ‰DIAK-HIGASHI SYNDROME	0.003981984	0.19803614750520418
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.003981984	0.19803614750520418
48,XXXY SYNDROME	0.003981984	0.19803614750520418
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.003981984	0.19803614750520418
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.003981984	0.19803614750520418
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.003981984	0.19803614750520418
49,XXXXY SYNDROME	0.003981984	0.19803614750520418
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00378788	0.1883827665836962
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.1883827665836962
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	0.1883827665836962
ALKAPTONURIA	0.00378788	0.1883827665836962
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.1883827665836962
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.1883827665836962
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	0.1883827665836962
XANTHINURIA, TYPE I	0.00378788	0.1883827665836962
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.1883827665836962
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.1883827665836962
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.1883827665836962
ACETYLATION, SLOW	0.00378788	0.1883827665836962
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.1883827665836962
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.1883827665836962
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.1883827665836962
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.1883827665836962
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.1883827665836962
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.1883827665836962
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.1883827665836962
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.1883827665836962
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.1883827665836962
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.1883827665836962
T-SUBSTANCE ANOMALY	0.00378788	0.1883827665836962
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.1883827665836962
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.1883827665836962
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.1883827665836962
ZINC, ELEVATED PLASMA	0.00378788	0.1883827665836962
BARTTER SYNDROME	0.00378788	0.1883827665836962
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.1883827665836962
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.1883827665836962
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.1883827665836962
HYPOASCORBEMIA	0.00378788	0.1883827665836962
REFSUM DISEASE	0.00378788	0.1883827665836962
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00378788	0.1883827665836962
MACROCYTOSIS, FAMILIAL	0.00378788	0.1883827665836962
ONCOCYTOMA	0.00378788	0.1883827665836962
GONADOBLASTOMA	0.00378788	0.1883827665836962
CALVARIAL HYPEROSTOSIS	0.00378788	0.1883827665836962
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.1883827665836962
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.1883827665836962
DELETED IN AZOOSPERMIA	0.00378788	0.1883827665836962
XM SYSTEM	0.00378788	0.1883827665836962
HOOFT DISEASE	0.00378788	0.1883827665836962
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.1883827665836962
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.1883827665836962
CEPHALIN LIPIDOSIS	0.00378788	0.1883827665836962
FINGERPRINT BODY MYOPATHY	0.00378788	0.1883827665836962
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.1883827665836962
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.1883827665836962
PREMATURE OVARIAN FAILURE 1	0.00378788	0.1883827665836962
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	0.1883827665836962
CEREBELLOPARENCHYMAL DISORDER V	0.00378788	0.1883827665836962
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.1883827665836962
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.1883827665836962
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.00378788	0.1883827665836962
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.1883827665836962
ALAND ISLAND EYE DISEASE	0.00378788	0.1883827665836962
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.1883827665836962
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.1883827665836962
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.1883827665836962
DERMATOLEUKODYSTROPHY	0.00378788	0.1883827665836962
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.1883827665836962
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.1883827665836962
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00378788	0.1883827665836962
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.1883827665836962
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.1883827665836962
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.1883827665836962
TRISOMY 18-LIKE SYNDROME	0.00378788	0.1883827665836962
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	0.1883827665836962
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.1883827665836962
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.1883827665836962
AREDYLD	0.00378788	0.1883827665836962
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.1883827665836962
SCHIZOPHRENIA 4	0.00378788	0.1883827665836962
HYPERLEUCINE-ISOLEUCINEMIA	0.00378788	0.1883827665836962
CITRULLINE TRANSPORT DEFECT	0.00378788	0.1883827665836962
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.1883827665836962
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00378788	0.1883827665836962
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.1883827665836962
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00378788	0.1883827665836962
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.1883827665836962
PENDRED SYNDROME	0.00378788	0.1883827665836962
HEINZ BODY ANEMIAS	0.00378788	0.1883827665836962
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.1883827665836962
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.1883827665836962
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.1883827665836962
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.1883827665836962
OSTEOGENIC SARCOMA	0.00378788	0.1883827665836962
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.1883827665836962
MACULAR CORNEAL DYSTROPHY	0.00378788	0.1883827665836962
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.1883827665836962
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.1883827665836962
HYPERPROGLUCAGONEMIA	0.00378788	0.1883827665836962
GLUTATHIONE REDUCTASE	0.00378788	0.1883827665836962
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.1883827665836962
ETHANOLAMINOSIS	0.00378788	0.1883827665836962
LARON SYNDROME	0.00378788	0.1883827665836962
PITUITARY DWARFISM IV	0.00378788	0.1883827665836962
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.1883827665836962
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.1883827665836962
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.1883827665836962
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	0.1883827665836962
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00378788	0.1883827665836962
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.1883827665836962
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.1883827665836962
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.1883827665836962
CARBOXYLESTERASE 1	0.00378788	0.1883827665836962
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.1883827665836962
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.1883827665836962
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.1883827665836962
COUMARIN RESISTANCE	0.00378788	0.1883827665836962
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.1883827665836962
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.1883827665836962
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.1883827665836962
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.1883827665836962
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.1883827665836962
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.1883827665836962
FLOOD FACTOR DEFICIENCY	0.00378788	0.1883827665836962
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.1883827665836962
GAPO SYNDROME; GAPOS	0.00378788	0.1883827665836962
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.1883827665836962
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.1883827665836962
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00378788	0.1883827665836962
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.1883827665836962
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.1883827665836962
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.1883827665836962
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.1883827665836962
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.1883827665836962
APOLIPOPROTEIN(A)	0.00378788	0.1883827665836962
PROGESTERONE RESISTANCE	0.00378788	0.1883827665836962
PARAOXONASE 1	0.00378788	0.1883827665836962
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.1883827665836962
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.1883827665836962
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.1883827665836962
ICHTHYOSIS AND MALE HYPOGONADISM	0.00378788	0.1883827665836962
LIPASE DEFICIENCY, COMBINED	0.00378788	0.1883827665836962
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00378788	0.1883827665836962
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	0.1883827665836962
OVARIAN CANCER	0.00378788	0.1883827665836962
PACMAN DYSPLASIA	0.00378788	0.1883827665836962
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.1883827665836962
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	0.1883827665836962
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.1883827665836962
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.1883827665836962
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.1883827665836962
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.1883827665836962
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.1883827665836962
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.1883827665836962
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.1883827665836962
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00378788	0.1883827665836962
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	0.1883827665836962
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00378788	0.1883827665836962
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.1883827665836962
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.1883827665836962
ICHTHYOSIS, X-LINKED	0.00378788	0.1883827665836962
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	0.1883827665836962
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	0.1883827665836962
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.1883827665836962
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.1883827665836962
OSTEOMESOPYKNOSIS	0.00378788	0.1883827665836962
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.1883827665836962
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.1883827665836962
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00378788	0.1883827665836962
X-LINKED ADRENOLEUKODYSTROPHY	0.00378788	0.1883827665836962
LYMPHOKINE DEFICIENCY	0.00378788	0.1883827665836962
PYGMY	0.00378788	0.1883827665836962
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.1883827665836962
BEETURIA	0.00378788	0.1883827665836962
SAGLIKER SYNDROME	0.00369004	0.18351688649178494
BETA-MANNOSIDOSIS	0.00369004	0.18351688649178494
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00369004	0.18351688649178494
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00369004	0.18351688649178494
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.00369004	0.18351688649178494
MCDONOUGH SYNDROME	0.00369004	0.18351688649178494
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00369004	0.18351688649178494
FOCAL FACIAL DERMAL DYSPLASIA TYPE I	0.00369004	0.18351688649178494
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.00369004	0.18351688649178494
UROFACIAL SYNDROME	0.00369004	0.18351688649178494
LICHTENSTEIN SYNDROME	0.00369004	0.18351688649178494
MENTAL RETARDATION, X-LINKED 100	0.00369004	0.18351688649178494
JUVENILE POLYPOSIS OF INFANCY	0.00369004	0.18351688649178494
ISOLATED AGAMMAGLOBULINEMIA	0.00369004	0.18351688649178494
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.00369004	0.18351688649178494
MENTAL RETARDATION, X-LINKED 14	0.00369004	0.18351688649178494
RODRIGUES BLINDNESS	0.00369004	0.18351688649178494
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00369004	0.18351688649178494
MILROY DISEASE	0.00369004	0.18351688649178494
CROUZON DISEASE	0.00369004	0.18351688649178494
PROLIDASE DEFICIENCY	0.00369004	0.18351688649178494
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00369004	0.18351688649178494
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00369004	0.18351688649178494
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00369004	0.18351688649178494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00369004	0.18351688649178494
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.00369004	0.18351688649178494
DIAMOND-BLACKFAN ANEMIA 4	0.00369004	0.18351688649178494
ZECHI-CEIDE SYNDROME	0.00369004	0.18351688649178494
SHPRINTZEN OMPHALOCELE SYNDROME	0.00369004	0.18351688649178494
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00369004	0.18351688649178494
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.00369004	0.18351688649178494
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00369004	0.18351688649178494
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.00369004	0.18351688649178494
HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	0.00369004	0.18351688649178494
HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIALFEATURES	0.00369004	0.18351688649178494
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00369004	0.18351688649178494
HAIRY ELBOWS	0.00369004	0.18351688649178494
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.00369004	0.18351688649178494
IRIDOGONIODYSGENESIS, TYPE 2	0.00369004	0.18351688649178494
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00369004	0.18351688649178494
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.00369004	0.18351688649178494
WAARDENBURG SYNDROME	0.00369004	0.18351688649178494
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.00369004	0.18351688649178494
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00369004	0.18351688649178494
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00369004	0.18351688649178494
ISOLATED BILIARY ATRESIA	0.00369004	0.18351688649178494
ATELOSTEOGENESIS TYPE II	0.00369004	0.18351688649178494
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00369004	0.18351688649178494
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00369004	0.18351688649178494
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00369004	0.18351688649178494
601095 HARROD SYNDROME	0.00369004	0.18351688649178494
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00369004	0.18351688649178494
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00369004	0.18351688649178494
KENNERKNECHT SYNDROME	0.00369004	0.18351688649178494
BOHRING-OPITZ SYNDROME	0.0034711839999999996	0.17263251350123573
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.0034711839999999996	0.17263251350123573
PITT-HOPKINS SYNDROME	0.0034711839999999996	0.17263251350123573
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.0034711839999999996	0.17263251350123573
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.0034711839999999996	0.17263251350123573
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.0034711839999999996	0.17263251350123573
COFFIN-SIRIS SYNDROME 5	0.0034711839999999996	0.17263251350123573
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.0034711839999999996	0.17263251350123573
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0034711839999999996	0.17263251350123573
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0034711839999999996	0.17263251350123573
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.0034711839999999996	0.17263251350123573
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.0034711839999999996	0.17263251350123573
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0034711839999999996	0.17263251350123573
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0034711839999999996	0.17263251350123573
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0034711839999999996	0.17263251350123573
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.0034711839999999996	0.17263251350123573
MARDEN-WALKER SYNDROME	0.0034711839999999996	0.17263251350123573
STT3A-CDG	0.0034711839999999996	0.17263251350123573
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.0034711839999999996	0.17263251350123573
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.0034711839999999996	0.17263251350123573
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0034711839999999996	0.17263251350123573
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0034711839999999996	0.17263251350123573
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0034711839999999996	0.17263251350123573
WIEACKER-WOLFF SYNDROME	0.0034711839999999996	0.17263251350123573
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0034711839999999996	0.17263251350123573
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0034711839999999996	0.17263251350123573
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.0034711839999999996	0.17263251350123573
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.0034711839999999996	0.17263251350123573
STT3B-CDG	0.0034711839999999996	0.17263251350123573
PEHO SYNDROME	0.0034711839999999996	0.17263251350123573
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.0034711839999999996	0.17263251350123573
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.0034711839999999996	0.17263251350123573
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.0034711839999999996	0.17263251350123573
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.0034711839999999996	0.17263251350123573
GENITOPATELLAR SYNDROME	0.0034711839999999996	0.17263251350123573
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.0034711839999999996	0.17263251350123573
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.0034711839999999996	0.17263251350123573
KBG SYNDROME	0.0034711839999999996	0.17263251350123573
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.0034711839999999996	0.17263251350123573
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.0034711839999999996	0.17263251350123573
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.0034711839999999996	0.17263251350123573
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.0034711839999999996	0.17263251350123573
BOHRING-OPITZ SYNDROME	0.0034711839999999996	0.17263251350123573
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.0034711839999999996	0.17263251350123573
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.0034711839999999996	0.17263251350123573
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0034711839999999996	0.17263251350123573
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0034711839999999996	0.17263251350123573
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.0034711839999999996	0.17263251350123573
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0034711839999999996	0.17263251350123573
EAR-PATELLA-SHORT STATURE SYNDROME	0.0034711839999999996	0.17263251350123573
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.0034711839999999996	0.17263251350123573
COG4-CDG	0.0034711839999999996	0.17263251350123573
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0034711839999999996	0.17263251350123573
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.0034711839999999996	0.17263251350123573
2P15P16.1 MICRODELETION SYNDROME	0.0034711839999999996	0.17263251350123573
PHELAN-MCDERMID SYNDROME	0.0034711839999999996	0.17263251350123573
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.0034711839999999996	0.17263251350123573
8P11.2 DELETION SYNDROME	0.0034711839999999996	0.17263251350123573
OROFACIODIGITAL SYNDROME TYPE 4	0.0034711839999999996	0.17263251350123573
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.0034711839999999996	0.17263251350123573
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.0034711839999999996	0.17263251350123573
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.0034711839999999996	0.17263251350123573
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.0034711839999999996	0.17263251350123573
DISTAL MONOSOMY 10Q	0.0034711839999999996	0.17263251350123573
COFFIN-SIRIS SYNDROME 4; CSS4	0.0034711839999999996	0.17263251350123573
COFFIN-SIRIS SYNDROME 3; CSS3	0.0034711839999999996	0.17263251350123573
16P13.11 MICRODELETION SYNDROME	0.0034711839999999996	0.17263251350123573
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.0034711839999999996	0.17263251350123573
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0034711839999999996	0.17263251350123573
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0034711839999999996	0.17263251350123573
2Q32Q33 MICRODELETION SYNDROME	0.0034711839999999996	0.17263251350123573
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.0034711839999999996	0.17263251350123573
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.0034711839999999996	0.17263251350123573
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.0034711839999999996	0.17263251350123573
CHROMOSOME 19P13.13 DELETION SYNDROME	0.0034711839999999996	0.17263251350123573
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.0034711839999999996	0.17263251350123573
NIPAH VIRUS DISEASE	0.00343643	0.1709040916214904
COMPLETE ANDROGEN INSENSITIVITY SYNDROME	0.00343643	0.1709040916214904
O'SULLIVAN-MCLEOD SYNDROME	0.00343643	0.1709040916214904
TYPHOID	0.00343643	0.1709040916214904
AMISH NEMALINE MYOPATHY	0.00343643	0.1709040916214904
TSH-SECRETING PITUITARY ADENOMA	0.00343643	0.1709040916214904
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00343643	0.1709040916214904
NON-FUNCTIONING PARAGANGLIOMA	0.00343643	0.1709040916214904
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00343643	0.1709040916214904
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.00343643	0.1709040916214904
PERRY SYNDROME	0.00343643	0.1709040916214904
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00343643	0.1709040916214904
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA TYPE 31	0.00343643	0.1709040916214904
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00343643	0.1709040916214904
EPISODIC ATAXIA, TYPE 1; EA1	0.00343643	0.1709040916214904
CEREBELLAR HYPOPLASIA	0.00343643	0.1709040916214904
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00343643	0.1709040916214904
BEHR SYNDROME	0.00343643	0.1709040916214904
DYSTONIA 11, MYOCLONIC	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA TYPE 14	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA TYPE 21	0.00343643	0.1709040916214904
ATAXIA WITH VITAMIN E DEFICIENCY	0.00343643	0.1709040916214904
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.00343643	0.1709040916214904
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00343643	0.1709040916214904
CYSTATHIONINURIA	0.00343643	0.1709040916214904
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00343643	0.1709040916214904
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00343643	0.1709040916214904
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.00343643	0.1709040916214904
SPONTANEOUS PERIODIC HYPOTHERMIA	0.00343643	0.1709040916214904
CEREBROTENDINOUS XANTHOMATOSIS	0.00343643	0.1709040916214904
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.00343643	0.1709040916214904
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00343643	0.1709040916214904
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00343643	0.1709040916214904
OROFACIODIGITAL SYNDROME TYPE 1	0.00343643	0.1709040916214904
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00343643	0.1709040916214904
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.00343643	0.1709040916214904
KALLMANN SYNDROME	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00343643	0.1709040916214904
MERCURY POISONING	0.00343643	0.1709040916214904
TETANUS	0.00343643	0.1709040916214904
ACERULOPLASMINEMIA	0.00343643	0.1709040916214904
PRIMARY ORTHOSTATIC TREMOR	0.00343643	0.1709040916214904
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00343643	0.1709040916214904
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00343643	0.1709040916214904
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.00343643	0.1709040916214904
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA 42	0.00343643	0.1709040916214904
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.00343643	0.1709040916214904
MOHR-TRANEBJAERG SYNDROME	0.00343643	0.1709040916214904
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.00343643	0.1709040916214904
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.00343643	0.1709040916214904
DYSTONIA 13, TORSION	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA 18	0.00343643	0.1709040916214904
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.00343643	0.1709040916214904
CORTICOBASAL SYNDROME	0.00343643	0.1709040916214904
ALEXANDER DISEASE	0.00343643	0.1709040916214904
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.00343643	0.1709040916214904
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.00343643	0.1709040916214904
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA TYPE 37	0.00343643	0.1709040916214904
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00343643	0.1709040916214904
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00343643	0.1709040916214904
YOUNG-ONSET PARKINSON DISEASE	0.00343643	0.1709040916214904
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.00343643	0.1709040916214904
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.00343643	0.1709040916214904
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00343643	0.1709040916214904
MYOCLONIC-ATONIC EPILEPSY	0.00343643	0.1709040916214904
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.00343643	0.1709040916214904
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.00343643	0.1709040916214904
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.00343643	0.1709040916214904
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.00343643	0.1709040916214904
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00343643	0.1709040916214904
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.00343643	0.1709040916214904
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA TYPE 38	0.00343643	0.1709040916214904
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.00343643	0.1709040916214904
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.00343643	0.1709040916214904
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.00343643	0.1709040916214904
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00343643	0.1709040916214904
KUFOR-RAKEB SYNDROME	0.00343643	0.1709040916214904
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00343643	0.1709040916214904
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.00343643	0.1709040916214904
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.00343643	0.1709040916214904
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00343643	0.1709040916214904
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00343643	0.1709040916214904
SENSORINEURAL HEARING LOSS-EARLY GRAYING-ESSENTIAL TREMOR SYNDROME	0.00343643	0.1709040916214904
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.00343643	0.1709040916214904
THYROTOXIC PERIODIC PARALYSIS	0.00343643	0.1709040916214904
CRIGLER-NAJJAR SYNDROME TYPE 1	0.00343643	0.1709040916214904
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00343643	0.1709040916214904
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.00343643	0.1709040916214904
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.00343643	0.1709040916214904
WILSON DISEASE	0.00343643	0.1709040916214904
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.00343643	0.1709040916214904
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.00343643	0.1709040916214904
SIALIDOSIS TYPE 1	0.00343643	0.1709040916214904
SNEDDON SYNDROME	0.00343643	0.1709040916214904
SCRUB TYPHUS	0.00343643	0.1709040916214904
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00343643	0.1709040916214904
ENCEPHALITIS LETHARGICA	0.00343643	0.1709040916214904
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.00343643	0.1709040916214904
PARKINSON-DEMENTIA SYNDROMESUPRANUCLEAR PALSY, PROGRESSIVE ATYPICAL, INCLUDED	0.00343643	0.1709040916214904
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00343643	0.1709040916214904
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.00343643	0.1709040916214904
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.00343643	0.1709040916214904
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.00343643	0.1709040916214904
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.00343643	0.1709040916214904
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00343643	0.1709040916214904
PARKINSON DISEASE 21; PARK21	0.00343643	0.1709040916214904
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.00343643	0.1709040916214904
SPASTIC PARAPARESIS AND DEAFNESS	0.00343643	0.1709040916214904
PROGRESSIVE SUPRANUCLEAR PALSY	0.00343643	0.1709040916214904
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.00343643	0.1709040916214904
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00343643	0.1709040916214904
DYSTONIA 3, TORSION, X-LINKED	0.00343643	0.1709040916214904
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.00343643	0.1709040916214904
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.00343643	0.1709040916214904
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.00343643	0.1709040916214904
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.00343643	0.1709040916214904
OPTIC ATROPHY 2	0.00343643	0.1709040916214904
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS	0.00343643	0.1709040916214904
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00343643	0.1709040916214904
ATAXIA-TELANGIECTASIA	0.00343643	0.1709040916214904
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.0029256299999999994	0.14550045761752192
KABUKI SYNDROME	0.0029256299999999994	0.14550045761752192
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.0029256299999999994	0.14550045761752192
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0029256299999999994	0.14550045761752192
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0029256299999999994	0.14550045761752192
DESMOSTEROLOSIS	0.0029256299999999994	0.14550045761752192
WIEDEMANN-STEINER SYNDROME	0.0029256299999999994	0.14550045761752192
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.0029256299999999994	0.14550045761752192
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.0029256299999999994	0.14550045761752192
MEIER-GORLIN SYNDROME 6; MGORS6	0.0029256299999999994	0.14550045761752192
CEREBROCOSTOMANDIBULAR SYNDROME	0.0029256299999999994	0.14550045761752192
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.0029256299999999994	0.14550045761752192
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.0029256299999999994	0.14550045761752192
CHARGE SYNDROME	0.0029256299999999994	0.14550045761752192
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0029256299999999994	0.14550045761752192
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.0029256299999999994	0.14550045761752192
14Q12 MICRODELETION SYNDROME	0.0029256299999999994	0.14550045761752192
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.0029256299999999994	0.14550045761752192
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.0029256299999999994	0.14550045761752192
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.0029256299999999994	0.14550045761752192
19Q13.11 MICRODELETION SYNDROME	0.0029256299999999994	0.14550045761752192
MEIER-GORLIN SYNDROME 3; MGORS3	0.0029256299999999994	0.14550045761752192
MEIER-GORLIN SYNDROME 2; MGORS2	0.0029256299999999994	0.14550045761752192
FONTAINE PROGEROID SYNDROME; FPS	0.0029256299999999994	0.14550045761752192
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0029256299999999994	0.14550045761752192
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.0027147539999999998	0.1350129542419917
48,XYYY SYNDROME	0.0027147539999999998	0.1350129542419917
TETRASOMY 9P	0.0027147539999999998	0.1350129542419917
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.0027147539999999998	0.1350129542419917
19P13.13 MICRODELETION SYNDROME	0.0027147539999999998	0.1350129542419917
PERMANENT CONGENITAL HYPOTHYROIDISM	0.0027147539999999998	0.1350129542419917
PMM2-CDG	0.0027147539999999998	0.1350129542419917
GALACTOSE EPIMERASE DEFICIENCY	0.0027147539999999998	0.1350129542419917
SPINOCEREBELLAR ATAXIA TYPE 7	0.0027147539999999998	0.1350129542419917
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.0027147539999999998	0.1350129542419917
ATHYREOSIS	0.0027147539999999998	0.1350129542419917
16P11.2P12.2 MICRODELETION SYNDROME	0.0027147539999999998	0.1350129542419917
17Q12 MICRODELETION SYNDROME	0.0027147539999999998	0.1350129542419917
PERIPHERAL HYPOTHYROIDISM	0.0027147539999999998	0.1350129542419917
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.0027147539999999998	0.1350129542419917
PRIMARY CONGENITAL HYPOTHYROIDISM	0.0027147539999999998	0.1350129542419917
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.0027147539999999998	0.1350129542419917
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.0027147539999999998	0.1350129542419917
NEPHROGENIC DIABETES INSIPIDUS	0.0027147539999999998	0.1350129542419917
X SMALL RINGS	0.0027147539999999998	0.1350129542419917
KRABBE DISEASE	0.0027147539999999998	0.1350129542419917
MONOSOMY 22Q13.3	0.0027147539999999998	0.1350129542419917
BILATERAL POLYMICROGYRIA	0.0027147539999999998	0.1350129542419917
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.0027147539999999998	0.1350129542419917
11Q22.2Q22.3 MICRODELETION SYNDROME	0.0027147539999999998	0.1350129542419917
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.0027147539999999998	0.1350129542419917
PRADER-WILLI-LIKE SYNDROME	0.0027147539999999998	0.1350129542419917
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.0027147539999999998	0.1350129542419917
MONOSOMY 9Q22.3	0.0027147539999999998	0.1350129542419917
HAREL-YOON SYNDROME; HAYOS	0.0027147539999999998	0.1350129542419917
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.0027147539999999998	0.1350129542419917
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0027147539999999998	0.1350129542419917
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.0027147539999999998	0.1350129542419917
AURICULOCONDYLAR SYNDROME	0.0027147539999999998	0.1350129542419917
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0027147539999999998	0.1350129542419917
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.0027147539999999998	0.1350129542419917
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.0027147539999999998	0.1350129542419917
SCHAAF-YANG SYNDROME; SHFYNG	0.0027147539999999998	0.1350129542419917
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.0027147539999999998	0.1350129542419917
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.0027147539999999998	0.1350129542419917
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.0027147539999999998	0.1350129542419917
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.0027147539999999998	0.1350129542419917
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.0027147539999999998	0.1350129542419917
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.0027147539999999998	0.1350129542419917
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.0027147539999999998	0.1350129542419917
POPOV-CHANG SYNDROME; POPCHAS	0.0027147539999999998	0.1350129542419917
TYSHCHENKO SYNDROME	0.0027147539999999998	0.1350129542419917
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0027147539999999998	0.1350129542419917
BAKER-GORDON SYNDROME; BAGOS	0.0027147539999999998	0.1350129542419917
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.0027147539999999998	0.1350129542419917
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.0027147539999999998	0.1350129542419917
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.0027147539999999998	0.1350129542419917
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.0027147539999999998	0.1350129542419917
COFFIN-SIRIS SYNDROME 2; CSS2	0.0027147539999999998	0.1350129542419917
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.0027147539999999998	0.1350129542419917
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0027147539999999998	0.1350129542419917
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.0027147539999999998	0.1350129542419917
ZTTK SYNDROME; ZTTKS	0.0027147539999999998	0.1350129542419917
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.0027147539999999998	0.1350129542419917
CHROMOSOME 17P13.1 DELETION SYNDROME	0.0027147539999999998	0.1350129542419917
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0027147539999999998	0.1350129542419917
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0027147539999999998	0.1350129542419917
GAUCHER DISEASE, TYPE II	0.0027147539999999998	0.1350129542419917
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.0027147539999999998	0.1350129542419917
DESANTO-SHINAWI SYNDROME	0.0027147539999999998	0.1350129542419917
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.0027147539999999998	0.1350129542419917
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.0027147539999999998	0.1350129542419917
COFFIN-SIRIS SYNDROME 7; CSS7	0.0027147539999999998	0.1350129542419917
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.0027147539999999998	0.1350129542419917
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.0027147539999999998	0.1350129542419917
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0027147539999999998	0.1350129542419917
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.0027147539999999998	0.1350129542419917
AU-KLINE SYNDROME; AUKS	0.0027147539999999998	0.1350129542419917
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.0027147539999999998	0.1350129542419917
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0027147539999999998	0.1350129542419917
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.0027147539999999998	0.1350129542419917
HELSMOORTEL-VAN DER AA SYNDROME	0.0027147539999999998	0.1350129542419917
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.0021691999999999996	0.10788089835827791
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.0021691999999999996	0.10788089835827791
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0021691999999999996	0.10788089835827791
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.0021691999999999996	0.10788089835827791
CRISPONI SYNDROME	0.0021691999999999996	0.10788089835827791
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.0021691999999999996	0.10788089835827791
16Q24.3 MICRODELETION SYNDROME	0.0021691999999999996	0.10788089835827791
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.0021691999999999996	0.10788089835827791
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.0021691999999999996	0.10788089835827791
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.0021691999999999996	0.10788089835827791
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.0021691999999999996	0.10788089835827791
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.0021691999999999996	0.10788089835827791
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.0021691999999999996	0.10788089835827791
BETA-THALASSEMIA MAJOR	0.0021691999999999996	0.10788089835827791
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.0021691999999999996	0.10788089835827791
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.0021691999999999996	0.10788089835827791
NEMALINE MYOPATHY 2; NEM2	0.0021691999999999996	0.10788089835827791
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.0021691999999999996	0.10788089835827791
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0021691999999999996	0.10788089835827791
PEROXISOME BIOGENESIS DISORDER 11B	0.0021691999999999996	0.10788089835827791
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.0021691999999999996	0.10788089835827791
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0021691999999999996	0.10788089835827791
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.0021691999999999996	0.10788089835827791
CHOANAL ATRESIA	0.0021691999999999996	0.10788089835827791
LARYNGOTRACHEAL ANGIOMA	0.0021691999999999996	0.10788089835827791
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0021691999999999996	0.10788089835827791
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.0021691999999999996	0.10788089835827791
LOCKED-IN SYNDROME	0.0021691999999999996	0.10788089835827791
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0021691999999999996	0.10788089835827791
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.0021691999999999996	0.10788089835827791
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0021691999999999996	0.10788089835827791
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0021691999999999996	0.10788089835827791
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0021691999999999996	0.10788089835827791
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.0021691999999999996	0.10788089835827791
DOUBLE OUTLET RIGHT VENTRICLE	0.0021691999999999996	0.10788089835827791
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.0021691999999999996	0.10788089835827791
ATRESIA OF SMALL INTESTINE	0.0021691999999999996	0.10788089835827791
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0021691999999999996	0.10788089835827791
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.0021691999999999996	0.10788089835827791
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.0021691999999999996	0.10788089835827791
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.0021691999999999996	0.10788089835827791
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.0021691999999999996	0.10788089835827791
RETINITIS PIGMENTOSA 59; RP59	0.0021691999999999996	0.10788089835827791
STUVE-WIEDEMANN SYNDROME	0.0021691999999999996	0.10788089835827791
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.0021691999999999996	0.10788089835827791
TYPICAL NEMALINE MYOPATHY	0.0021691999999999996	0.10788089835827791
INFANTILE SYSTEMIC HYALINOSIS	0.0021691999999999996	0.10788089835827791
CENTRAL CONGENITAL HYPOTHYROIDISM	0.0021691999999999996	0.10788089835827791
ADULT-ONSET NEMALINE MYOPATHY	0.0021691999999999996	0.10788089835827791
ADENOCARCINOMA OF OVARY	0.0021691999999999996	0.10788089835827791
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.0021691999999999996	0.10788089835827791
CHIARI MALFORMATION TYPE II	0.0021691999999999996	0.10788089835827791
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.0021691999999999996	0.10788089835827791
17Q24.2 MICRODELETION SYNDROME	0.0021691999999999996	0.10788089835827791
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.0021691999999999996	0.10788089835827791
NEONATAL MARFAN SYNDROME	0.0021691999999999996	0.10788089835827791
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0021691999999999996	0.10788089835827791
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.0021691999999999996	0.10788089835827791
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.0021691999999999996	0.10788089835827791
COMBINED SAPOSIN DEFICIENCY	0.0021691999999999996	0.10788089835827791
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0021691999999999996	0.10788089835827791
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0021691999999999996	0.10788089835827791
SANDIFER SYNDROME	0.0021691999999999996	0.10788089835827791
TRIGEMINAL NEURALGIA	0.0021691999999999996	0.10788089835827791
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.0021691999999999996	0.10788089835827791
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.0021691999999999996	0.10788089835827791
CHILDHOOD APRAXIA OF SPEECH	0.0021691999999999996	0.10788089835827791
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0021691999999999996	0.10788089835827791
NATIVE AMERICAN MYOPATHY	0.0021691999999999996	0.10788089835827791
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0021691999999999996	0.10788089835827791
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.0021691999999999996	0.10788089835827791
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0021691999999999996	0.10788089835827791
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.0021691999999999996	0.10788089835827791
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.0021691999999999996	0.10788089835827791
ACUTE BILIRUBIN ENCEPHALOPATHY	0.0021691999999999996	0.10788089835827791
5Q14.3 MICRODELETION SYNDROME	0.0021691999999999996	0.10788089835827791
PARAMYOTONIA CONGENITA OF VON EULENBURG	0.0021691999999999996	0.10788089835827791
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001301984	0.06475161514295782
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.001301984	0.06475161514295782
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.001301984	0.06475161514295782
HOYERAAL-HREIDARSSON SYNDROME	0.001301984	0.06475161514295782
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.001301984	0.06475161514295782
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001301984	0.06475161514295782
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.001301984	0.06475161514295782
RING CHROMOSOME 14 SYNDROME	0.001301984	0.06475161514295782
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.001301984	0.06475161514295782
CRANIOSYNOSTOSIS 6; CRS6	0.001301984	0.06475161514295782
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.001301984	0.06475161514295782
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001301984	0.06475161514295782
CHROMOSOME 1P35 DELETION SYNDROME	0.001301984	0.06475161514295782
BRESEK SYNDROME	0.001301984	0.06475161514295782
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001301984	0.06475161514295782
AL-RAQAD SYNDROME; ARS	0.001301984	0.06475161514295782
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001301984	0.06475161514295782
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001301984	0.06475161514295782
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.001301984	0.06475161514295782
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.001301984	0.06475161514295782
DISTAL TRISOMY 17Q	0.001301984	0.06475161514295782
MUCOLIPIDOSIS IV; ML4	0.001301984	0.06475161514295782
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001301984	0.06475161514295782
15Q24 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.001301984	0.06475161514295782
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.001301984	0.06475161514295782
CONGENITAL TOXOPLASMOSIS	0.001301984	0.06475161514295782
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.001301984	0.06475161514295782
TRISOMY 18	0.001301984	0.06475161514295782
SECKEL SYNDROME 9; SCKL9	0.001301984	0.06475161514295782
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001301984	0.06475161514295782
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001301984	0.06475161514295782
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.001301984	0.06475161514295782
HEART AND BRAIN MALFORMATION SYNDROME	0.001301984	0.06475161514295782
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.001301984	0.06475161514295782
DYSTONIA 28, CHILDHOOD-ONSET	0.001301984	0.06475161514295782
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001301984	0.06475161514295782
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.001301984	0.06475161514295782
WALKER-WARBURG SYNDROME	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001301984	0.06475161514295782
LISSENCEPHALY 8; LIS8	0.001301984	0.06475161514295782
ROBERTS SYNDROME	0.001301984	0.06475161514295782
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001301984	0.06475161514295782
MEVALONIC ACIDURIA	0.001301984	0.06475161514295782
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001301984	0.06475161514295782
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001301984	0.06475161514295782
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.001301984	0.06475161514295782
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001301984	0.06475161514295782
ALAZAMI-YUAN SYNDROME	0.001301984	0.06475161514295782
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.001301984	0.06475161514295782
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.001301984	0.06475161514295782
RUVALCABA SYNDROME	0.001301984	0.06475161514295782
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001301984	0.06475161514295782
MACDERMOT-WINTER SYNDROME	0.001301984	0.06475161514295782
OPTIC ATROPHY 11; OPA11	0.001301984	0.06475161514295782
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.001301984	0.06475161514295782
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.001301984	0.06475161514295782
CONGENITAL VARICELLA SYNDROME	0.001301984	0.06475161514295782
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.001301984	0.06475161514295782
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.001301984	0.06475161514295782
DPAGT1-CDG	0.001301984	0.06475161514295782
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.001301984	0.06475161514295782
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.001301984	0.06475161514295782
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.001301984	0.06475161514295782
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.001301984	0.06475161514295782
FILIPPI SYNDROME	0.001301984	0.06475161514295782
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.001301984	0.06475161514295782
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.001301984	0.06475161514295782
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.001301984	0.06475161514295782
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001301984	0.06475161514295782
MARINESCO-SJOGREN SYNDROME; MSS	0.001301984	0.06475161514295782
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001301984	0.06475161514295782
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001301984	0.06475161514295782
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.001301984	0.06475161514295782
DUPLICATION OF THE PITUITARY GLAND	0.001301984	0.06475161514295782
RAINE SYNDROME	0.001301984	0.06475161514295782
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.001301984	0.06475161514295782
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.001301984	0.06475161514295782
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.001301984	0.06475161514295782
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.001301984	0.06475161514295782
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.001301984	0.06475161514295782
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.001301984	0.06475161514295782
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.001301984	0.06475161514295782
GLASS SYNDROME	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.001301984	0.06475161514295782
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001301984	0.06475161514295782
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001301984	0.06475161514295782
MENTAL RETARDATION, X-LINKED 106; MRX106	0.001301984	0.06475161514295782
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.001301984	0.06475161514295782
HADZISELIMOVIC SYNDROME	0.001301984	0.06475161514295782
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.001301984	0.06475161514295782
BETA-UREIDOPROPIONASE DEFICIENCY	0.001301984	0.06475161514295782
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001301984	0.06475161514295782
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.001301984	0.06475161514295782
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001301984	0.06475161514295782
WARSAW BREAKAGE SYNDROME; WABS	0.001301984	0.06475161514295782
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.001301984	0.06475161514295782
BARATELA-SCOTT SYNDROME	0.001301984	0.06475161514295782
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.001301984	0.06475161514295782
LATHOSTEROLOSIS	0.001301984	0.06475161514295782
FORSYTHE-WAKELING SYNDROME; FWS	0.001301984	0.06475161514295782
OGDEN SYNDROME; OGDNS	0.001301984	0.06475161514295782
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.001301984	0.06475161514295782
%300712 CRANIOFACIOSKELETAL SYNDROME	0.001301984	0.06475161514295782
MEVALONIC ACIDURIA; MEVA	0.001301984	0.06475161514295782
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001301984	0.06475161514295782
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.001301984	0.06475161514295782
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.001301984	0.06475161514295782
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001301984	0.06475161514295782
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001301984	0.06475161514295782
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001301984	0.06475161514295782
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.001301984	0.06475161514295782
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.001301984	0.06475161514295782
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.001301984	0.06475161514295782
MULTIPLE SULFATASE DEFICIENCY	0.001301984	0.06475161514295782
GENITOPATELLAR SYNDROME; GTPTS	0.001301984	0.06475161514295782
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.001301984	0.06475161514295782
LIG4 SYNDROME	0.001301984	0.06475161514295782
LOWRY-MACLEAN SYNDROME	0.001301984	0.06475161514295782
MARINESCO-SJÃ–GREN SYNDROME	0.001301984	0.06475161514295782
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.001301984	0.06475161514295782
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.001301984	0.06475161514295782
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.001301984	0.06475161514295782
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001301984	0.06475161514295782
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001301984	0.06475161514295782
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001301984	0.06475161514295782
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.001301984	0.06475161514295782
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001301984	0.06475161514295782
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001301984	0.06475161514295782
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001301984	0.06475161514295782
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.001301984	0.06475161514295782
ALPERS-HUTTENLOCHER SYNDROME	0.001301984	0.06475161514295782
GOLDBERG-SHPRINTZEN SYNDROME	0.001301984	0.06475161514295782
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.001301984	0.06475161514295782
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.001301984	0.06475161514295782
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001301984	0.06475161514295782
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001301984	0.06475161514295782
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.001301984	0.06475161514295782
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001301984	0.06475161514295782
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.001301984	0.06475161514295782
ROTHMUND-THOMSON SYNDROME	0.001301984	0.06475161514295782
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.001301984	0.06475161514295782
DESBUQUOIS DYSPLASIA 2; DBQD2	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001301984	0.06475161514295782
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.001301984	0.06475161514295782
SECKEL SYNDROME 8; SCKL8	0.001301984	0.06475161514295782
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001301984	0.06475161514295782
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.001301984	0.06475161514295782
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.001301984	0.06475161514295782
FANCONI ANEMIA	0.001301984	0.06475161514295782
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.001301984	0.06475161514295782
OROFACIODIGITAL SYNDROME IX; OFD9	0.001301984	0.06475161514295782
DISTAL MONOSOMY 1Q	0.001301984	0.06475161514295782
HARTSFIELD SYNDROME; HRTFDS	0.001301984	0.06475161514295782
20Q11.2 MICRODUPLICATION SYNDROME	0.001301984	0.06475161514295782
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001301984	0.06475161514295782
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001301984	0.06475161514295782
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001301984	0.06475161514295782
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001301984	0.06475161514295782
LISSENCEPHALY 2; LIS2	0.001301984	0.06475161514295782
CEREBELLOFACIODENTAL SYNDROME	0.001301984	0.06475161514295782
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001301984	0.06475161514295782
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001301984	0.06475161514295782
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001301984	0.06475161514295782
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001301984	0.06475161514295782
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.001301984	0.06475161514295782
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.001301984	0.06475161514295782
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001301984	0.06475161514295782
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001301984	0.06475161514295782
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001301984	0.06475161514295782
LISSENCEPHALY 4	0.001301984	0.06475161514295782
19P13.3 MICRODUPLICATION SYNDROME	0.001301984	0.06475161514295782
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001301984	0.06475161514295782
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.001301984	0.06475161514295782
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001301984	0.06475161514295782
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001301984	0.06475161514295782
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001301984	0.06475161514295782
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.001301984	0.06475161514295782
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001301984	0.06475161514295782
ADAMS-OLIVER SYNDROME 2; AOS2	0.001301984	0.06475161514295782
HOLOPROSENCEPHALY 11	0.001301984	0.06475161514295782
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001301984	0.06475161514295782
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.001301984	0.06475161514295782
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001301984	0.06475161514295782
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001301984	0.06475161514295782
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.001301984	0.06475161514295782
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.001301984	0.06475161514295782
PHACE SYNDROME	0.001301984	0.06475161514295782
ALG3-CDG	0.001301984	0.06475161514295782
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.001301984	0.06475161514295782
ADAMS-OLIVER SYNDROME 3; AOS3	0.001301984	0.06475161514295782
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.001301984	0.06475161514295782
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001301984	0.06475161514295782
ALAZAMI SYNDROME; ALAZS	0.001301984	0.06475161514295782
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.001301984	0.06475161514295782
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.001301984	0.06475161514295782
DOORS SYNDROME	0.001301984	0.06475161514295782
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001301984	0.06475161514295782
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.001301984	0.06475161514295782
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001301984	0.06475161514295782
1Q44 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
17Q21.31 MICRODUPLICATION SYNDROME	0.001301984	0.06475161514295782
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.001301984	0.06475161514295782
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.001301984	0.06475161514295782
OKAMOTO SYNDROME	0.001301984	0.06475161514295782
DUANE RETRACTION SYNDROME	0.001301984	0.06475161514295782
6Q16 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.001301984	0.06475161514295782
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.001301984	0.06475161514295782
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001301984	0.06475161514295782
KLEEFSTRA SYNDROME	0.001301984	0.06475161514295782
ADAMS-OLIVER SYNDROME 1; AOS1	0.001301984	0.06475161514295782
17P11.2 MICRODUPLICATION SYNDROME	0.001301984	0.06475161514295782
17Q11.2 MICRODUPLICATION SYNDROME	0.001301984	0.06475161514295782
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001301984	0.06475161514295782
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001301984	0.06475161514295782
FETAL TRIMETHADIONE SYNDROME	0.001301984	0.06475161514295782
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.001301984	0.06475161514295782
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.001301984	0.06475161514295782
TOLUENE EMBRYOPATHY	0.001301984	0.06475161514295782
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.001301984	0.06475161514295782
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.001301984	0.06475161514295782
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.001301984	0.06475161514295782
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.001301984	0.06475161514295782
RING CHROMOSOME 22 SYNDROME	0.001301984	0.06475161514295782
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001301984	0.06475161514295782
TOWNES-BROCKS SYNDROME 1; TBS1	0.001301984	0.06475161514295782
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.001301984	0.06475161514295782
MIETENS SYNDROME	0.001301984	0.06475161514295782
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001301984	0.06475161514295782
MOSAIC TRISOMY 9	0.001301984	0.06475161514295782
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001301984	0.06475161514295782
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001301984	0.06475161514295782
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.001301984	0.06475161514295782
8Q22.1 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
CRANIOTELENCEPHALIC DYSPLASIA	0.001301984	0.06475161514295782
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.001301984	0.06475161514295782
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.001301984	0.06475161514295782
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.001301984	0.06475161514295782
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.001301984	0.06475161514295782
KBG SYNDROME	0.001301984	0.06475161514295782
OCULO-PALATO-CEREBRAL SYNDROME	0.001301984	0.06475161514295782
MICROPHTHALMIA, SYNDROMIC 3	0.001301984	0.06475161514295782
LIG4 SYNDROME	0.001301984	0.06475161514295782
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001301984	0.06475161514295782
HYPERTRICHOSIS CUBITI	0.001301984	0.06475161514295782
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.001301984	0.06475161514295782
HOLOPROSENCEPHALY 3; HPE3	0.001301984	0.06475161514295782
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.001301984	0.06475161514295782
PHENOBARBITAL EMBRYOPATHY	0.001301984	0.06475161514295782
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.001301984	0.06475161514295782
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.001301984	0.06475161514295782
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.001301984	0.06475161514295782
6Q25 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.001301984	0.06475161514295782
3Q29 MICRODUPLICATION SYNDROME	0.001301984	0.06475161514295782
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001301984	0.06475161514295782
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.001301984	0.06475161514295782
3Q29 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
2Q31.1 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
MICRO SYNDROME	0.001301984	0.06475161514295782
TRISOMY 17P	0.001301984	0.06475161514295782
DISTAL MONOSOMY 15Q	0.001301984	0.06475161514295782
1Q21.1 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
C SYNDROME	0.001301984	0.06475161514295782
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.001301984	0.06475161514295782
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.001301984	0.06475161514295782
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001301984	0.06475161514295782
HOLOPROSENCEPHALY 2; HPE2	0.001301984	0.06475161514295782
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.001301984	0.06475161514295782
MYHRE SYNDROME	0.001301984	0.06475161514295782
MONOSOMY 18P	0.001301984	0.06475161514295782
8P23.1 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
TRISOMY 9P	0.001301984	0.06475161514295782
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.001301984	0.06475161514295782
MONOSOMY 9P	0.001301984	0.06475161514295782
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.001301984	0.06475161514295782
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.001301984	0.06475161514295782
15Q14 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.001301984	0.06475161514295782
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.001301984	0.06475161514295782
CK SYNDROME	0.001301984	0.06475161514295782
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001301984	0.06475161514295782
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.001301984	0.06475161514295782
10Q22.3Q23.3 MICRODELETION SYNDROME	0.001301984	0.06475161514295782
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00075643	0.03761955925924404
CHROMOSOME XP11.3 DELETION SYNDROME	0.00075643	0.03761955925924404
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00075643	0.03761955925924404
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00075643	0.03761955925924404
JOHANSON-BLIZZARD SYNDROME	0.00075643	0.03761955925924404
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.00075643	0.03761955925924404
DE SANCTIS-CACCHIONE SYNDROME	0.00075643	0.03761955925924404
CRANIOFRONTONASAL DYSPLASIA	0.00075643	0.03761955925924404
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00075643	0.03761955925924404
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00075643	0.03761955925924404
DISTAL MONOSOMY 3P	0.00075643	0.03761955925924404
JUBERG-HAYWARD SYNDROME	0.00075643	0.03761955925924404
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00075643	0.03761955925924404
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.00075643	0.03761955925924404
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.00075643	0.03761955925924404
JUNG SYNDROME	0.00075643	0.03761955925924404
ANE SYNDROME	0.00075643	0.03761955925924404
SANJAD-SAKATI SYNDROME	0.00075643	0.03761955925924404
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.00075643	0.03761955925924404
DISTAL MONOSOMY 17Q	0.00075643	0.03761955925924404
KERATOSIS FOLLICULARIS-DWARFISM-CEREBRAL ATROPHY SYNDROME	0.00075643	0.03761955925924404
MENTAL RETARDATION, X-LINKED 63	0.00075643	0.03761955925924404
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00075643	0.03761955925924404
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00075643	0.03761955925924404
MONOSOMY 13Q14	0.00075643	0.03761955925924404
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00075643	0.03761955925924404
FEINGOLD SYNDROME 2; FGLDS2	0.00075643	0.03761955925924404
PERRAULT SYNDROME 3	0.00075643	0.03761955925924404
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00075643	0.03761955925924404
DISTAL MONOSOMY 13Q	0.00075643	0.03761955925924404
JOHNSON NEUROECTODERMAL SYNDROME	0.00075643	0.03761955925924404
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.00075643	0.03761955925924404
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00075643	0.03761955925924404
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00075643	0.03761955925924404
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.03761955925924404
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00075643	0.03761955925924404
SJÃ–GREN-LARSSON SYNDROME	0.00075643	0.03761955925924404
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00075643	0.03761955925924404
ROBERTS SYNDROME; RBS	0.00075643	0.03761955925924404
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00075643	0.03761955925924404
SHPRINTZEN-GOLDBERG SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00075643	0.03761955925924404
CAREY-FINEMAN-ZITER SYNDROME	0.00075643	0.03761955925924404
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.00075643	0.03761955925924404
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00075643	0.03761955925924404
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00075643	0.03761955925924404
RHIZOMELIC SYNDROME	0.00075643	0.03761955925924404
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00075643	0.03761955925924404
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.00075643	0.03761955925924404
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00075643	0.03761955925924404
SYMMETRICAL THALAMIC CALCIFICATIONS	0.00075643	0.03761955925924404
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00075643	0.03761955925924404
PSEUDOTRISOMY 13 SYNDROME	0.00075643	0.03761955925924404
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00075643	0.03761955925924404
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00075643	0.03761955925924404
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00075643	0.03761955925924404
FEINGOLD SYNDROME	0.00075643	0.03761955925924404
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00075643	0.03761955925924404
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00075643	0.03761955925924404
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00075643	0.03761955925924404
BRANCHIOSKELETOGENITAL SYNDROME	0.00075643	0.03761955925924404
MÃœLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00075643	0.03761955925924404
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00075643	0.03761955925924404
OTOMANDIBULAR SYNDROME	0.00075643	0.03761955925924404
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00075643	0.03761955925924404
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00075643	0.03761955925924404
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.03761955925924404
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.00075643	0.03761955925924404
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.00075643	0.03761955925924404
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00075643	0.03761955925924404
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00075643	0.03761955925924404
JACOBSEN SYNDROME	0.00075643	0.03761955925924404
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00075643	0.03761955925924404
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00075643	0.03761955925924404
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00075643	0.03761955925924404
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00075643	0.03761955925924404
TEEBI-SHALTOUT SYNDROME; TBSH	0.00075643	0.03761955925924404
RING CHROMOSOME 6 SYNDROME	0.00075643	0.03761955925924404
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00075643	0.03761955925924404
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00075643	0.03761955925924404
FILIPPI SYNDROME; FLPIS	0.00075643	0.03761955925924404
FRYNS-SMEETS-THIRY SYNDROME	0.00075643	0.03761955925924404
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00075643	0.03761955925924404
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.00075643	0.03761955925924404
LARYNGEAL ABDUCTOR PARALYSIS	0.00075643	0.03761955925924404
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.00075643	0.03761955925924404
OCULOAURICULOFRONTONASAL SYNDROME	0.00075643	0.03761955925924404
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00075643	0.03761955925924404
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.00075643	0.03761955925924404
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.00075643	0.03761955925924404
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.03761955925924404
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.00075643	0.03761955925924404
HYPERREFLEXIA	0.00075643	0.03761955925924404
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00075643	0.03761955925924404
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00075643	0.03761955925924404
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.00075643	0.03761955925924404
CYCLIC VOMITING SYNDROME	0.00075643	0.03761955925924404
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.00075643	0.03761955925924404
GAUCHER DISEASE, PERINATAL LETHAL	0.00075643	0.03761955925924404
PAINE SYNDROME	0.00075643	0.03761955925924404
OROFACIODIGITAL SYNDROME I; OFD1	0.00075643	0.03761955925924404
DIABETIC EMBRYOPATHY	0.00075643	0.03761955925924404
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00075643	0.03761955925924404
MICROPHTHALMIA, SYNDROMIC 1	0.00075643	0.03761955925924404
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00075643	0.03761955925924404
MOWAT-WILSON SYNDROME	0.00075643	0.03761955925924404
FETAL METHYLMERCURY SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00075643	0.03761955925924404
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00075643	0.03761955925924404
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00075643	0.03761955925924404
1Q21.1 RECURRENT MICRODELETION (SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00075643	0.03761955925924404
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00075643	0.03761955925924404
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.00075643	0.03761955925924404
ANGELMAN SYNDROME	0.00075643	0.03761955925924404
RENPENNING SYNDROME 1; RENS1	0.00075643	0.03761955925924404
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.00075643	0.03761955925924404
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00075643	0.03761955925924404
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00075643	0.03761955925924404
SEVERE COMBINED IMMUNODEFICIENCY	0.00075643	0.03761955925924404
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00075643	0.03761955925924404
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00075643	0.03761955925924404
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00075643	0.03761955925924404
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00075643	0.03761955925924404
INCONTINENTIA PIGMENTI; IP	0.00075643	0.03761955925924404
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.00075643	0.03761955925924404
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00075643	0.03761955925924404
WARBURG MICRO SYNDROME 1	0.00075643	0.03761955925924404
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00075643	0.03761955925924404
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00075643	0.03761955925924404
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00075643	0.03761955925924404
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00075643	0.03761955925924404
601453 TRICHODENTAL DYSPLASIA	0.00075643	0.03761955925924404
GENITOPALATOCARDIAC SYNDROME	0.00075643	0.03761955925924404
NEVUS COMEDONICUS SYNDROME	0.00075643	0.03761955925924404
CRI DU CHAT SYNDROME (5P DELETION)	0.00075643	0.03761955925924404
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.00075643	0.03761955925924404
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00075643	0.03761955925924404
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.00075643	0.03761955925924404
MILLER-DIEKER SYNDROME (MDS)	0.00075643	0.03761955925924404
SCHISIS ASSOCIATION	0.00075643	0.03761955925924404
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00075643	0.03761955925924404
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00075643	0.03761955925924404
FRASER SYNDROME	0.00075643	0.03761955925924404
HARROD SYNDROME	0.00075643	0.03761955925924404
PRIMARY CUTIS VERTICIS GYRATA	0.00075643	0.03761955925924404
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00075643	0.03761955925924404
PELIZAEUS-MERZBACHER DISEASE	0.00075643	0.03761955925924404
ANGELMAN SYNDROME (TYPE 1)	0.00075643	0.03761955925924404
MUCOLIPIDOSIS TYPE IV	0.00075643	0.03761955925924404
9Q SUBTELOMERIC DELETION SYNDROME	0.00075643	0.03761955925924404
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.00075643	0.03761955925924404
ANGELMAN SYNDROME (TYPE 2)	0.00075643	0.03761955925924404
MICROPHTHALMIA, LENZ TYPE	0.00075643	0.03761955925924404
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00075643	0.03761955925924404
MECKEL SYNDROME	0.00075643	0.03761955925924404
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00075643	0.03761955925924404
LATHOSTEROLOSIS	0.00075643	0.03761955925924404
HALLERMANN-STREIFF SYNDROME	0.00075643	0.03761955925924404
DIAMOND-BLACKFAN ANEMIA 1	0.00075643	0.03761955925924404
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00075643	0.03761955925924404
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.00075643	0.03761955925924404
NON-DISTAL TRISOMY 13Q	0.00075643	0.03761955925924404
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.00075643	0.03761955925924404
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00075643	0.03761955925924404
CORNELIA DE LANGE SYNDROME 1	0.00075643	0.03761955925924404
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00075643	0.03761955925924404
PRIMARY PULMONARY HYPOPLASIA	0.00075643	0.03761955925924404
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00075643	0.03761955925924404
FRONTONASAL DYSPLASIA 2; FND2	0.00075643	0.03761955925924404
TRISOMY 18P	0.00075643	0.03761955925924404
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00075643	0.03761955925924404
DISTAL TRISOMY 15Q	0.00075643	0.03761955925924404
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00075643	0.03761955925924404
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.00075643	0.03761955925924404
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00075643	0.03761955925924404
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00075643	0.03761955925924404
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.03761955925924404
TRISOMY 4P	0.00075643	0.03761955925924404
SECKEL SYNDROME 4	0.00075643	0.03761955925924404
PAGOD SYNDROME	0.00075643	0.03761955925924404
NON-DISTAL TRISOMY 10Q	0.00075643	0.03761955925924404
CERNUNNOS-XLF DEFICIENCY	0.00075643	0.03761955925924404
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.00075643	0.03761955925924404
SECKEL SYNDROME 5; SCKL5	0.00075643	0.03761955925924404
2Q23.1 MICRODELETION SYNDROME	0.00075643	0.03761955925924404
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00075643	0.03761955925924404
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00075643	0.03761955925924404
5Q35 MICRODUPLICATION SYNDROME	0.00075643	0.03761955925924404
ISOLATED OSTEOPOIKILOSIS	0.00075643	0.03761955925924404
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00075643	0.03761955925924404
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.00075643	0.03761955925924404
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00075643	0.03761955925924404
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.00075643	0.03761955925924404
FACIOCARDIOMELIC SYNDROME	0.00075643	0.03761955925924404
FOCAL DERMAL HYPOPLASIA; FDH	0.00075643	0.03761955925924404
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.00075643	0.03761955925924404
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00075643	0.03761955925924404
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00075643	0.03761955925924404
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.00075643	0.03761955925924404
KLEEFSTRA SYNDROME	0.00075643	0.03761955925924404
LOWRY-WOOD SYNDROME	0.00075643	0.03761955925924404
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00075643	0.03761955925924404
DYSOSTOSIS, STANESCU TYPE	0.00075643	0.03761955925924404
COFFIN-LOWRY SYNDROME; CLS	0.00075643	0.03761955925924404
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00075643	0.03761955925924404
MASA SYNDROME	0.00075643	0.03761955925924404
PITT-HOPKINS SYNDROME	0.00075643	0.03761955925924404
XFE PROGEROID SYNDROME; XFEPS	0.00075643	0.03761955925924404
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00075643	0.03761955925924404
9Q33.3Q34.11 MICRODELETION SYNDROME	0.00075643	0.03761955925924404
MECKEL SYNDROME, TYPE 4; MKS4	0.00075643	0.03761955925924404
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.00075643	0.03761955925924404
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00075643	0.03761955925924404
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00075643	0.03761955925924404
LISSENCEPHALY 3; LIS3	0.00075643	0.03761955925924404
BRANCHIOOCULOFACIAL SYNDROME	0.00075643	0.03761955925924404
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00075643	0.03761955925924404
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00075643	0.03761955925924404
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.00075643	0.03761955925924404
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00075643	0.03761955925924404
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00075643	0.03761955925924404
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00075643	0.03761955925924404
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.00075643	0.03761955925924404
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00075643	0.03761955925924404
RETT SYNDROME	0.00075643	0.03761955925924404
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.00075643	0.03761955925924404
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00075643	0.03761955925924404
WOLF-HIRSCHHORN SYNDROME	0.00075643	0.03761955925924404
NEU-LAXOVA SYNDROME 2; NLS2	0.00075643	0.03761955925924404
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00075643	0.03761955925924404
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00075643	0.03761955925924404
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.00075643	0.03761955925924404
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00075643	0.03761955925924404
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00075643	0.03761955925924404
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00075643	0.03761955925924404
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00075643	0.03761955925924404
LAMBOTTE SYNDROME	0.00075643	0.03761955925924404
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.00075643	0.03761955925924404
ERYTHROKERATODERMIA VARIABILIS	0.00075643	0.03761955925924404
CONGENITAL RUBELLA SYNDROME	0.00075643	0.03761955925924404
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.00075643	0.03761955925924404
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00075643	0.03761955925924404
POLAND SYNDROME	0.00075643	0.03761955925924404
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00075643	0.03761955925924404
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00075643	0.03761955925924404
OROFACIODIGITAL SYNDROME TYPE 5	0.00075643	0.03761955925924404
OLIVER SYNDROME	0.00075643	0.03761955925924404
VELOCARDIOFACIAL SYNDROME	0.00075643	0.03761955925924404
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00075643	0.03761955925924404
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00075643	0.03761955925924404
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00075643	0.03761955925924404
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.00075643	0.03761955925924404
BARDET-BIEDL SYNDROME 20	0.00075643	0.03761955925924404
STIMMLER SYNDROME	0.00075643	0.03761955925924404
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00075643	0.03761955925924404
WAARDENBURG SYNDROME TYPE 3	0.00075643	0.03761955925924404
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00075643	0.03761955925924404
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.03761955925924404
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.00075643	0.03761955925924404
FAMILIAL VISCERAL MYOPATHY	0.00075643	0.03761955925924404
BLOOM SYNDROME	0.00075643	0.03761955925924404
HUMERO-RADIAL SYNOSTOSIS	0.00075643	0.03761955925924404
PIEBALDISM	0.00075643	0.03761955925924404
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00075643	0.03761955925924404
SUPRABULBAR PARESIS, CONGENITAL	0.00075643	0.03761955925924404
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.00075643	0.03761955925924404
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.00075643	0.03761955925924404
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00075643	0.03761955925924404
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00075643	0.03761955925924404
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.00075643	0.03761955925924404
RENPENNING SYNDROME	0.00075643	0.03761955925924404
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00075643	0.03761955925924404
MARDEN-WALKER SYNDROME	0.00075643	0.03761955925924404
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.03761955925924404
BANGSTAD SYNDROME	0.00075643	0.03761955925924404
ENCEPHALOMALACIA, MULTILOCULAR	0.00075643	0.03761955925924404
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.00075643	0.03761955925924404
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00075643	0.03761955925924404
WAGR SYNDROME	0.00075643	0.03761955925924404
JOHANSON-BLIZZARD SYNDROME; JBS	0.00075643	0.03761955925924404
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.00075643	0.03761955925924404
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.00075643	0.03761955925924404
STROMME SYNDROME; STROMS	0.00075643	0.03761955925924404
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00075643	0.03761955925924404
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.00075643	0.03761955925924404
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.00075643	0.03761955925924404
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00075643	0.03761955925924404
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00075643	0.03761955925924404
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00075643	0.03761955925924404
HALLERMANN-STREIFF SYNDROME; HSS	0.00075643	0.03761955925924404
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00075643	0.03761955925924404
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00075643	0.03761955925924404
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.00075643	0.03761955925924404
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.03761955925924404
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00075643	0.03761955925924404
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00075643	0.03761955925924404
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.00075643	0.03761955925924404
XERODERMA PIGMENTOSUM	0.00075643	0.03761955925924404
NEU-LAXOVA SYNDROME	0.00075643	0.03761955925924404
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00075643	0.03761955925924404
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00075643	0.03761955925924404
MOWAT-WILSON SYNDROME; MOWS	0.00075643	0.03761955925924404
SECKEL SYNDROME 1; SCKL1	0.00075643	0.03761955925924404
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00075643	0.03761955925924404
RENAL TUBULAR DYSGENESIS	0.00075643	0.03761955925924404
PSEUDOPROGERIA SYNDROME	0.00075643	0.03761955925924404
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00075643	0.03761955925924404
SECKEL SYNDROME 10; SCKL10	0.00075643	0.03761955925924404
ADDUCTED THUMBS SYNDROME	0.00075643	0.03761955925924404
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.00075643	0.03761955925924404
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.03761955925924404
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.03761955925924404
FANCONI ANEMIA	0.00075643	0.03761955925924404
KLIPPEL-TRÃ‰NAUNAY SYNDROME	0.00075643	0.03761955925924404
MEIER-GORLIN SYNDROME 8; MGORS8	0.00075643	0.03761955925924404
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.00075643	0.03761955925924404
20P13 MICRODELETION SYNDROME	0.00075643	0.03761955925924404
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00075643	0.03761955925924404
SATOYOSHI SYNDROME	0.00075643	0.03761955925924404
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00075643	0.03761955925924404
LEUKOCYTE ADHESION DEFICIENCY	0.00075643	0.03761955925924404
GERODERMA OSTEODYSPLASTICUM; GO	0.00075643	0.03761955925924404
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00075643	0.03761955925924404
207790 ARACHNOID CYSTS, INTRACRANIAL	0.00075643	0.03761955925924404
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00075643	0.03761955925924404
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00075643	0.03761955925924404
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00075643	0.03761955925924404
RHIZOMELIC SYNDROME, URBACH TYPE	0.00075643	0.03761955925924404
ACROOTOOCULAR SYNDROME	0.00075643	0.03761955925924404
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00075643	0.03761955925924404
TRIPLE A SYNDROME	0.00075643	0.03761955925924404
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00075643	0.03761955925924404
OCULODENTODIGITAL DYSPLASIA; ODDD	0.00075643	0.03761955925924404
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00075643	0.03761955925924404
BOWEN-CONRADI SYNDROME	0.00075643	0.03761955925924404
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00075643	0.03761955925924404
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00075643	0.03761955925924404
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.00075643	0.03761955925924404
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00075643	0.03761955925924404
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00075643	0.03761955925924404
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.03761955925924404
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00075643	0.03761955925924404
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.00075643	0.03761955925924404
XK APROSENCEPHALY SYNDROME	0.00075643	0.03761955925924404
WORSTER-DROUGHT SYNDROME	0.00075643	0.03761955925924404
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00075643	0.03761955925924404
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00075643	0.03761955925924404
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00075643	0.03761955925924404
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.00075643	0.03761955925924404
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.03761955925924404
ANONYCHIA-MICROCEPHALY SYNDROME	0.00075643	0.03761955925924404
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.03761955925924404
WEAVER-WILLIAMS SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO ZNF335 DEFICIENCY	0.00075643	0.03761955925924404
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00075643	0.03761955925924404
MMEP SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.00075643	0.03761955925924404
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.00075643	0.03761955925924404
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.00075643	0.03761955925924404
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00075643	0.03761955925924404
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00075643	0.03761955925924404
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.00075643	0.03761955925924404
3MC SYNDROME 1	0.00075643	0.03761955925924404
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.00075643	0.03761955925924404
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00075643	0.03761955925924404
BONNEMANN-MEINECKE-REICH SYNDROME	0.00075643	0.03761955925924404
BLOOM SYNDROME	0.00075643	0.03761955925924404
OCULOPALATOCEREBRAL SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00075643	0.03761955925924404
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.00075643	0.03761955925924404
MICROFORM HOLOPROSENCEPHALY	0.00075643	0.03761955925924404
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00075643	0.03761955925924404
ACROCRANIOFACIAL DYSOSTOSIS	0.00075643	0.03761955925924404
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00075643	0.03761955925924404
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00075643	0.03761955925924404
BARTSOCAS-PAPAS SYNDROME	0.00075643	0.03761955925924404
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.00075643	0.03761955925924404
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00075643	0.03761955925924404
MECKEL SYNDROME 12; MKS12	0.00075643	0.03761955925924404
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.00075643	0.03761955925924404
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00075643	0.03761955925924404
ATAXIA-PANCYTOPENIA SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00075643	0.03761955925924404
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00075643	0.03761955925924404
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00075643	0.03761955925924404
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.00075643	0.03761955925924404
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00075643	0.03761955925924404
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.00075643	0.03761955925924404
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00075643	0.03761955925924404
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00075643	0.03761955925924404
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00075643	0.03761955925924404
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00075643	0.03761955925924404
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.03761955925924404
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY-CARDIOMYOPATHY	0.00075643	0.03761955925924404
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00075643	0.03761955925924404
TETRASOMY 18P	0.00075643	0.03761955925924404
MOYNAHAN SYNDROME	0.00075643	0.03761955925924404
TETRAPLOIDY	0.00075643	0.03761955925924404
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00075643	0.03761955925924404
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00075643	0.03761955925924404
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.03761955925924404
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00075643	0.03761955925924404
RUVALCABA SYNDROME	0.00075643	0.03761955925924404
COFFIN-SIRIS SYNDROME 10; CSS10	0.00075643	0.03761955925924404
RENIER-GABREELS-JASPER SYNDROME	0.00075643	0.03761955925924404
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.00075643	0.03761955925924404
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00075643	0.03761955925924404
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00075643	0.03761955925924404
FEINGOLD SYNDROME 1; FGLDS1	0.00075643	0.03761955925924404
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00075643	0.03761955925924404
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000545554	0.02713205588371379
GRISCELLI SYNDROME, TYPE 1	0.000545554	0.02713205588371379
THYROID ECTOPIA	0.000545554	0.02713205588371379
AARSKOG-SCOTT SYNDROME	0.000545554	0.02713205588371379
HARTNUP DISORDER	0.000545554	0.02713205588371379
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.02713205588371379
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.02713205588371379
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.02713205588371379
PETTIGREW SYNDROME	0.000545554	0.02713205588371379
WOLMAN DISEASE	0.000545554	0.02713205588371379
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000545554	0.02713205588371379
THYROID HYPOPLASIA	0.000545554	0.02713205588371379
CODAS SYNDROME	0.000545554	0.02713205588371379
PFEIFFER SYNDROME TYPE 2	0.000545554	0.02713205588371379
PALLISTER-HALL SYNDROME	0.000545554	0.02713205588371379
FG SYNDROME TYPE 1	0.000545554	0.02713205588371379
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.02713205588371379
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000545554	0.02713205588371379
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.02713205588371379
THYROID HEMIAGENESIS	0.000545554	0.02713205588371379
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.02713205588371379
POTOCKI-SHAFFER SYNDROME	0.000545554	0.02713205588371379
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.02713205588371379
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.02713205588371379
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000545554	0.02713205588371379
ELSAHY-WATERS SYNDROME; ESWS	0.000545554	0.02713205588371379
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.02713205588371379
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.02713205588371379
TEMTAMY SYNDROME; TEMTYS	0.000545554	0.02713205588371379
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000545554	0.02713205588371379
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.02713205588371379
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.02713205588371379
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000545554	0.02713205588371379
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.02713205588371379
8P23.1 DUPLICATION SYNDROME	0.000545554	0.02713205588371379
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000545554	0.02713205588371379
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.02713205588371379
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02713205588371379
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.02713205588371379
COACH SYNDROME	0.000545554	0.02713205588371379
PERMANENT NEONATAL DIABETES MELLITUS	0.000545554	0.02713205588371379
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.02713205588371379
MENTAL RETARDATION, X-LINKED 9	0.000545554	0.02713205588371379
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.02713205588371379
TARP SYNDROME; TARPS	0.000545554	0.02713205588371379
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.02713205588371379
TRANSIENT NEONATAL DIABETES MELLITUS	0.000545554	0.02713205588371379
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.02713205588371379
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000545554	0.02713205588371379
CRANIOFRONTONASAL SYNDROME; CFNS	0.000545554	0.02713205588371379
DISTAL MONOSOMY 6P	0.000545554	0.02713205588371379
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000545554	0.02713205588371379
OROFACIODIGITAL SYNDROME VI	0.000545554	0.02713205588371379
WAARDENBURG-SHAH SYNDROME	0.000545554	0.02713205588371379
WEAVER SYNDROME	0.000545554	0.02713205588371379
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000545554	0.02713205588371379
PRADER-WILLI SYNDROME; PWS	0.000545554	0.02713205588371379
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.02713205588371379
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.000545554	0.02713205588371379
CURRARINO SYNDROME	0.000545554	0.02713205588371379
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000545554	0.02713205588371379
RAYNAUD-CLAES SYNDROME; MRXSRC	0.000545554	0.02713205588371379
FRIED SYNDROME	0.000545554	0.02713205588371379
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.02713205588371379
TREACHER-COLLINS SYNDROME	0.000545554	0.02713205588371379
ALG6-CDG	0.000545554	0.02713205588371379
MENTAL RETARDATION, X-LINKED 72	0.000545554	0.02713205588371379
PALLISTER-HALL SYNDROME	0.000545554	0.02713205588371379
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.02713205588371379
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.000545554	0.02713205588371379
SEPTOOPTIC DYSPLASIA	0.000545554	0.02713205588371379
MYOCLONIC EPILEPSY OF INFANCY	0.000545554	0.02713205588371379
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000545554	0.02713205588371379
RIGID SPINE SYNDROME	0.000545554	0.02713205588371379
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000545554	0.02713205588371379
CHAR SYNDROME	0.000545554	0.02713205588371379
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.02713205588371379
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.02713205588371379
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.02713205588371379
OROTIC ACIDURIA	0.000545554	0.02713205588371379
TAY-SACHS DISEASE	0.000545554	0.02713205588371379
CHROMOSOME 9P DELETION SYNDROME	0.000545554	0.02713205588371379
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.02713205588371379
PELLAGRA-LIKE SYNDROME	0.000545554	0.02713205588371379
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.02713205588371379
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.02713205588371379
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.02713205588371379
JOUBERT SYNDROME 1	0.000545554	0.02713205588371379
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000545554	0.02713205588371379
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.02713205588371379
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000545554	0.02713205588371379
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000545554	0.02713205588371379
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.02713205588371379
KEUTEL SYNDROME	0.000545554	0.02713205588371379
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000545554	0.02713205588371379
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.02713205588371379
ELEJALDE DISEASE	0.000545554	0.02713205588371379
INFANTILE SIALIC ACID STORAGE DISEASE	0.000545554	0.02713205588371379
SCHIZENCEPHALY	0.000545554	0.02713205588371379
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.02713205588371379
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.02713205588371379
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.02713205588371379
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.02713205588371379
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.02713205588371379
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.000545554	0.02713205588371379
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000545554	0.02713205588371379
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.02713205588371379
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.02713205588371379
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000545554	0.02713205588371379
MEND SYNDROME; MEND	0.000545554	0.02713205588371379
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.000545554	0.02713205588371379
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.02713205588371379
XQ25 DUPLICATION SYNDROME	0.000545554	0.02713205588371379
MENTAL RETARDATION, X-LINKED 103	0.000545554	0.02713205588371379
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.02713205588371379
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.000545554	0.02713205588371379
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000545554	0.02713205588371379
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.02713205588371379
RECOMBINANT 8 SYNDROME	0.000545554	0.02713205588371379
ARIMA SYNDROME	0.000545554	0.02713205588371379
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.02713205588371379
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.02713205588371379
INFANTILE REFSUM DISEASE	0.000545554	0.02713205588371379
SHUKLA-VERNON SYNDROME; SHUVER	0.000545554	0.02713205588371379
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.02713205588371379
HYPERPROLINEMIA, TYPE I	0.000545554	0.02713205588371379
AUSTRALIA ANTIGEN	0.000545554	0.02713205588371379
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000545554	0.02713205588371379
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.02713205588371379
DISTAL MONOSOMY 19P13.3	0.000545554	0.02713205588371379
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000545554	0.02713205588371379
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.02713205588371379
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.02713205588371379
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.02713205588371379
MENTAL RETARDATION, X-LINKED 41	0.000545554	0.02713205588371379
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000545554	0.02713205588371379
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.02713205588371379
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.000545554	0.02713205588371379
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.02713205588371379
ZEBRA BODY MYOPATHY	0.000545554	0.02713205588371379
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.000545554	0.02713205588371379
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.02713205588371379
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.02713205588371379
LANDAU-KLEFFNER SYNDROME	0.000545554	0.02713205588371379
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.02713205588371379
HEREDITARY FOLATE MALABSORPTION	0.000545554	0.02713205588371379
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02713205588371379
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.000545554	0.02713205588371379
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.02713205588371379
MENTAL RETARDATION, X-LINKED 90	0.000545554	0.02713205588371379
MENTAL RETARDATION, X-LINKED 88	0.000545554	0.02713205588371379
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.02713205588371379
KETOADIPICACIDURIA	0.000545554	0.02713205588371379
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.02713205588371379
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.02713205588371379
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.02713205588371379
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.02713205588371379
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000545554	0.02713205588371379
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.02713205588371379
3MC SYNDROME 2	0.000545554	0.02713205588371379
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.02713205588371379
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000545554	0.02713205588371379
LEBER CONGENITAL AMAUROSIS	0.000545554	0.02713205588371379
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.02713205588371379
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.02713205588371379
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.02713205588371379
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.02713205588371379
TARP SYNDROME	0.000545554	0.02713205588371379
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.02713205588371379
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.02713205588371379
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.02713205588371379
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000545554	0.02713205588371379
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000545554	0.02713205588371379
JOUBERT SYNDROME 30; JBTS30	0.000545554	0.02713205588371379
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02713205588371379
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.02713205588371379
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000545554	0.02713205588371379
1P21.3 MICRODELETION SYNDROME	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000545554	0.02713205588371379
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.02713205588371379
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.02713205588371379
MECKEL SYNDROME 13; MKS13	0.000545554	0.02713205588371379
COHEN-GIBSON SYNDROME; COGIS	0.000545554	0.02713205588371379
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.02713205588371379
PERLMAN SYNDROME	0.000545554	0.02713205588371379
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000545554	0.02713205588371379
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.02713205588371379
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.000545554	0.02713205588371379
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.02713205588371379
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.02713205588371379
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.02713205588371379
LATERAL MENINGOCELE SYNDROME	0.000545554	0.02713205588371379
OTOFACIOCERVICAL SYNDROME	0.000545554	0.02713205588371379
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000545554	0.02713205588371379
HYPEREKPLEXIA 4; HKPX4	0.000545554	0.02713205588371379
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.02713205588371379
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.02713205588371379
W SYNDROME	0.000545554	0.02713205588371379
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.02713205588371379
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000545554	0.02713205588371379
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000545554	0.02713205588371379
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.02713205588371379
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.02713205588371379
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.02713205588371379
RAHMAN SYNDROME	0.000545554	0.02713205588371379
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000545554	0.02713205588371379
HEREDITARY OROTIC ACIDURIA	0.000545554	0.02713205588371379
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.02713205588371379
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.02713205588371379
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000545554	0.02713205588371379
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.02713205588371379
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.02713205588371379
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.02713205588371379
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000545554	0.02713205588371379
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000545554	0.02713205588371379
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.02713205588371379
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.02713205588371379
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.02713205588371379
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.02713205588371379
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.02713205588371379
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.02713205588371379
LUSCAN-LUMISH SYNDROME; LLS	0.000545554	0.02713205588371379
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.02713205588371379
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.02713205588371379
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000545554	0.02713205588371379
SIALURIA	0.000545554	0.02713205588371379
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.02713205588371379
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.02713205588371379
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.02713205588371379
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.02713205588371379
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.02713205588371379
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000545554	0.02713205588371379
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.02713205588371379
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.000545554	0.02713205588371379
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.02713205588371379
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.000545554	0.02713205588371379
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.000545554	0.02713205588371379
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.000545554	0.02713205588371379
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.02713205588371379
2Q23.1 MICRODUPLICATION SYNDROME	0.000545554	0.02713205588371379
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000545554	0.02713205588371379
JOUBERT SYNDROME 28	0.000545554	0.02713205588371379
JOUBERT SYNDROME 27	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000545554	0.02713205588371379
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.02713205588371379
SEVERE CANAVAN DISEASE	0.000545554	0.02713205588371379
SENIOR-LOKEN SYNDROME	0.000545554	0.02713205588371379
OGDEN SYNDROME	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.000545554	0.02713205588371379
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.02713205588371379
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.02713205588371379
ICF SYNDROME	0.000545554	0.02713205588371379
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02713205588371379
MOSAIC TRISOMY 14	0.000545554	0.02713205588371379
TRISOMY 12P	0.000545554	0.02713205588371379
8Q12 MICRODUPLICATION SYNDROME	0.000545554	0.02713205588371379
DEXTROCARDIA	0.000545554	0.02713205588371379
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.02713205588371379
DISTAL MONOSOMY 9P	0.000545554	0.02713205588371379
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000545554	0.02713205588371379
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.000545554	0.02713205588371379
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.000545554	0.02713205588371379
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.02713205588371379
USHER SYNDROME TYPE 1	0.000545554	0.02713205588371379
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.000545554	0.02713205588371379
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.02713205588371379
15Q11Q13 MICRODUPLICATION SYNDROME	0.000545554	0.02713205588371379
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.02713205588371379
MULTIPLE CARBOXYLASE DEFICIENCY	0.000545554	0.02713205588371379
CODAS SYNDROME	0.000545554	0.02713205588371379
CINCA SYNDROME	0.000545554	0.02713205588371379
XQ21 MICRODELETION SYNDROME	0.000545554	0.02713205588371379
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.000545554	0.02713205588371379
DISTAL TRISOMY 18Q	0.000545554	0.02713205588371379
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02713205588371379
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.000545554	0.02713205588371379
EARLY MYOCLONIC ENCEPHALOPATHY	0.000545554	0.02713205588371379
GERMAN SYNDROME	0.000545554	0.02713205588371379
GERODERMA OSTEODYSPLASTICA	0.000545554	0.02713205588371379
OPTIC PATHWAY GLIOMA	0.000545554	0.02713205588371379
COLE-CARPENTER SYNDROME	0.000545554	0.02713205588371379
FOIX-CHAVANY-MARIE SYNDROME	0.000545554	0.02713205588371379
COWDEN SYNDROME	0.000545554	0.02713205588371379
EAST SYNDROME	0.000545554	0.02713205588371379
OCCIPITAL HORN SYNDROME	0.000545554	0.02713205588371379
HARTNUP DISEASE	0.000545554	0.02713205588371379
MYOCLONIC-ASTASTIC EPILEPSY	0.000545554	0.02713205588371379
HERNÃNDEZ-AGUIRRE NEGRETE SYNDROME	0.000545554	0.02713205588371379
DISTAL TRISOMY 6P	0.000545554	0.02713205588371379
DONNAI-BARROW SYNDROME	0.000545554	0.02713205588371379
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000545554	0.02713205588371379
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.02713205588371379
ZECHI-CEIDE SYNDROME	0.000545554	0.02713205588371379
ACROMELIC FRONTONASAL DYSPLASIA	0.000545554	0.02713205588371379
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.02713205588371379
TEMTAMY SYNDROME	0.000545554	0.02713205588371379
DYSKERATOSIS CONGENITA	0.000545554	0.02713205588371379
TRISOMY 8Q	0.000545554	0.02713205588371379
PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.02713205588371379
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.02713205588371379
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000545554	0.02713205588371379
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.02713205588371379
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000545554	0.02713205588371379
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000545554	0.02713205588371379
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.02713205588371379
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.02713205588371379
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.000545554	0.02713205588371379
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000545554	0.02713205588371379
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.02713205588371379
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.000545554	0.02713205588371379
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.02713205588371379
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000545554	0.02713205588371379
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.02713205588371379
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.02713205588371379
20P12.3 MICRODELETION SYNDROME	0.000545554	0.02713205588371379
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.02713205588371379
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000545554	0.02713205588371379
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.02713205588371379
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000545554	0.02713205588371379
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.000545554	0.02713205588371379
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.000545554	0.02713205588371379
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.02713205588371379
OPITZ G/BBB SYNDROME	0.000545554	0.02713205588371379
OROFACIODIGITAL SYNDROME TYPE 2	0.000545554	0.02713205588371379
L1 SYNDROME	0.000545554	0.02713205588371379
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000545554	0.02713205588371379
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.02713205588371379
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02713205588371379
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.02713205588371379
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.02713205588371379
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.000545554	0.02713205588371379
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.02713205588371379
AYMÃ‰-GRIPP SYNDROME	0.000545554	0.02713205588371379
1Q21.1 MICRODUPLICATION SYNDROME	0.000545554	0.02713205588371379
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.02713205588371379
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.02713205588371379
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.02713205588371379
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.000545554	0.02713205588371379
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.02713205588371379
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000545554	0.02713205588371379
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.000545554	0.02713205588371379
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000545554	0.02713205588371379
NOONAN SYNDROME 11; NS11	0.000545554	0.02713205588371379
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.000545554	0.02713205588371379
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.02713205588371379
N SYNDROME	0.000545554	0.02713205588371379
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000545554	0.02713205588371379
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000545554	0.02713205588371379
DISTAL 16P11.2 MICRODELETION SYNDROME	0.000545554	0.02713205588371379
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.02713205588371379
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000545554	0.02713205588371379
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.02713205588371379
LAMB-SHAFFER SYNDROME	0.000545554	0.02713205588371379
JOUBERT SYNDROME 7	0.000545554	0.02713205588371379
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.02713205588371379
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.02713205588371379
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.000545554	0.02713205588371379
JOUBERT SYNDROME 8	0.000545554	0.02713205588371379
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.02713205588371379
611961 STEVENSON-CAREY SYNDROME	0.000545554	0.02713205588371379
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.02713205588371379
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.02713205588371379
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000545554	0.02713205588371379
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.02713205588371379
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.02713205588371379
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02713205588371379
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.000545554	0.02713205588371379
HOLOPROSENCEPHALY 7	0.000545554	0.02713205588371379
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000545554	0.02713205588371379
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.02713205588371379
JOUBERT SYNDROME 6	0.000545554	0.02713205588371379
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.000545554	0.02713205588371379
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.000545554	0.02713205588371379
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000545554	0.02713205588371379
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.000545554	0.02713205588371379
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.02713205588371379
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.02713205588371379
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000545554	0.02713205588371379
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000545554	0.02713205588371379
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000545554	0.02713205588371379
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.000545554	0.02713205588371379
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.02713205588371379
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000545554	0.02713205588371379
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.02713205588371379
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000545554	0.02713205588371379
INCONTINENTIA PIGMENTI	0.000545554	0.02713205588371379
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000545554	0.02713205588371379
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.02713205588371379
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.02713205588371379
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.02713205588371379
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.02713205588371379
CHAR SYNDROME	0.000545554	0.02713205588371379
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.02713205588371379
NOONAN SYNDROME 6; NS6	0.000545554	0.02713205588371379
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.000545554	0.02713205588371379
GABA-TRANSAMINASE DEFICIENCY	0.000545554	0.02713205588371379
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.000545554	0.02713205588371379
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000545554	0.02713205588371379
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.02713205588371379
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000545554	0.02713205588371379
NOONAN SYNDROME 3; NS3	0.000545554	0.02713205588371379
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.000545554	0.02713205588371379
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.02713205588371379
ALPHA-MANNOSIDOSIS	0.000545554	0.02713205588371379
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000545554	0.02713205588371379
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.02713205588371379
PHACE ASSOCIATION	0.000545554	0.02713205588371379
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.000545554	0.02713205588371379
MUCOPOLYSACCHARIDOSIS TYPE 2	0.000545554	0.02713205588371379
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.02713205588371379
FRONTOOCULAR SYNDROME	0.000545554	0.02713205588371379
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.02713205588371379
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.02713205588371379
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.02713205588371379
NOONAN SYNDROME 2; NS2	0.000545554	0.02713205588371379
HURLER SYNDROME	0.000545554	0.02713205588371379
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.02713205588371379
WIEDEMANN-STEINER SYNDROME; WDSTS	0.000545554	0.02713205588371379
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000545554	0.02713205588371379
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.02713205588371379
NARP SYNDROME	0.000545554	0.02713205588371379
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000545554	0.02713205588371379
CDAGS SYNDROME	0.000545554	0.02713205588371379
MUENKE SYNDROME	0.000545554	0.02713205588371379
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.02713205588371379
GRACILE BONE DYSPLASIA; GCLEB	0.000545554	0.02713205588371379
ATELOSTEOGENESIS TYPE III	0.000545554	0.02713205588371379
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.02713205588371379
FRIAS SYNDROME	0.000545554	0.02713205588371379
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000545554	0.02713205588371379
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.02713205588371379
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.02713205588371379
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000545554	0.02713205588371379
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.02713205588371379
SCHINDLER DISEASE, TYPE I	0.000545554	0.02713205588371379
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.02713205588371379
MAPLE SYRUP URINE DISEASE	0.000545554	0.02713205588371379
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000545554	0.02713205588371379
XQ25 MICRODUPLICATION SYNDROME	0.000545554	0.02713205588371379
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.02713205588371379
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000545554	0.02713205588371379
KAGAMI-OGATA SYNDROME	0.000545554	0.02713205588371379
JOUBERT SYNDROME 2	0.000545554	0.02713205588371379
DIAPHANOSPONDYLODYSOSTOSIS	0.000545554	0.02713205588371379
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.02713205588371379
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000545554	0.02713205588371379
WYBURN-MASON SYNDROME	0.000545554	0.02713205588371379
NIEMANN-PICK DISEASE, TYPE C2	0.000545554	0.02713205588371379
CRANIOPHARYNGIOMA	0.000545554	0.02713205588371379
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.02713205588371379
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000545554	0.02713205588371379
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000545554	0.02713205588371379
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.02713205588371379
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.000545554	0.02713205588371379
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.000545554	0.02713205588371379
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.02713205588371379
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.02713205588371379
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000545554	0.02713205588371379
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.02713205588371379
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.02713205588371379
CATEL-MANZKE SYNDROME; CATMANS	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000545554	0.02713205588371379
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000545554	0.02713205588371379
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000545554	0.02713205588371379
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.000545554	0.02713205588371379
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000545554	0.02713205588371379
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.02713205588371379
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.02713205588371379
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.02713205588371379
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.02713205588371379
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.02713205588371379
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000545554	0.02713205588371379
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.02713205588371379
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.000545554	0.02713205588371379
BARDET-BIEDL SYNDROME 2	0.000545554	0.02713205588371379
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000545554	0.02713205588371379
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.02713205588371379
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.02713205588371379
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.000545554	0.02713205588371379
JOUBERT SYNDROME 26	0.000545554	0.02713205588371379
JOUBERT SYNDROME 25	0.000545554	0.02713205588371379
TETRASOMY 5P	0.000545554	0.02713205588371379
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000545554	0.02713205588371379
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.02713205588371379
FARBER DISEASE	0.000545554	0.02713205588371379
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.02713205588371379
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.02713205588371379
JOUBERT SYNDROME 24	0.000545554	0.02713205588371379
SENIOR-LOKEN SYNDROME 9	0.000545554	0.02713205588371379
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.000545554	0.02713205588371379
NOONAN SYNDROME 9; NS9	0.000545554	0.02713205588371379
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000545554	0.02713205588371379
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.02713205588371379
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.02713205588371379
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.02713205588371379
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000545554	0.02713205588371379
FUCOSIDOSIS	0.000545554	0.02713205588371379
ISOLATED PLAGIOCEPHALY	0.000545554	0.02713205588371379
CHOPS SYNDROME; CHOPS	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000545554	0.02713205588371379
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000545554	0.02713205588371379
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.02713205588371379
DYSTONIA-APHONIA SYNDROME	0.000545554	0.02713205588371379
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000545554	0.02713205588371379
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.02713205588371379
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000545554	0.02713205588371379
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000545554	0.02713205588371379
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.02713205588371379
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.02713205588371379
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.000545554	0.02713205588371379
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.02713205588371379
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.000545554	0.02713205588371379
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.02713205588371379
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.02713205588371379
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000545554	0.02713205588371379
JOUBERT SYNDROME 15	0.000545554	0.02713205588371379
JOUBERT SYNDROME 14	0.000545554	0.02713205588371379
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.02713205588371379
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.02713205588371379
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.02713205588371379
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.02713205588371379
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.02713205588371379
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.02713205588371379
CULLER-JONES SYNDROME; CJS	0.000545554	0.02713205588371379
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000545554	0.02713205588371379
XIA-GIBBS SYNDROME	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.02713205588371379
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.02713205588371379
CHROMOSOME 5Q12 DELETION SYNDROME	0.000545554	0.02713205588371379
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000545554	0.02713205588371379
JOUBERT SYNDROME 21	0.000545554	0.02713205588371379
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000545554	0.02713205588371379
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.02713205588371379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000545554	0.02713205588371379
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.02713205588371379
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.000545554	0.02713205588371379
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000545554	0.02713205588371379
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.02713205588371379
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000545554	0.02713205588371379
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.02713205588371379
MEND SYNDROME	0.000545554	0.02713205588371379
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.02713205588371379
STEEL SYNDROME; STLS	0.000545554	0.02713205588371379
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.02713205588371379
